Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AC008687.1		ENSG00000267335			19	49022953-49036895	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"pancreas: 8.2;pituitary gland: 19.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 7.4;U-251 MG: 10.6"									HPA038925	Uncertain		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA038925: AB_2676272"																		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	8.2	0.0	19.9	0.5		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.9	0.2	0.1	0.2	0.0	1.9	0.0	0.0	0.1	0.3	0.1	1.2	0.0	0.3	0.0	0.3	1.1	0.0	0.0	0.6	0.2	0.9	0.0	0.9	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.0	0.2	0.5	0.2	0.0	0.0	0.1	0.2	1.2	0.2	0.0	0.0	0.0	0.7	0.2	0.1	0.4	0.1	0.5	0.0	0.2	0.4	0.0	2.7	2.3	0.7	10.6	0.5	2.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ACP7	"FLJ16165, PAPL, PAPL1"	ENSG00000183760	"Acid phosphatase 7, tartrate resistant (putative)"	Q6ZNF0	19	39083913-39111493	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.2;lymphoid tissue: 6.1;skin 1: 14.1;tongue: 5.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 21.5;U-87 MG: 28.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA042613	Uncertain				"Secreted - unknown location"	NA	NA					"HPA042613: AB_10963214"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.51e-5)"	"unprognostic (4.36e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.42e-1)"	0.3	0.3	1.6	0.3	5.5	0.3	1.0	15.2	5.4	0.9	0.3	4.2	0.3	0.4	0.4	1.4	1.1	0.3	0.9	0.3	2.5	1.2	0.3	0.3	0.4	0.3	6.5	0.7	0.3	0.3	0.3	0.0	0.3	5.2	1.2	0.3	0.0	0.6	0.3	0.3	14.1	0.3	0.3	4.1	0.3	0.6	0.4	5.3	0.0	0.3	5.5	6.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.5	0.3	3.2	0.0	0.0	0.0	21.5	0.2	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.9	0.7	0.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.5	15.2	5.4	2.5	1.2	6.5	0.7	5.2	5.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAM9	"CORD9, KIAA0021, MCMP, MDC9, Mltng"	ENSG00000168615	"ADAM metallopeptidase domain 9"	Q13443	8	38996869-39105144	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 140.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 11.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004000			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted - unknown location"	NA	NA		640000	Vesicles	"Endoplasmic reticulum"	"HPA004000: AB_1844584"	"prognostic unfavorable (1.14e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (5.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.80e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.23e-2)"	36.7	25.0	14.7	21.7	13.6	10.4	17.1	20.9	14.4	21.8	24.4	13.2	21.8	19.4	24.9	19.8	24.1	15.5	31.7	28.5	12.5	10.1	29.4	11.6	39.2	20.3	19.2	12.9	17.6	11.1	37.5	10.4	30.1	15.8	23.8	23.8	15.4	44.5	21.4	18.3	12.8	25.4	32.8	22.0	25.7	33.2	13.7	12.7	2.4	24.0	14.9	11.7	34.8	19.2	0.6	8.1	3.4	11.4	3.1	0.8	2.8	41.2	29.9	11.8	7.2	19.2	61.9	15.4	56.1	61.4	31.5	29.5	14.2	30.0	2.1	21.2	38.6	32.2	17.7	5.0	39.6	61.1	2.0	5.1	2.2	20.8	12.2	38.8	1.6	4.8	47.5	23.5	31.0	35.3	60.1	42.9	3.6	4.3	14.1	65.5	4.0	1.6	1.0	1.7	29.5	9.7	1.4	21.4	7.2	51.2	11.8	1.6	2.4	14.9	18.0	13.6	13.3	14.5	3.0	73.6	24.1	23.2	45.5	25.6	4.5	6.9	2.3	40.0	2.7	16.4	1.4	11.4	2.2	0.6	6.1	0.3	0.1	0.3	0.8	8.1	0.6	0.1	0.6	3.4	3.1	2.6	2.7	0.4	2.8	14.7	13.6	20.9	14.4	12.5	10.1	19.2	12.9	15.8	12.7	44.7	35.4	8.2	50.9	31.9	18.5	45.6	25.5	14.7	39.8	33.2	19.6	17.9	3.3	80.4	10.3	23.6	20.8	0.0	100.4	80.2	38.5	85.4	4.7	6.7	104.9	4.8	10.3	26.4	54.2	5.1	26.4	39.7	20.3	22.6	26.3	15.2	140.3	25.9	23.3	36.6	23.8	12.9	32.5	4.3	2.0	18.7	28.7	4.1	25.8	75.5
ADCK1	FLJ39600	ENSG00000063761	"AarF domain containing kinase 1"	Q86TW2	14	77800083-77935012	"Enzymes, Predicted secreted proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051012, HPA055014"	Uncertain		Uncertain	Nucleoplasm	"Secreted - unknown location"	NA	NA			Nucleoplasm		"HPA051012: AB_2681310, HPA055014: AB_2682672"	"unprognostic (6.36e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.70e-4)"	"prognostic favorable (4.11e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.82e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.57e-2)"	"unprognostic (4.06e-1)"	7.2	11.0	11.0	7.0	15.2	7.4	6.9	6.8	20.5	5.6	10.3	19.0	7.7	11.2	7.7	10.3	7.7	7.1	9.1	11.1	12.4	10.4	8.8	10.5	6.2	6.0	13.5	9.4	6.6	9.8	11.3	11.3	7.8	15.0	8.2	10.3	13.8	10.6	8.9	13.7	8.5	8.5	10.5	10.6	9.7	7.5	5.5	11.5	10.8	9.1	7.8	7.5	6.9	5.0	4.0	8.9	1.4	7.2	3.4	5.3	3.1	3.3	5.4	3.3	10.8	8.1	4.6	4.3	3.4	5.7	3.1	3.8	3.0	8.0	7.3	5.5	6.0	5.7	6.4	17.8	5.4	2.0	4.2	5.6	1.9	3.4	4.9	8.3	2.8	4.1	5.8	10.1	1.2	3.9	3.2	4.4	6.4	7.0	4.5	4.0	16.8	3.4	5.6	6.4	12.3	6.4	5.6	0.5	5.8	4.4	8.5	7.2	4.0	6.6	9.3	4.0	5.1	13.3	6.2	3.9	2.9	2.3	5.9	3.1	4.6	5.0	4.2	4.4	4.9	3.8	1.4	4.7	1.3	5.3	7.2	3.5	1.7	2.2	3.1	8.9	4.0	2.5	4.6	0.4	3.4	2.8	7.0	3.7	3.1	11.0	15.2	6.8	20.5	12.4	10.4	13.5	9.4	15.0	11.5	0.0	3.0	0.8	1.8	0.8	5.0	4.8	0.0	1.4	1.2	0.0	19.6	6.8	3.3	3.6	1.2	1.2	2.1	0.0	4.3	3.6	2.0	1.3	1.1	5.8	8.2	7.9	1.7	1.8	5.1	0.4	1.4	5.4	0.0	1.0	3.6	3.2	3.0	0.0	1.8	3.3	8.8	0.0	1.9	1.7	9.7	1.3	4.5	1.8	4.9	0.9
ADGRF1	"GPR110, hGPCR36, PGR19"	ENSG00000153292	"Adhesion G protein-coupled receptor F1"	Q5T601	6	46997703-47042363	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 27.4"	"Cell type enhanced"	"Detected in some"	24	"Collecting duct cells: 102.9;Pancreatic endocrine cells: 59.1;Urothelial cells: 305.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.6;CAPAN-2: 40.0;HaCaT: 8.9;PC-3: 13.0;RPTEC TERT1: 18.3;RT4: 45.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038438	Approved				"Secreted - unknown location"	NA	NA					"HPA038438: AB_10672645"	"unprognostic (4.83e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.95e-3)"	"unprognostic (3.02e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (1.35e-5)"	"unprognostic (7.41e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	6.5	6.1	0.0	3.7	0.1	1.3	4.2	15.7	0.8	10.0	0.0	0.0	0.0	27.4	0.1	5.4	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.6	0.0	7.5	0.2	0.0	3.2	1.9	0.1	0.1	5.5	2.1	0.1	0.1	1.5	1.3	0.0	0.0	11.3	5.6	12.3	16.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.7	0.0	0.0	8.9	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	13.0	0.0	0.0	0.0	18.3	45.7	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.9	0.0	12.6	0.0	0.0	0.4	15.3	26.8	25.0	102.9	0.0	0.0	19.9	25.6	0.0	0.0	0.0	0.0	16.7	0.0	0.0	30.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	59.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.4	305.8
ADM5	"AM5, C19orf76"	ENSG00000224420	"Adrenomedullin 5 (putative)"	C9JUS6	19	49688664-49690575	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 5.5;Early spermatids: 5.7;Melanocytes: 5.0;Suprabasal keratinocytes: 5.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.9"														"Secreted - unknown location"	NA	NA						"unprognostic (2.34e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.08e-3)"	"unprognostic (5.62e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.21e-11)"	"unprognostic (2.39e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.92e-3)"	"prognostic favorable (6.74e-4)"	5.5	0.9	1.0	1.8	1.2	3.2	4.2	2.6	1.5	1.8	1.1			2.2	3.1	1.0	2.0	3.9	1.8	0.7	0.7	1.0	1.5	0.7	3.5	2.7	1.0		1.4	1.0	0.4	1.7	2.2		2.6	0.6		1.6	1.1	2.4	6.5	1.6	2.3	0.9	5.0	1.1	1.6			1.5		2.0	1.3	2.1	0.6	0.2	0.0	0.3	0.0	1.1	0.0	3.0	5.1	3.0	2.1	0.1	0.0	3.6	0.3	0.2	1.0	0.5	5.9	2.8	4.6	1.1	0.2	0.2	0.9	5.4	1.7	0.4	5.3	10.3	5.1	1.2	3.7	0.1	1.5	3.5	0.5	3.9	0.7	0.4	0.8	1.0	4.9	3.7	3.4	0.2	4.8	2.3	15.9	4.1	0.5	1.5	6.5	2.3	4.7	0.5	5.3	1.9	0.8	0.7	1.5	1.3	0.8	3.3	2.2	0.8	1.7	6.2	0.9	1.2	11.7	9.1	5.2	1.1	8.9	1.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	1.1	0.2	0.6	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0											0.0	1.0	0.0	0.9	5.5	3.9	0.0	2.5	1.4	1.2	0.0	0.0	0.4	0.0	0.4	5.7	3.3	0.5	0.0	1.0	0.4	1.4	0.7	0.0	0.0	0.2	0.0	1.2	4.3	1.8	2.3	0.6	1.1	5.0	0.0	1.2	0.9	0.4	0.0	0.7	0.0	2.0	0.0	0.3	0.9	0.3	5.5	0.1	0.0	1.6	0.9
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104361-44114562	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Cell type enhanced"	"Detected in many"	19	"Fibroblasts: 159.0;Leydig cells: 140.4;Peritubular cells: 478.4;Smooth muscle cells: 174.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 34.9;BJ: 45.9;BJ hTERT+: 30.3;fHDF/TERT166: 49.3;JURKAT: 34.8;WM-115: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2300000	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	46.5	19.0	8.9	23.9	9.5	3.1	90.9	1.7	5.4	78.1	20.5	17.9	15.8	5.8	73.7	39.4	20.7	43.7	47.9	35.4	12.7	6.4	19.6	6.3	35.5	13.0	12.5	10.8	84.8	8.8	2.7	10.9	26.7	17.2	46.1	7.9	33.3	11.9	70.2	11.4	19.7	16.9	42.6	43.7	16.6	17.6	30.6	9.6	48.0	19.6	12.3	7.5	58.2	177.1	2.3	10.5	0.0	0.0	0.2	1.4	0.4	0.1	0.0	10.8	0.0	34.9	12.4	0.2	45.9	30.3	5.2	1.1	0.0	0.0	1.2	5.1	49.3	0.0	0.0	0.5	0.8	2.2	0.1	0.0	3.1	0.0	0.0	9.8	0.0	0.0	18.8	0.0	17.7	0.0	0.2	2.3	34.8	1.9	0.0	0.0	0.0	19.9	3.7	4.6	0.0	0.0	16.5	0.4	0.3	1.2	0.0	1.1	6.1	0.0	0.0	20.1	10.6	0.1	3.3	8.0	0.0	21.3	0.1	0.0	0.2	0.2	24.2	0.1	0.0	28.2	0.0	0.0	0.0	0.4	0.0	0.3	2.1	0.4	0.0	0.0	2.3	1.4	0.8	0.0	0.2	0.0	10.5	0.0	0.4	8.9	9.5	1.7	5.4	12.7	6.4	12.5	10.8	17.2	9.6	0.0	4.5	6.7	5.4	30.7	0.2	15.5	0.0	4.0	2.3	7.0	0.0	1.7	0.0	0.8	2.0	14.4	0.0	0.0	0.0	2.6	159.0	2.4	2.3	0.0	3.1	0.0	0.0	38.6	1.9	9.5	140.4	3.8	81.0	1.0	0.0	0.1	0.7	0.0	478.4	0.6	0.6	38.8	174.1	2.4	4.5	24.0	2.9	0.7	0.0	2.0
ALKAL1	"AUGB, FAM150A, UNQ9433"	ENSG00000196711	"ALK and LTK ligand 1"	Q6UXT8	8	52534037-52565507	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 8.7;prostate: 6.8;urinary bladder: 9.9"	"Cell type enhanced"	"Detected in some"	28	"Club cells: 2.3;Distal tubular cells: 5.0;Pancreatic endocrine cells: 1.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.2;HMC-1: 1.6;NTERA-2: 1.9"	"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Low region specificity"	"Detected in all"			HPA027368	Uncertain				"Secreted - unknown location"	NA	NA					"HPA027368: AB_10602317"			"unprognostic (1.18e-1)"	"unprognostic (1.13e-4)"				"unprognostic (9.47e-2)"		"unprognostic (9.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.70e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.58e-3)"	0.0	0.0	0.3	1.6	0.2	0.0	0.0	0.0	0.4	3.2	3.0	0.0	0.0	1.5	0.1	0.0	3.9	0.6	8.7	0.0	0.1	0.2	0.3	1.1	1.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.3	0.2	6.8	0.3	0.0	2.4	0.0	0.0	0.2	2.2	4.6	0.2	0.0	1.0	0.4	0.3	0.3	6.0	0.0	0.0	9.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.1	0.2	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALKAL2	"AUGA, FAM150B"	ENSG00000189292	"ALK and LTK ligand 2"	Q6UX46	2	279558-288851	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 70.8;retina: 81.0"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 8.3;Ductal cells: 31.1;Proximal tubular cells: 26.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	21	"AF22: 56.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (1.39e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.35e-1)"	"unprognostic (9.29e-3)"	"unprognostic (5.19e-2)"	"unprognostic (3.68e-1)"	5.7	70.8	1.6	1.2	4.9	0.1	6.7	0.4	1.2	4.5	2.7	2.2	3.3	1.2	8.2	8.6	2.2	6.8	7.4	1.4	1.3	1.1	36.8	1.8	8.6	6.9	0.4	1.0	24.7	30.3	1.3	3.0	3.9	2.4	1.8	2.3	81.0	2.0	2.9	1.1	4.9	2.6	3.7	3.0	2.9	3.4	22.2	0.6	0.9	2.5	1.4	1.4	2.9	1.8	1.3	0.9	0.0	0.6	1.0	1.9	0.5	0.0	0.0	56.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.4	0.6	1.1	1.3	0.9	0.8	0.1	0.5	1.9	0.9	0.0	1.0	0.0	0.9	1.5	0.5	1.6	4.9	0.4	1.2	1.3	1.1	0.4	1.0	2.4	0.6	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.3	31.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ANKDD1A	FLJ25870	ENSG00000166839	"Ankyrin repeat and death domain containing 1A"	Q495B1	15	64911902-64958700	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Leydig cells: 57.2;Muller glia cells: 36.1;Peritubular cells: 73.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.2;RT4: 14.4;U-266/84: 18.6"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 29.1"	HPA040757	Approved		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA			Nucleoplasm		"HPA040757: AB_10960566"	"unprognostic (3.72e-4)"	"unprognostic (1.86e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.25e-2)"	"unprognostic (4.78e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.11e-3)"	"unprognostic (5.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.64e-2)"	3.9	12.4	7.9	3.7	9.5	3.2	2.3	7.9	9.4	4.3	2.2	0.6	3.5	1.9	4.7	7.6	5.1	5.9	3.9	3.6	8.3	3.9	2.0	1.3	4.4	6.3	4.2	9.8	5.8	7.6	3.5	4.4	5.4	3.5	3.3	0.5	2.4	3.3	4.2	1.5	4.9	2.4	6.5	3.0	14.2	2.6	8.6	1.1	0.0	3.8	0.9	1.6	5.1	4.0	1.0	1.5	1.4	1.9	6.8	4.0	0.8	1.0	2.9	1.4	1.3	2.2	1.7	5.7	1.3	3.5	1.4	2.0	1.6	1.4	1.3	1.5	2.9	1.2	1.4	2.9	0.2	1.1	0.7	0.8	1.4	3.0	1.1	1.6	1.1	2.3	1.3	0.4	0.9	0.5	0.8	1.0	1.3	0.2	19.2	0.4	2.7	0.5	2.1	1.7	0.5	1.3	0.8	0.8	9.1	0.1	14.4	2.9	3.5	0.7	1.0	1.3	1.3	1.1	1.1	1.4	2.6	2.7	2.3	1.3	5.3	18.6	1.0	2.9	2.6	0.8	1.0	0.9	0.1	2.1	1.9	0.8	1.0	1.1	3.2	1.5	0.7	0.8	0.8	1.4	6.8	1.8	0.0	4.0	0.8	7.9	9.5	7.9	9.4	8.3	3.9	4.2	9.8	3.5	1.1	0.0	2.2	0.0	4.9	4.9	9.4	1.2	0.0	0.0	1.2	0.0	11.8	2.7	0.0	0.7	0.8	8.0	0.0	0.0	1.9	4.6	7.0	2.2	5.7	0.0	4.9	3.2	1.2	1.3	5.4	0.9	57.2	7.9	10.1	0.0	0.0	36.1	4.2	0.0	73.9	0.0	6.6	12.9	13.9	1.4	1.1	3.1	1.8	4.1	0.0	4.1
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase, copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Peritubular cells: 70.4;Sertoli cells: 116.4;Smooth muscle cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enriched"	"Detected in some"	18	"ASC diff: 85.5"	"Low region specificity"	"Detected in many"							"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	97.0	11.5	0.4	18.7	1.0	0.0	67.7	0.5	1.3	26.9	44.3	1.0	16.3	3.6	44.7	34.8	36.1	18.5	50.9	12.1	0.4	0.4	5.8	8.3	48.0	7.9	0.5	1.2	23.8	2.4	2.2	1.3	10.8	2.0	36.5	9.4	32.1	8.0	24.7	7.7	5.5	15.0	79.2	0.6	7.5	17.7	16.2	0.3	1.0	6.6	11.6	2.6	75.9	20.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	85.5	0.1	1.3	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.3	1.5	0.1	0.1	4.7	0.2	0.0	0.2	0.9	0.2	0.1	0.2	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.7	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	1.2	1.4	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.5	1.3	0.4	0.4	0.5	1.2	2.0	0.3	3.0	8.9	0.8	0.0	2.6	0.0	3.2	0.0	1.4	3.4	0.0	0.0	0.1	0.0	0.1	3.8	4.7	0.0	0.0	0.2	0.1	2.6	0.2	1.1	0.0	1.1	0.0	0.0	22.7	3.0	2.1	3.1	0.5	3.3	0.0	0.0	0.4	0.1	0.0	70.4	0.7	0.5	116.4	56.5	0.9	0.7	1.6	0.2	0.0	0.0	0.3
AP000790.4		ENSG00000285010			11	59964033-59970146	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"blood: 5.9;kidney: 1.5"	"Not detected"	"Not detected"											"Cell type enriched"	"Detected in single"	10	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 5.9"	"Group enriched"	"Detected in some"	5	"HEL: 2.9;K-562: 7.3"														"Secreted - unknown location"	NA	NA																							0.0	0.1		0.4		0.2	0.0		0.7	0.2	0.2			0.0	0.1	0.0	0.0	0.0	0.0	0.0			1.5	0.0	0.0	0.0			0.5	0.0	0.0		0.0		0.0	0.3		0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.8			0.0		0.0	0.0		0.5	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	2.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP002347.1		ENSG00000285231			11	59878809-59896481	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"blood: 7.4;testis: 2.5"	"Not detected"	"Not detected"											"Cell type enriched"	"Detected in single"	24	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 7.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.4;HAP1: 1.4;K-562: 2.4;U-698: 3.1"														"Secreted - unknown location"	NA	NA																							0.0	0.0		0.5		0.7	0.0		0.3	0.0	0.3			0.6	0.1	0.0	0.2	0.0	0.0	0.0			0.5	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.2		0.6	0.0	0.6	0.0	0.0	0.0		0.0	0.4	2.5			0.0		0.0	0.0		0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.4	0.9	1.4	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.4	0.3	0.4	0.7	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.5	0.4	0.7	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3	3.1	0.0	0.2	0.3	7.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BMP5		ENSG00000112175	"Bone morphogenetic protein 5"	P22003	6	55753645-55875564	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.7;prostate: 29.4;retina: 21.2"	"Cell type enhanced"	"Detected in some"	20	"Cardiomyocytes: 4.9;Erythroid cells: 23.3;Fibroblasts: 12.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 22.6;U-2 OS: 17.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (2.84e-4)"		"unprognostic (9.07e-4)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.39e-3)"		"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.76e-2)"	2.1	0.6	0.2	3.3	0.2	0.1	1.5	0.7	0.7	0.2	4.3	0.0	0.0	5.0	0.1	0.2	1.9	0.2	1.5	3.4	0.3	0.2	1.6	1.9	14.3	0.2	2.0	1.4	0.2	1.2	0.1	5.0	42.7	5.2	29.4	4.7	21.2	1.7	0.0	7.0	0.2	10.2	5.5	3.6	0.1	1.9	0.2	0.0	0.0	1.5	5.0	0.1	11.8	1.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.7	0.3	0.2	2.0	1.4	5.2	0.0	0.0	4.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.4	12.4	0.0	0.0	0.0	2.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0
BPIFB4	"C20orf186, dJ726C3.5, LPLUNC4"	ENSG00000186191	"BPI fold containing family B member 4"	P59827	20	33079644-33111751	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 4.0;pituitary gland: 12.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HSkMC: 5.4;U-2 OS: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA							"unprognostic (1.32e-1)"		"unprognostic (1.16e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.31e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.98e-4)"			"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"		"unprognostic (8.97e-2)"	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.0	12.2	0.0		0.0	0.0		2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8			0.0		0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1
C10orf95	FLJ14280	ENSG00000120055	"Chromosome 10 open reading frame 95"		10	102449837-102451543	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 12.7"	"Cell type enhanced"	"Detected in many"	11	"Rod photoreceptor cells: 16.7;Syncytiotrophoblasts: 31.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 11.5;JURKAT: 11.4"	"Not detected"	"Not detected"												"Secreted - unknown location"	NA	NA						"unprognostic (2.31e-1)"	"unprognostic (7.76e-3)"	"unprognostic (3.19e-1)"	"unprognostic (5.62e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.80e-3)"	0.0	1.0	0.4	1.2	0.4	1.1	0.0	1.0	1.2	1.7	1.4	0.0	0.0	2.0	0.7	12.7	0.9	9.7	1.2	0.0	0.4		1.0	0.0	9.8	2.2	0.0	0.2	8.9	4.2	0.0	2.6	7.0	0.9	1.0	0.0	10.1	3.4	3.4	0.1	3.6	1.9	0.0	0.0	1.9	3.2	0.9	0.0	0.1	5.0	2.7	4.1	0.5	0.0	9.3	5.6	1.6	1.2	8.4	11.6	4.5	5.4	1.0	0.1	2.2	0.0	0.0	4.8	0.2	0.0	0.0	0.0	4.4	9.5	4.7	2.2	0.0	0.7	9.5	0.0	0.4	0.0	4.1	11.5	3.0	3.9	3.6	0.0	4.1	3.0	0.1	1.8	0.0	0.1	3.1	0.0	11.4	5.2	4.0	0.0	4.3	2.2	3.9	2.2	1.9	3.2	6.6	0.1	5.2	1.1	2.0	8.8	1.3	2.3	1.5	3.0	1.8	4.7	0.3	0.4	0.2	1.1	0.2	0.5	3.5	2.7	3.2	0.2	6.2	0.1	1.6	1.2	1.5	7.4	0.5	7.0	9.3	8.2	7.6	3.2	7.5	11.6	9.7	1.0	8.4	0.2	5.6	8.2	4.5											0.0	2.7	2.2	2.8	1.3	4.5	0.0	2.5	9.4	6.8	5.2	9.8	2.1	3.3	1.4	0.0	0.7	1.3	0.0	1.0	1.5	0.2	3.0	0.0	0.2	2.1	3.2	1.2	0.6	0.3	0.0	0.6	0.7	0.0	2.8	1.7	1.5	0.7	0.0	0.7	3.0	16.7	0.0	0.1	0.4	1.7	1.4	31.8	2.9	2.8	2.3
C11orf45	"FLJ43646, MGC35558"	ENSG00000174370	"Chromosome 11 open reading frame 45"	Q8TAV5	11	128899565-128906035	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"Hofbauer cells: 8.1;Kupffer cells: 4.1;Late spermatids: 5.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;monocytes: 1.8;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 12.4;U-937: 9.6"									HPA039716	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA039716: AB_10672892"	"unprognostic (8.32e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.97e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.55e-9)"	"unprognostic (2.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.87e-2)"	"unprognostic (7.22e-2)"	0.7	4.9	1.1	0.3	5.3	0.4	0.7	0.0	1.0	0.9	0.4			1.2	0.3	0.4	3.3	0.9	2.1	5.0	0.7	0.9	1.6	0.2	2.8	0.3	1.1		0.7	4.1	4.7	3.7	2.1		1.2	0.6		1.7	3.6	0.0	8.0	0.6	0.1	1.5	1.6	2.0	1.0			1.8		0.6	1.7	1.8	0.4	3.5	0.0	1.8	0.0	1.1	0.6	2.4	4.8	0.0	0.0	0.1	0.4	1.8	0.8	5.1	1.9	4.8	6.9	6.2	0.0	3.5	0.4	4.4	2.5	2.5	12.4	0.9	0.0	1.2	0.3	3.0	0.0	0.2	0.0	0.0	0.3	1.7	1.4	0.8	4.1	1.1	3.8	0.0	0.3	2.1	1.3	2.7	2.5	2.0	1.0	3.5	1.2	5.0	0.5	4.4	1.2	0.0	0.2	2.0	5.7	0.4	1.4	0.8	4.1	0.6	0.0	7.1	0.0	0.8	0.1	0.0	0.0	0.9	9.6	0.2	0.0	1.8	0.0	0.3	0.8	0.7	0.4	0.5	0.5	3.5	0.4	1.1	0.7	0.0	0.0	0.0	0.7	0.0	0.6											0.0	0.3	0.0	1.0	2.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.0	1.7	0.6	1.4	0.0	0.0	0.0	0.7	2.1	0.2	0.1	1.1	0.0	8.1	0.0	0.0	0.0	4.1	5.7	0.0	2.6	0.0	1.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.9	0.6	1.0	0.0	0.0	0.7
C12orf49	FLJ21415	ENSG00000111412	"Chromosome 12 open reading frame 49"	Q9H741	12	116710185-116738070	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 41.4"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 95.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026905	Uncertain				"Secreted - unknown location"	NA	NA		260000			"HPA026905: AB_10603446"	"unprognostic (2.74e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (8.44e-4)"	"unprognostic (2.56e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.91e-11)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.73e-1)"	6.2	8.6	10.9	8.6	14.1	6.3	8.6	5.4	16.9	4.7	12.2	10.1	6.1	7.6	5.3	10.4	9.0	4.4	6.8	6.3	8.8	10.0	13.0	9.1	20.4	9.0	10.8	7.2	4.7	7.6	7.3	6.7	5.2	19.6	4.7	9.9	5.9	14.7	5.6	3.6	6.9	8.2	4.8	9.2	7.8	11.9	8.7	7.0	14.0	41.4	5.5	9.7	5.8	4.3	9.4	7.3	6.4	5.4	4.7	8.2	2.6	7.4	10.1	9.4	9.3	11.0	8.8	11.8	5.2	7.0	5.9	5.1	19.9	5.7	19.3	10.3	7.2	8.8	9.7	13.0	8.0	6.7	15.3	10.4	5.5	5.4	18.9	7.7	10.4	17.0	10.6	10.1	7.7	8.7	10.0	8.8	13.0	5.8	4.5	9.4	11.2	9.4	9.7	15.0	11.4	11.8	14.2	6.3	8.4	14.9	20.3	8.7	10.8	8.5	8.6	15.5	11.1	10.4	10.9	11.4	8.8	12.2	12.3	10.2	9.3	27.5	27.0	14.3	10.9	10.3	4.1	4.3	6.4	8.1	5.4	8.2	9.4	6.4	6.5	3.8	8.2	5.7	7.5	3.0	4.7	3.7	7.3	6.4	2.6	10.9	14.1	5.4	16.9	8.8	10.0	10.8	7.2	19.6	7.0	95.3	22.2	23.2	16.8	17.5	10.8	5.4	17.8	5.3	15.9	27.9	11.8	10.3	41.4	55.0	36.4	11.9	30.9	0.0	36.3	30.5	10.3	25.5	6.9	6.4	36.5	28.6	15.5	16.5	15.9	20.7	8.9	14.4	16.9	22.6	16.9	6.7	43.3	34.5	8.9	49.7	12.2	6.5	10.4	12.7	36.3	13.4	15.0	24.9	18.7	49.8
C12orf73	"DKFZp547P055, FLJ13975"	ENSG00000204954	"Chromosome 12 open reading frame 73"	Q69YU5	12	103950202-103965708	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.8"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038883	Uncertain		Approved	"Plasma membrane,Centrosome,Mitochondria"	"Secreted - unknown location"	NA	NA			"Centrosome, Mitochondria"	"Plasma membrane"	"HPA038883: AB_10794735"	"unprognostic (9.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.66e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.27e-2)"	"prognostic favorable (1.61e-4)"	6.7	11.4	14.3	8.3	14.5	4.4	9.7	15.5	17.5	7.2	7.4	11.4	7.2	7.7	9.5	13.2	7.0	8.9	5.5	11.1	13.0	14.6	9.4	8.3	5.8	10.0	13.3	13.3	11.5	9.7	9.4	21.0	7.3	13.6	10.7	9.5	8.3	8.3	11.1	43.8	9.0	7.7	7.9	14.1	7.0	9.9	10.1	13.8	11.4	11.5	12.9	10.2	6.6	6.9	11.7	11.3	8.6	5.1	12.0	14.5	3.9	5.9	11.1	16.9	10.3	4.9	6.4	11.0	6.4	3.9	7.2	5.9	11.8	5.2	7.0	8.6	3.9	6.3	9.6	10.0	8.2	5.5	10.1	20.3	10.6	16.3	14.8	7.2	15.6	9.7	5.7	9.4	3.6	6.4	17.6	6.6	20.6	13.6	4.8	6.6	6.8	17.3	23.6	8.2	5.7	19.0	10.0	6.3	6.9	9.4	8.0	27.7	9.5	6.5	11.3	14.9	7.6	19.3	8.5	3.3	8.8	4.9	6.5	6.5	13.1	20.1	14.7	10.0	8.9	7.7	7.3	5.1	8.6	10.5	4.2	10.4	11.7	9.8	10.0	7.2	10.7	14.5	13.5	1.4	12.0	3.8	11.3	13.8	3.9	14.3	14.5	15.5	17.5	13.0	14.6	13.3	13.3	13.6	13.8	6.0	5.0	6.7	8.5	5.4	16.5	14.9	7.6	13.4	5.7	8.7	0.0	9.7	23.2	20.3	59.5	6.7	9.2	0.0	10.6	10.4	7.6	8.0	9.2	11.6	14.8	7.9	10.9	6.2	8.3	25.4	8.1	7.1	1.7	11.8	10.9	12.3	16.5	3.5	8.1	17.7	13.1	6.5	7.2	23.1	21.2	4.5	7.4	4.9	11.5	7.0
C14orf93	"FLJ12154, RTFC"	ENSG00000100802	"Chromosome 14 open reading frame 93"	Q9H972	14	22985908-23010166	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Intestinal endocrine cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002569	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Plasma membrane"		"HPA002569: AB_1078334"	"prognostic favorable (5.05e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.11e-2)"	10.4	6.1	10.2	11.8	7.3	12.4	9.8	14.3	7.9	12.0	12.2	8.3	16.7	8.1	10.8	13.5	10.3	11.1	10.3	7.2	9.6	4.6	10.3	9.7	8.7	10.3	6.8	5.9	12.2	15.9	12.9	18.9	5.4	7.4	11.0	10.9	9.1	9.8	10.2	7.3	20.3	9.4	8.4	11.0	12.9	9.5	5.8	9.0	22.7	16.3	7.8	14.6	11.6	9.5	9.7	8.8	21.3	11.3	8.8	12.4	6.6	3.9	7.4	6.3	8.8	10.2	22.9	8.8	4.6	7.2	3.7	4.9	4.6	11.7	11.1	4.4	4.2	5.2	8.4	3.8	11.7	3.5	4.3	2.7	7.0	9.0	10.5	8.9	5.0	6.0	16.5	9.2	5.5	7.0	13.5	6.8	7.2	7.5	2.4	3.8	11.1	6.4	9.4	2.1	8.5	5.2	10.4	6.0	6.7	4.8	6.0	23.0	10.0	6.2	6.0	6.3	7.1	9.3	8.9	3.8	7.0	9.3	3.1	4.6	8.6	2.3	7.6	4.8	6.3	7.1	11.7	7.5	21.3	8.3	6.9	7.3	9.7	6.8	8.6	8.8	9.4	10.2	9.8	10.7	8.8	11.3	6.2	12.4	6.6	10.2	7.3	14.3	7.9	9.6	4.6	6.8	5.9	7.4	9.0	8.9	0.6	4.7	4.8	2.7	1.2	2.8	2.5	5.3	1.2	0.0	3.9	3.0	6.6	2.8	0.5	2.9	2.9	0.0	2.6	4.3	2.4	2.0	6.9	1.1	3.3	0.0	15.1	1.3	2.7	1.0	4.0	3.4	5.0	0.0	5.2	2.9	3.4	7.0	3.9	3.0	1.9	6.5	3.1	1.5	7.9	1.4	2.5	4.3	4.9	1.4
C15orf61	LOC145853	ENSG00000189227	"Chromosome 15 open reading frame 61"	A6NNL5	15	67521068-67530143	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062820			Approved	Nucleoli,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoli, Vesicles"	Cytosol	"HPA062820: AB_2684874"	"unprognostic (1.35e-1)"	"unprognostic (9.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.95e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.45e-2)"	"prognostic favorable (5.31e-5)"	"unprognostic (2.42e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	9.9	10.0	10.8	4.7	18.1	11.0	17.9	14.5	17.2	5.5	6.0	2.4	5.6	7.5	6.3	5.9	5.5	5.2	5.1	21.0	8.7	7.2	8.4	6.4	7.2	7.5	6.9	10.9	7.9	20.7	8.8	10.9	5.8	7.3	7.2	6.4	5.9	7.0	6.4	45.8	8.4	5.0	7.0	5.8	5.0	6.6	25.2	5.5	3.6	7.7	16.9	3.7	4.6	8.0	7.2	7.2	10.7	6.6	5.1	9.8	5.0	4.2	4.6	1.2	5.1	5.4	7.8	3.3	1.9	3.4	3.5	2.8	3.5	3.0	3.6	4.1	2.1	4.1	5.0	4.6	1.3	2.9	2.1	10.9	3.8	3.5	4.6	3.5	4.7	3.2	8.1	3.5	1.1	4.3	2.5	1.6	11.1	4.3	8.0	1.1	2.4	3.8	7.7	1.9	3.4	5.8	5.2	2.6	13.1	2.5	3.0	6.8	5.1	3.3	3.2	5.8	2.3	2.8	7.2	1.6	4.7	7.2	5.9	4.8	7.6	11.0	8.7	2.0	9.2	2.4	8.6	6.6	10.7	7.0	5.2	8.0	7.2	9.2	6.9	6.9	5.6	9.8	7.9	0.8	5.1	4.4	7.2	5.6	5.0	10.8	18.1	14.5	17.2	8.7	7.2	6.9	10.9	7.3	5.5	20.8	9.1	25.1	28.7	59.6	71.3	69.8	20.4	6.7	7.9	15.7	35.3	35.6	68.0	21.1	136.1	26.6	30.6	0.0	25.8	25.7	33.5	30.2	33.5	33.8	26.4	12.7	26.0	17.2	20.2	22.0	38.0	16.0	35.4	7.2	47.0	62.2	24.4	38.6	24.1	54.0	68.8	32.3	28.3	136.2	21.8	53.2	17.2	31.9	43.0	15.6
C17orf67		ENSG00000214226	"Chromosome 17 open reading frame 67"	Q0P5P2	17	56791913-56838773	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"vagina: 24.4"	"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 18.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 10.0;MOLT-4: 15.3;PC-3: 10.6"	"Region enriched"	"Detected in single"	5	"olfactory region: 3.8"	"Low region specificity"	"Detected in many"			HPA043479	Approved				"Secreted - unknown location"	NA	NA					"HPA043479: AB_10964083"	"unprognostic (2.78e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.64e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.49e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.43e-3)"	3.2	1.9	5.5	3.4	7.3	1.0	7.4	9.9	6.2	5.1	2.2	2.0	3.5	1.9	5.2	4.0	2.4	3.3	4.8	2.2	5.2	2.9	2.1	3.3	3.1	3.9	6.4	1.6	4.4	3.3	2.1	3.2	2.2	5.8	4.9	1.4	1.3	2.8	3.5	1.7	2.0	2.7	4.8	3.6	6.9	2.8	3.8	8.5	9.1	2.4	0.5	2.7	5.2	24.4	3.8	1.1	0.9	0.8	0.6	3.9	1.0	3.3	2.2	1.4	1.5	0.7	1.0	0.6	2.0	2.5	1.7	2.0	2.7	1.1	1.8	3.5	0.8	1.8	1.7	1.0	0.5	1.7	10.0	3.7	1.7	2.3	1.7	0.9	1.3	3.4	0.4	2.7	1.2	1.1	1.3	1.7	3.6	1.6	8.6	1.1	2.6	15.3	2.3	1.3	1.0	10.6	3.3	2.7	1.9	1.2	0.9	0.7	1.8	2.0	0.4	1.0	0.5	2.2	0.9	2.3	1.8	4.5	1.2	1.4	3.6	8.9	1.0	1.3	1.5	0.6	0.0	0.5	0.9	0.6	0.7	1.2	3.8	1.9	2.6	0.4	2.3	2.0	2.5	0.8	0.6	0.8	1.1	3.9	1.0	5.5	7.3	9.9	6.2	5.2	2.9	6.4	1.6	5.8	8.5	3.0	0.0	7.8	11.9	2.1	10.8	0.8	10.2	1.4	0.0	7.0	13.7	0.1	0.0	2.8	7.5	10.1	5.4	0.0	1.2	0.7	2.8	10.1	1.1	4.4	2.3	4.8	8.5	4.3	6.1	5.3	7.2	3.2	1.7	4.6	2.0	2.4	1.9	2.5	1.1	0.0	18.8	0.0	3.1	11.5	6.8	1.5	0.2	6.4	1.7	5.5
C1QTNF8	"CTRP8, UNQ5829"	ENSG00000184471	"C1q and TNF related 8"	P60827	16	1090005-1096244	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 2.6;brain: 2.1;fallopian tube: 4.5;pituitary gland: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.3;HEK 293: 1.0"					"Not detected"	"Not detected"			HPA056438	Uncertain				"Secreted - unknown location"	NA	NA					"HPA056438: AB_2683134"			"unprognostic (8.65e-2)"		"unprognostic (2.56e-2)"									"unprognostic (5.46e-2)"				0.0	2.6	0.7	0.0	1.7	0.0	0.0	0.0	0.5	0.1	0.0			0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.8	2.1	0.1	0.0	0.3	0.0	0.4		0.0	0.0	0.0	4.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1QTNF9B	CTRP9B	ENSG00000205863	"C1q and TNF related 9B"	B2RNN3	13	23890525-23902655	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 17.7;testis: 8.5"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 1.6;Late spermatids: 1.4"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.8"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 8.6;OE19: 6.5"									HPA056632	Uncertain				"Secreted - unknown location"	NA	NA					"HPA056632: AB_2683197"	"unprognostic (3.43e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.04e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-1)"	1.5	0.5	0.6	0.3	0.5	0.0	0.8	0.0	0.5	0.1	0.6			0.3	0.5	0.0	1.4	0.1	0.5	3.2	4.4	1.3	0.1	0.1	0.1	0.0	0.1		0.2	0.5	0.0	1.1	0.4		4.8	0.0		1.5	0.0	3.5	17.7	0.2	0.4	0.0	1.4	0.6	8.5			0.5		0.0	0.8	0.2	2.3	3.0	1.7	1.6	1.3	1.2	0.5	1.3	3.0	1.2	1.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	1.2	1.9	0.3	0.0	0.1	2.4	3.1	0.0	0.0	0.0	1.9	2.5	0.7	1.6	1.6	0.3	0.3	0.7	0.1	0.0	0.0	0.0	1.5	0.0	8.6	0.7	1.6	0.0	2.0	0.4	0.1	2.0	6.5	3.0	1.2	1.5	2.4	0.0	0.2	3.7	0.1	1.8	0.1	3.0	0.9	0.9	0.4	0.2	2.9	0.8	0.2	1.8	2.6	0.4	1.3	3.6	1.1	0.6	0.0	0.8	1.7	1.2	1.1	0.4	1.0	0.2	0.1	0.6	2.3	0.4	0.6	0.0	1.3	1.6	3.0	0.0	0.5											0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0
C21orf62	"B37, C21orf120, PRED81"	ENSG00000205929	"Chromosome 21 open reading frame 62"	Q9NYP8	21	32793564-32813743	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 13.4;kidney: 18.2;ovary: 16.2;pituitary gland: 38.6"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 40.8;Distal tubular cells: 19.9"	"Cancer enriched"	"Detected in some"	6	"glioma: 11.0"	"Region enriched"	"Detected in many"	4	"pons and medulla: 13.4"	"Cell type enhanced"	"Detected in some"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"AF22: 7.2;RPTEC TERT1: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016899	Enhanced				"Secreted - unknown location"	NA	NA					"HPA016899: AB_1845704"	"unprognostic (1.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.37e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	2.2	0.4	1.6	1.1	2.1	0.3	0.3	0.3	2.4	0.1	0.3	3.9	0.0	0.1	0.2	8.4	0.3	1.2	0.4	0.4	3.0	2.4	18.2	0.3	0.2	0.2	1.5	1.0	16.2	5.6	0.1	38.6	0.1	13.4	4.1	0.1	0.0	0.3	0.3	0.3	0.3	0.6	0.3	1.8	0.2	0.3	0.4	3.1	0.0	0.2	0.0	1.1	0.2	0.3	0.0	0.4	1.1	0.0	0.0	1.7	0.1	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.4	1.7	0.1	1.6	2.1	0.3	2.4	3.0	2.4	1.5	1.0	13.4	3.1	0.0	0.0	0.5	0.8	0.8	5.1	0.1	40.8	0.0	0.0	5.2	5.9	1.1	19.9	0.0	1.2	0.6	0.0	0.0	0.0	0.4	1.1	0.3	0.0	0.0	0.2	0.0	2.9	2.5	0.6	0.0	3.7	0.0	3.3	0.0	0.0	5.6	0.0	0.0	1.8	2.1	6.2	0.0	0.4	0.9	1.1	0.9	0.2	1.7	0.0	0.3
C22orf46	"CTA-216E10.6, FLJ23584"	ENSG00000184208	"Chromosome 22 open reading frame 46"	C9J442	22	41688939-41698136	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 19.8"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 65.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			HPA052741	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted - unknown location"	NA	NA			Nucleoplasm	Nucleoli	"HPA052741: AB_2681933"	"unprognostic (3.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (4.70e-4)"	"unprognostic (1.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	3.9	2.0	8.1	3.1	6.8	1.0	3.9	2.2	5.7	2.7	2.4			2.3	3.1	4.5	1.7	2.4	2.7	4.8	8.7	7.5	2.7	2.3	2.2	3.1	12.8		5.2	1.4	8.3	3.5	2.1		3.3	2.8		2.8	3.0	3.3	3.3	2.6	2.9	19.8	2.8	2.4	6.2			3.5		3.1	2.2	1.5	1.1	0.4	0.1	2.6	3.5	1.2	0.7	8.8	4.5	11.1	6.8	8.2	8.7	10.1	7.5	8.1	6.4	8.6	4.5	5.8	5.5	5.5	6.2	6.3	4.1	5.7	5.8	7.7	19.7	5.4	6.1	9.4	3.8	4.8	4.5	12.0	6.9	7.8	10.7	7.6	4.9	1.6	8.6	9.9	8.2	5.6	14.6	3.5	5.5	4.5	13.4	3.5	5.1	9.2	6.1	5.4	6.1	2.7	4.2	8.7	7.9	11.3	8.5	9.0	5.5	4.3	8.4	14.4	4.4	3.9	17.5	17.8	5.1	5.0	5.5	11.4	0.1	0.5	0.0	0.7	0.4	0.9	1.1	1.1	1.1	0.2	0.5	0.9	1.2	0.1	3.5	2.6	0.4	0.7	0.7											11.9	16.5	7.1	3.9	1.9	9.4	18.9	5.1	8.1	11.4	7.0	13.7	8.3	1.7	4.2	65.6	7.1	8.4	0.0	4.2	5.8	4.9	2.0	7.0	4.0	4.2	3.2	2.9	9.2	7.3	8.2	4.9	8.3	1.7	9.0	7.2	9.7	3.7	3.7	6.0	1.3	6.2	0.0	3.5	12.0	11.5	2.3	7.1	15.8	4.0	1.4
C2orf66	UNQ6411	ENSG00000187944	"Chromosome 2 open reading frame 66"	Q6UXQ4	2	196805002-196810276	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 7.0;pituitary gland: 6.4"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 27.1"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 9.4;RT4: 3.5;TIME: 3.9"									HPA020869	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA020869: AB_1851545"	"unprognostic (1.19e-1)"	"unprognostic (4.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.10e-3)"	"unprognostic (4.54e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.75e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.86e-2)"	7.0	4.0	0.4	0.2	0.7	0.2	1.0	0.1	0.4	0.0	0.2			0.0	0.1	1.2	0.1	1.1	0.4	0.7	0.4	2.8	0.3	0.0	0.2	0.0	0.7		0.3	0.6	0.0	6.4	0.1		0.3	0.4		0.0	0.2	0.0	2.8	0.3	0.1	0.0	0.2	0.0	2.6			0.1		0.2	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.4	1.1	0.5	0.3	0.0	0.5	0.2	0.2	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	1.1	0.2	0.3	0.6	9.4	1.0	0.1	0.0	0.1	0.8	0.7	1.4	0.2	0.2	0.2	0.8	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	3.5	0.4	0.2	0.0	0.1	0.1	0.4	0.0	0.0	3.9	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
C2orf69	FLJ38973	ENSG00000178074	"Chromosome 2 open reading frame 69"	Q8N8R5	2	199911256-199955935	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 96.7;Spermatocytes: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045225	Approved				"Secreted - unknown location"	NA	Yes					"HPA045225: AB_10960841"	"unprognostic (6.94e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.86e-2)"	11.6	18.4	17.7	8.9	18.5	23.6	12.1	14.3	20.0	7.9	9.9	7.3	5.1	10.4	8.3	8.7	8.8	6.0	8.0	8.2	16.2	16.3	11.3	12.3	7.6	8.4	15.9	13.4	8.8	10.2	11.4	8.5	6.7	13.3	8.5	10.4	6.4	9.0	6.6	13.5	8.2	9.0	9.7	15.8	8.3	8.8	18.6	12.7	10.2	8.6	8.9	9.0	7.4	8.5	5.2	3.6	10.8	5.4	2.9	8.6	4.3	11.5	5.3	9.9	13.4	14.0	17.7	16.7	16.6	10.0	11.3	13.5	11.8	8.4	9.6	9.8	11.7	12.0	9.4	10.4	8.8	19.1	14.2	9.5	14.7	9.2	15.0	8.2	14.7	18.3	9.1	8.0	12.9	11.3	6.1	12.6	6.5	10.5	19.0	19.0	10.0	8.1	12.9	14.5	5.1	14.2	7.9	12.9	8.6	11.1	12.0	16.2	7.1	8.0	6.1	12.3	13.3	8.9	12.8	10.9	17.7	14.5	19.7	13.2	12.6	20.3	9.5	14.1	9.5	8.8	7.1	4.2	10.8	6.0	5.4	8.6	5.2	6.7	5.6	3.6	4.8	7.1	7.4	3.5	2.9	4.0	2.1	6.1	4.3	17.7	18.5	14.3	20.0	16.2	16.3	15.9	13.4	13.3	12.7	3.0	3.2	25.1	23.0	33.8	19.4	9.8	2.5	13.4	5.7	15.7	27.5	9.4	23.2	10.8	96.7	15.0	11.7	0.0	16.1	15.1	16.4	16.8	8.1	16.3	10.6	12.7	17.9	23.9	16.4	55.3	12.4	16.2	15.1	10.0	15.8	55.2	12.3	10.5	20.5	15.7	24.7	19.4	21.7	107.2	44.6	39.3	8.2	18.5	15.3	13.9
C3orf33	"AC3-33, FLJ31139"	ENSG00000174928	"Chromosome 3 open reading frame 33"	Q6P1S2	3	155762617-155806351	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037663	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA037663: AB_10672610"	"unprognostic (1.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (6.48e-7)"	"unprognostic (3.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.56e-1)"	4.3	16.9	6.7	3.1	7.9	2.3	6.8	9.2	9.5	5.0	3.6	6.5	5.0	4.1	6.1	9.7	2.5	5.4	3.5	9.3	7.6	7.9	9.4	4.1	5.2	2.8	5.6	11.0	6.9	19.4	11.7	8.6	2.1	7.9	7.2	3.4	5.5	4.5	6.6	5.6	1.6	2.8	11.1	5.0	2.8	4.3	6.2	6.9	1.7	13.4	2.4	1.7	4.0	6.3	2.3	3.0	3.0	1.8	6.1	7.7	3.4	6.0	8.5	4.0	5.6	0.3	5.1	1.8	2.5	4.0	2.5	6.1	2.9	7.7	1.1	6.2	2.6	3.8	0.9	4.1	0.1	4.6	2.9	6.0	3.7	1.4	7.8	7.1	5.0	1.2	4.0	4.5	2.7	5.3	3.3	4.3	6.3	5.8	2.9	4.3	4.4	5.3	4.5	5.4	5.5	1.9	5.4	2.2	5.9	14.1	2.8	3.1	4.1	5.8	7.8	5.2	2.2	10.7	6.6	2.7	2.9	2.1	6.1	6.5	4.9	4.6	0.0	2.1	4.7	2.9	3.0	1.8	0.2	6.2	1.6	7.7	2.3	4.9	5.5	3.0	2.2	6.2	6.4	0.1	6.1	1.1	2.4	3.2	3.4	6.7	7.9	9.2	9.5	7.6	7.9	5.6	11.0	7.9	6.9	3.0	7.9	0.0	5.1	1.1	7.9	9.8	2.5	5.3	7.9	0.0	5.9	3.0	5.0	3.2	5.2	2.2	1.3	0.0	2.9	2.5	4.6	4.0	6.9	3.0	2.2	6.4	3.5	1.3	0.3	4.2	5.8	1.6	1.7	0.0	3.1	15.6	1.6	3.4	7.4	5.3	7.0	0.0	3.1	11.3	17.2	1.3	3.1	2.5	4.1	2.0
C5orf38	"CEI, IRX2NB"	ENSG00000186493	"Chromosome 5 open reading frame 38"	Q86SI9	5	2752131-2755397	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"salivary gland: 34.9"	"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 32.4;Distal tubular cells: 87.9;Melanocytes: 37.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 38.2;HaCaT: 13.1;hTCEpi: 20.9;MCF7: 11.1;SiHa: 16.0;SK-BR-3: 15.0"									HPA073667			Approved	"Golgi apparatus,Vesicles"	"Secreted - unknown location"	NA	NA			"Golgi apparatus, Vesicles"		"HPA073667: AB_2686624"	"unprognostic (5.00e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-5)"	"unprognostic (4.08e-2)"	"unprognostic (2.24e-2)"		"unprognostic (2.67e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.84e-7)"	"unprognostic (2.60e-2)"	"unprognostic (8.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.60e-2)"	8.3	0.5	4.5	0.6	7.6	0.5	16.3	10.4	3.0	0.6	1.1	1.5	9.8	0.7	0.7	6.8	4.1	0.6	0.6	2.4	6.0	7.0	6.6	0.5	19.4	1.1	10.5	2.0	0.5	3.8	5.0	2.6	4.3	14.8	5.9	0.7	3.4	34.9	3.9	0.9	10.6	0.5	0.5	12.2	0.7	11.2	1.5	4.7	0.0	5.0	1.6	2.4	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	6.9	0.0	3.0	2.1	38.2	4.9	3.9	3.3	2.9	1.9	0.0	0.0	0.0	0.9	0.0	13.1	0.7	3.8	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	20.9	0.8	2.7	0.0	0.0	0.0	0.0	0.0	0.8	11.1	0.0	0.1	1.0	4.3	0.0	0.0	1.4	0.0	4.3	0.0	1.0	0.0	16.0	15.0	0.0	2.3	6.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	7.6	10.4	0.3	6.0	7.0	10.5	2.0	14.8	4.7	11.9	8.3	0.0	13.3	21.9	0.0	0.6	0.0	1.4	6.8	12.2	0.0	32.4	87.9	0.0	0.7	0.6	0.0	0.0	0.2	12.9	3.0	11.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.3	0.0	0.5	37.1	0.0	1.3	0.0	0.5	0.0	0.4	0.7	0.6	0.0	17.8	0.4	0.9	18.7	12.2	0.0	1.2	2.4
C6orf15	STG	ENSG00000204542	"Chromosome 6 open reading frame 15"	Q6UXA7	6	31111223-31112559	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix, uterine: 5.6;lymphoid tissue: 7.3;skin 1: 10.8;tongue: 11.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"RH-30: 8.3;U-2 OS: 3.7"					"Not detected"	"Not detected"			HPA001436	Uncertain				"Secreted - unknown location"	NA	NA					"HPA001436: AB_2243752"	"unprognostic (2.73e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-1)"		"unprognostic (1.77e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"			"unprognostic (1.72e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.3	10.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	7.3	0.0	11.5	3.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C9orf47	"bA791O21.3, C9orf108, FLJ37523"	ENSG00000186354	"Chromosome 9 open reading frame 47"	Q6ZRZ4	9	88990863-88996140	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 12.9"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"classical monocyte: 2.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.2"	"Cell line enhanced"	"Detected in some"		"AF22: 6.6;ASC diff: 3.2;HeLa: 5.6;JURKAT: 3.5"									CAB009902	Approved				"Secreted - unknown location"	NA	NA					"CAB009902: AB_2184764"	"unprognostic (6.51e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.94e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.39e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.19e-6)"	"unprognostic (5.61e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.77e-2)"	1.7	5.3	0.6	1.0	0.7	0.8	2.3	0.0	0.7	1.8	1.0			0.3	1.1	0.6	2.1	2.1	0.9	1.8	0.8	0.5	3.9	0.8	1.0	1.7	0.4		0.4	1.7	0.0	3.3	1.2		1.9	0.2		0.3	0.8	0.0	0.0	0.8	1.4	0.5	1.7	1.0	0.0			0.7		0.5	0.9	1.9	0.0	0.2	0.3	2.2	0.0	0.0	0.4	0.0	0.4	6.6	0.2	3.2	1.9	0.1	1.1	0.3	0.4	0.5	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.4	0.5	0.0	0.1	0.0	5.6	0.0	0.0	0.4	0.0	0.2	0.1	0.7	0.0	0.2	0.7	3.5	0.3	0.0	0.0	0.5	1.6	1.4	0.4	0.0	0.3	0.7	0.0	0.0	0.0	0.6	0.2	0.5	0.3	0.1	0.0	0.7	0.1	1.8	1.8	0.6	1.4	1.1	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	2.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4											0.0	0.0	0.0	2.0	2.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	1.2	1.0	0.0	0.0	0.2	3.2	0.0	0.6	0.0	0.0	0.3	0.0	1.7	0.0	0.0	2.6	0.0	0.0	0.4	0.0	0.0	12.9	1.4	0.0	0.2	0.3	0.2	0.0	0.0	0.6
C9orf72	"DENNL72, MGC23980"	ENSG00000147894	"Chromosome 9 open reading frame 72"	Q96LT7	9	27546545-27573866	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 77.6;Kupffer cells: 86.3;Macrophages: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 8.0;classical monocyte: 15.5;intermediate monocyte: 21.8;myeloid DC: 11.7;neutrophil: 15.6;non-classical monocyte: 16.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.7;granulocytes: 15.6;monocytes: 21.8"	"Cell line enhanced"	"Detected in many"		"AF22: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023873	Uncertain		Supported	"Vesicles,Midbody ring,Cytosol"	"Secreted - unknown location"	NA	NA			"Vesicles, Cytosol"	"Midbody ring"	"HPA023873: AB_1845834"	"unprognostic (1.78e-2)"	"unprognostic (5.01e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-2)"	"unprognostic (9.13e-2)"	10.0	11.2	9.7	14.2	17.6	19.1	8.0	31.2	21.3	7.4	6.0	10.9	6.7	5.8	10.7	10.6	5.8	14.6	8.9	7.4	9.4	14.6	4.2	14.0	13.0	10.7	11.0	10.7	19.5	8.4	6.7	15.3	10.3	20.0	13.3	7.1	9.4	5.3	5.9	11.0	6.2	6.1	7.6	11.5	13.7	6.5	14.8	6.7	8.0	11.0	3.2	7.3	9.7	6.3	1.7	11.7	15.6	21.8	2.9	2.5	4.4	2.8	2.5	21.1	3.2	4.3	5.3	3.2	4.1	3.5	2.6	1.3	0.3	1.0	7.2	2.7	3.6	5.4	2.2	6.0	5.2	1.9	13.1	2.5	3.4	7.5	2.1	6.6	2.3	3.7	5.6	6.4	0.6	11.9	2.5	5.5	7.4	6.5	13.1	3.1	0.5	4.4	3.5	10.2	4.7	11.6	1.7	6.3	3.2	2.0	2.5	7.2	17.7	2.7	3.1	2.6	8.3	2.6	2.0	4.7	0.0	10.6	6.2	2.7	3.4	10.2	4.7	8.0	7.6	2.6	8.0	15.5	1.0	0.9	21.8	1.7	1.7	1.4	1.2	11.7	1.2	2.5	1.5	15.6	2.9	16.5	1.8	1.8	4.4	9.7	17.6	31.2	21.3	9.4	14.6	11.0	10.7	20.0	6.7	14.9	17.1	6.9	37.1	31.9	22.0	12.8	5.1	77.6	12.5	7.0	19.6	18.4	1.7	6.9	1.7	10.8	3.9	0.0	8.3	6.2	12.4	25.8	16.1	7.8	23.9	11.1	10.9	6.7	86.3	3.3	5.8	73.0	18.6	19.8	9.9	46.1	6.4	8.6	3.5	4.1	28.5	0.0	20.6	30.7	19.3	25.5	28.9	10.9	5.2	35.5
CCER2		ENSG00000262484	"Coiled-coil glutamate rich protein 2"	I3L3R5	19	38908980-38912158	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.5;skin 1: 9.9"	"Cell type enriched"	"Detected in some"	9	"Melanocytes: 585.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.0;THP-1: 4.0"	"Low region specificity"	"Detected in many"							HPA069716	Uncertain				"Secreted - unknown location"	NA	NA					"HPA069716: AB_2686183"	"unprognostic (6.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.01e-9)"	"unprognostic (1.75e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.32e-4)"	0.9	1.0	2.7	1.1	5.1	2.4	1.6	4.7	4.6	1.2	0.9	2.7	0.4	1.3	1.5	1.6	3.9	1.0	0.6	0.6	3.1	2.4	0.9	2.1	0.9	1.5	2.5	0.4	1.0	0.6	1.4	2.6	0.7	9.5	1.1	0.9	1.4	1.1	1.2	4.4	9.9	1.4	0.8	3.5	1.2	1.1	4.0	1.4	0.4	0.8	0.4	0.8	0.4	0.4	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.3	4.0	1.0	0.4	0.7	0.2	0.8	0.0	0.0	0.1	0.2	0.3	1.5	2.8	0.3	0.2	0.2	0.4	0.6	0.1	0.0	1.1	1.3	0.2	0.8	0.0	0.0	1.6	1.6	0.4	0.7	0.3	0.0	0.1	0.0	2.8	0.7	2.7	0.0	2.7	0.6	1.2	0.9	0.2	0.5	2.0	0.4	0.7	0.3	1.9	1.2	0.8	0.5	0.5	0.0	0.3	3.0	4.0	0.0	0.2	2.0	0.1	0.1	1.8	1.3	0.7	0.3	2.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	2.7	5.1	4.7	4.6	3.1	2.4	2.5	0.4	9.5	1.4	3.0	0.0	0.0	0.0	68.3	3.0	0.1	2.5	0.0	0.0	1.8	3.9	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.5	0.2	0.0	1.2	0.0	0.0	3.7	0.3	0.5	585.4	0.0	0.2	1.8	0.1	0.0	0.0	0.1	3.8	0.0	0.1	0.9	1.6	2.6	0.2	0.0	0.6	0.0
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138870-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 888.0;Ductal cells: 858.7;Suprabasal keratinocytes: 895.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 139.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		2400000000	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	45.5	9.0	10.5	42.5	21.7	53.0	35.6	4.7	13.4	43.2	19.5	26.3	8.3	10.6	80.5	20.3	66.5	18.6	48.0	11.7	14.9	9.3	12.4	9.1	43.4	48.4	31.5	6.1	12.8	83.9	0.8	3.8	19.4	40.7	30.1	24.5	30.2	148.2	22.4	15.9	107.7	18.9	44.5	100.5	30.9	19.9	7.2	20.3	17.9	20.6	53.9	53.7	55.0	54.2	22.7	41.0	19.1	65.2	54.6	53.1	59.9	39.7	35.9	0.3	0.0	21.7	60.0	0.1	77.9	60.9	43.4	24.2	2.4	12.5	0.0	10.4	110.3	89.3	68.5	0.8	84.7	59.6	8.5	0.4	1.4	17.7	0.0	21.4	20.2	93.5	27.0	66.8	58.3	47.4	139.4	15.1	0.0	0.3	13.0	41.6	0.2	1.8	13.3	0.7	0.7	10.6	0.1	7.4	0.6	63.6	11.5	0.1	0.1	14.7	0.4	35.2	3.4	2.1	1.2	43.5	54.1	9.8	66.3	80.0	22.5	24.3	0.2	82.1	11.4	78.6	19.1	65.2	6.0	26.2	45.7	37.0	22.7	39.8	34.9	41.0	16.2	34.5	28.7	16.4	54.6	59.3	14.2	53.1	59.9	10.5	21.7	4.7	13.4	14.9	9.3	31.5	6.1	40.7	20.3	89.3	339.9	168.9	263.7	888.0	0.0	4.0	25.5	18.7	135.4	19.2	2.0	4.0	1.7	858.7	30.1	53.0	5.0	23.3	741.5	3.7	143.9	293.1	733.4	2.5	234.7	0.0	96.2	20.3	427.0	13.8	20.8	611.7	573.6	514.0	84.8	26.6	787.6	8.6	0.4	0.6	1.6	155.2	254.2	0.4	0.4	895.8	15.0	244.8	66.1	304.0
CDCP2		ENSG00000157211	"CUB domain containing protein 2"	Q5VXM1	1	54132968-54153770	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.4"	HPA031143	Uncertain				"Secreted - unknown location"	NA	NA					"HPA031143: AB_10611819"	"unprognostic (1.08e-1)"	"unprognostic (5.16e-2)"		"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-2)"	"unprognostic (7.67e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.12e-1)"	"unprognostic (2.21e-2)"	0.5	0.3	0.1	0.1	0.5	0.3	0.9	0.1	0.6	1.1	0.2			0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.1	0.4	0.3	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.1	0.0		0.2	0.5	0.0	0.6	0.3	0.2	0.0	2.2	0.2	0.1			0.6		0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.4	0.0	0.7	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CELA1	ELA1	ENSG00000139610	"Chymotrypsin like elastase family member 1"	Q9UNI1	12	51328443-51346679	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 6.3;blood: 12.6;pancreas: 11.8"	"Group enriched"	"Detected in some"	6	"Exocrine glandular cells: 15.1;Kupffer cells: 7.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Cell type enhanced"	"Detected in many"		"basophil: 9.0;naive CD4 T-cell: 12.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 9.0;T-cells: 12.6"	"Cell line enriched"	"Detected in some"	4	"BEWO: 11.0"	"Low region specificity"	"Detected in all"												"Secreted - unknown location"	NA	NA						"unprognostic (3.54e-2)"	"unprognostic (1.64e-1)"		"unprognostic (4.73e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.70e-1)"		"unprognostic (1.52e-1)"		"unprognostic (1.13e-1)"	"unprognostic (3.59e-2)"		"unprognostic (3.83e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-1)"			0.0	6.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1		0.0	11.8	0.0	0.0	0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.6			0.0		0.3	0.0	0.0	0.3	0.9	9.0	1.6	0.2	12.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	9.0	1.6	0.1	1.1	0.8	0.4	0.3	2.7	0.8	0.9	0.0	12.6	5.9	0.2	0.2	0.9	0.0	0.3	1.3											0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	1.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0
CER1	DAND4	ENSG00000147869	"Cerberus 1, DAN family BMP antagonist"	O95813	9	14719724-14722717	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.5;epididymis: 5.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	82	"testis cancer: 17.3"	"Group enriched"	"Detected in many"	8	"basal ganglia: 2.5;cerebellum: 2.2;cerebral cortex: 1.1;pons and medulla: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 6.4;NTERA-2: 11.8;SCLC-21H: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019917	Uncertain				"Secreted - unknown location"	NA	NA					"HPA019917: AB_1846539"					"unprognostic (2.98e-2)"						"unprognostic (5.36e-2)"				"unprognostic (5.99e-2)"			0.1	0.0	0.1	0.1	2.5	0.1	0.2	2.2	1.1	0.1	0.2	0.1	0.1	0.7	0.7	5.5	0.1	0.0	0.4	0.2	0.1	0.2	1.2	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.2	0.1	0.1	1.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	2.2	1.1	0.1	0.2	0.1	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CES4A	"CES8, FLJ37464"	ENSG00000172824	"Carboxylesterase 4A"	Q5XG92	16	66988589-67009758	"Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 32.3"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 49.5;Spermatocytes: 27.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 19.8"	"Not detected"	"Not detected"							HPA035701	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA035701: AB_10696357"	"unprognostic (6.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (2.35e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-3)"	3.2	3.6	12.9	2.4	11.8	2.2	3.6	8.7	13.8	2.6	1.7	8.5	3.5	2.3	1.6	13.0	2.2	32.3	2.0	3.2	9.1	2.6	3.9	11.7	3.1	1.4	5.8	13.7	2.1	3.0	3.3	10.0	2.2	7.2	2.1	1.7	2.1	4.2	3.5	5.8	13.9	2.3	1.4	2.4	1.5	2.3	2.0	9.9	0.0	5.0	1.0	2.0	2.4	1.6	0.9	1.6	0.0	5.0	0.0	1.6	1.3	0.3	1.2	0.1	0.0	1.0	0.9	0.0	0.1	0.4	0.1	0.0	0.0	1.5	0.0	0.1	1.5	0.0	0.7	0.0	0.2	0.0	19.8	0.0	0.0	0.9	0.0	0.1	0.0	4.7	1.6	3.3	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	3.5	0.2	0.0	1.2	0.0	0.2	0.9	0.9	4.3	2.1	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	4.6	1.3	0.0	1.8	0.0	0.0	0.0	2.1	0.0	0.7	3.3	0.9	0.9	1.6	1.1	1.6	0.0	1.2	0.2	0.0	0.0	5.0	1.5	0.4	1.3	12.9	11.8	8.7	13.8	9.1	2.6	5.8	13.7	7.2	9.9	0.0	10.7	2.7	3.8	4.7	21.1	2.7	7.6	49.5	6.8	5.2	13.7	3.5	1.7	0.9	1.4	0.4	4.0	0.0	1.4	0.4	4.1	3.9	9.2	19.7	4.5	0.0	8.6	1.3	3.8	0.8	12.7	2.9	0.0	6.4	1.7	12.1	0.9	5.8	12.0	1.0	16.1	0.0	1.0	27.7	4.8	4.5	3.8	2.9	2.6	4.8
CFC1	"CRYPTIC, HTX2"	ENSG00000136698	"Cripto, FRL-1, cryptic family 1"	P0CG37	2	130592168-130599575	"Disease related genes, Predicted secreted proteins"	Gastrulation	"Developmental protein"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"brain: 13.0;pancreas: 21.9;pituitary gland: 22.4;prostate: 7.6;stomach 1: 9.4"	"Cell type enriched"	"Detected in some"	5	"Intestinal endocrine cells: 19.8"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 4.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"RPMI-8226: 19.3;SCLC-21H: 11.0;SuSa: 5.1"									HPA041773	Uncertain				"Secreted - unknown location"	NA	NA					"HPA041773: AB_2677664"					"unprognostic (6.65e-2)"						"unprognostic (2.19e-3)"	"unprognostic (1.11e-3)"			"unprognostic (2.01e-1)"			0.1	0.1	0.9	0.0	2.1	0.0	0.0	2.3	1.1	0.1	0.5			0.1	0.1	0.1	0.0	1.2	0.1	0.3	0.2	13.0	0.1	0.0	0.0	0.0	2.5		0.1	21.9	0.0	22.4	0.0		7.6	0.3		0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	9.4	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	11.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFC1B		ENSG00000152093	"Cripto, FRL-1, cryptic family 1B"	P0CG36	2	130521197-130528604	"Predicted secreted proteins"	Gastrulation	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"brain: 3.4;pancreas: 13.0;pituitary gland: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"SCLC-21H: 2.2;U-2 OS: 2.1"									HPA041773	Approved				"Secreted - unknown location"	NA	NA					"HPA041773: AB_2677664"																		0.3	0.1	0.4	0.1	1.6	0.1	0.1	1.5	0.5	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.3	0.1	0.3	0.1	3.4	0.2	0.1	0.2	0.1	0.6	0.1	0.1	13.0	0.1	8.1	0.1	1.0	0.8	0.7	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.6	1.5	0.5	0.1	3.4	0.6	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHSY1	"CSS1, KIAA0990"	ENSG00000131873	"Chondroitin sulfate synthase 1"	Q86X52	15	101175723-101251932	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 72.5"	"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 69.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (7.28e-2)"	"unprognostic (6.39e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	23.2	15.6	14.4	14.6	13.7	15.7	17.7	8.5	11.1	17.7	6.5	9.6	8.6	4.9	15.6	11.6	9.1	14.1	19.0	19.0	11.4	7.5	9.0	8.1	20.6	12.4	15.3	5.5	21.9	6.0	5.9	8.7	72.5	12.9	13.6	7.0	12.1	9.8	10.1	7.3	13.7	6.8	16.4	11.9	18.4	9.3	10.8	13.5	8.3	9.7	9.2	8.7	14.3	20.0	1.9	1.5	8.7	2.4	1.2	3.2	1.0	2.8	3.5	11.9	6.0	6.2	8.4	7.9	6.9	6.1	8.4	8.6	3.0	2.3	6.8	4.1	11.5	5.5	7.9	7.9	8.8	9.3	7.6	3.9	13.5	4.0	3.5	7.7	20.5	14.0	7.7	7.4	7.2	6.6	9.6	9.9	3.1	4.9	69.8	6.3	2.4	2.8	14.1	13.7	5.5	2.5	6.4	12.0	10.1	5.8	5.6	2.1	11.3	7.3	3.6	12.5	10.2	4.1	25.5	8.3	13.8	7.9	6.5	14.5	12.4	28.6	4.0	10.7	19.5	10.2	0.0	2.4	5.1	2.9	1.5	3.1	1.7	1.8	3.1	1.5	1.9	1.0	1.9	8.7	1.2	1.6	0.9	3.2	1.0	14.4	13.7	8.5	11.1	11.4	7.5	15.3	5.5	12.9	13.5	0.0	17.8	6.2	17.2	51.4	9.0	7.1	2.5	10.7	11.4	15.7	5.9	5.6	1.7	4.4	0.7	37.9	0.9	23.3	1.9	19.4	44.1	15.0	24.4	4.9	14.0	36.5	2.9	57.7	14.0	1.3	50.9	17.6	25.3	1.0	3.4	9.1	4.6	3.4	44.2	1.9	7.3	45.3	68.0	3.9	7.2	54.6	11.6	8.7	3.1	8.5
CLEC19A		ENSG00000261210	"C-type lectin domain containing 19A"	Q6UXS0	16	19285739-19322145	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	13	"brain: 7.2;retina: 24.4"	"Group enriched"	"Detected in some"	16	"Ciliated cells: 2.7;Club cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.1;EFO-21: 1.2;MCF7: 1.6;NTERA-2: 1.0;OE19: 2.5;RPMI-8226: 1.8;U-2 OS: 1.5"														"Secreted - unknown location"	NA	NA									"unprognostic (3.19e-1)"				"unprognostic (3.72e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.53e-1)"				0.1	0.0	2.6	0.0	0.2	0.0	0.0	0.8	7.2	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	4.5	1.3	0.0	0.1	0.5	0.3	0.3	0.2	0.0	0.1	0.0	0.3	0.1	1.2	0.8	0.1	24.4	0.4	0.0	0.3	1.2	0.1	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	1.0	2.5	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	2.6	0.2	0.8	5.0	4.5	1.3	0.3	0.2	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CPXM2	"CPX2, UNQ676"	ENSG00000121898	"Carboxypeptidase X, M14 family member 2"	Q8N436	10	123706207-123940267	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"Early spermatids: 85.6;Late spermatids: 150.5;Peritubular cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BJ: 9.8;fHDF/TERT166: 38.3;SuSa: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048375	Uncertain				"Secreted - unknown location"	NA	NA					"HPA048375: AB_2680377"	"unprognostic (1.50e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-3)"	17.0	4.1	0.8	5.0	2.1	0.1	12.3	1.3	1.6	6.4	40.9	6.7	5.7	3.8	12.2	37.8	20.0	9.1	9.4	14.3	1.7	4.0	6.6	1.5	4.6	3.7	6.1	0.7	12.8	3.2	1.9	7.1	11.6	16.9	14.7	4.5	26.5	5.6	8.3	5.0	4.5	9.1	45.5	21.6	13.8	14.4	7.7	3.4	2.6	9.5	11.9	4.0	32.5	20.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.4	0.6	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	2.1	1.3	1.6	1.7	4.0	6.1	0.7	16.9	3.4	0.0	1.1	0.0	0.0	1.9	0.0	1.4	0.0	0.0	0.0	1.8	0.0	6.6	1.7	0.1	85.6	13.5	0.0	0.0	0.2	0.2	2.3	0.0	0.0	0.0	0.3	1.6	0.0	13.5	0.0	150.5	10.0	0.0	3.3	0.0	0.5	0.0	0.2	0.0	74.3	0.0	0.0	0.0	2.8	1.1	1.9	1.8	4.2	0.0	1.1	0.0
CRHR2	"CRF-RB, CRF2, HM-CRF"	ENSG00000106113	"Corticotropin releasing hormone receptor 2"	Q13324	7	30651943-30700129	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell type enriched"	"Detected in single"	13	"Horizontal cells: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;HeLa: 1.8;NTERA-2: 3.0;SCLC-21H: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (7.14e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.24e-3)"	"unprognostic (5.69e-2)"	"unprognostic (8.58e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.86e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.02e-2)"	"unprognostic (8.29e-4)"	"unprognostic (3.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.84e-1)"	1.4	0.7	0.9	0.5	4.1	0.4	1.6	0.5	11.7	0.8	0.6	0.0	3.6	2.1	1.1	0.5	1.7	2.1	1.0	3.2	4.3	3.2	0.8	0.4	0.6	0.6	0.9	3.2	1.0	3.9	0.9	8.0	0.4	3.1	0.9	0.9	1.7	0.7	6.2	5.5	0.8	1.2	1.1	0.8	0.3	1.0	1.8	1.0	0.0	1.7	3.2	0.6	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	1.3	0.0	1.8	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.2	0.2	3.0	0.0	0.4	0.0	0.0	0.6	0.0	0.9	1.7	0.1	0.2	0.0	0.2	0.6	0.1	0.0	0.5	0.4	1.0	0.3	0.2	0.8	0.3	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.1	0.5	11.7	4.3	3.2	0.9	3.2	3.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CRISPLD1	"Cocoacrisp, DKFZp762F133, LCRISP1"	ENSG00000121005	"Cysteine rich secretory protein LCCL domain containing 1"	Q9H336	8	74984515-75034558	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.4"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 22.7;Cytotrophoblasts: 18.0;Glandular cells: 13.7;Ito cells: 28.3"	"Cancer enhanced"	"Detected in many"		"glioma: 30.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	32	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	32	"dendritic cells: 3.2"	"Cell line enhanced"	"Detected in some"		"AF22: 51.9;SH-SY5Y: 28.1;SuSa: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024725	Uncertain				"Secreted - unknown location"	NA	NA					"HPA024725: AB_1847238"	"unprognostic (2.16e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.39e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	3.2	1.0	5.3	1.7	24.7	1.0	22.4	0.7	8.2	5.4	3.8	15.9	0.0	0.5	7.1	4.0	4.0	5.9	7.8	8.4	10.2	6.4	1.6	1.6	2.2	1.8	7.8	4.7	4.7	1.8	12.1	1.9	5.7	34.4	20.0	1.2	3.1	15.1	2.2	0.7	3.2	1.7	5.4	29.6	1.4	1.7	3.2	9.3	6.0	12.9	1.6	1.1	2.4	1.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	51.9	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.7	0.3	0.0	0.0	7.4	0.0	0.8	0.0	4.3	0.0	0.0	0.0	1.9	0.0	1.9	0.0	1.1	0.0	0.4	2.8	0.1	0.0	0.4	6.5	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	5.3	0.0	1.9	0.0	7.1	0.0	0.0	0.0	0.3	28.1	0.0	0.0	2.9	11.2	3.9	2.4	0.0	1.4	7.8	0.0	0.2	0.9	0.3	0.0	1.8	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	5.3	24.7	0.7	8.2	10.2	6.4	7.8	4.7	34.4	9.3	3.0	0.0	0.0	7.5	0.7	1.0	0.4	0.0	22.7	9.1	1.8	0.0	18.0	0.0	0.0	10.9	0.7	0.0	0.0	0.0	1.0	4.8	13.7	3.5	0.0	1.6	0.0	0.0	28.3	2.4	1.1	3.7	0.0	6.8	0.0	0.0	9.7	0.0	0.0	1.4	0.0	0.7	0.0	1.0	1.4	4.1	0.9	10.1	0.0	0.0	0.4
CST9	"CLM, CTES7A"	ENSG00000173335	"Cystatin 9"	Q5W186	20	23602410-23605876	"Predicted secreted proteins"		"Antimicrobial, Protease inhibitor, Thiol protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	11	"breast: 6.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	37	"breast cancer: 9.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029190	Uncertain				"Secreted - unknown location"	NA	NA					"HPA029190: AB_10602804"	"unprognostic (2.06e-2)"									"unprognostic (2.21e-4)"								0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CXorf36	"DIA1R, FLJ14103"	ENSG00000147113	"Chromosome X open reading frame 36"	Q9H7Y0	X	45148374-45200901	"Disease related genes, Predicted secreted proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"Endothelial cells: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.4"	"Cell line enriched"	"Detected in single"	59	"HUVEC TERT2: 43.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA002806	Uncertain				"Secreted - unknown location"	NA	NA		370000			"HPA002806: AB_1078595"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.47e-2)"	"unprognostic (3.11e-2)"	42.1	3.2	3.8	6.2	4.4	0.8	47.7	1.4	3.2	17.9	7.3	2.9	6.7	2.4	28.5	10.2	8.0	9.9	7.5	23.6	4.7	3.7	4.5	2.1	9.3	12.1	6.8	1.2	7.9	4.2	4.3	3.7	39.6	4.2	12.0	3.5	4.3	4.4	7.7	14.4	4.9	4.7	17.7	6.4	5.0	4.2	5.6	2.0	0.3	12.3	12.0	3.7	10.6	26.5	0.5	0.2	2.4	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.3	0.1	0.3	0.4	0.4	0.4	0.0	0.5	0.4	0.3	2.4	0.1	0.0	0.2	0.1	0.1	3.8	4.4	1.4	3.2	4.7	3.7	6.8	1.2	4.2	2.0	3.0	2.2	0.0	0.4	3.9	0.0	4.5	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.2	94.9	0.0	0.0	0.2	0.1	1.0	0.1	1.1	0.0	0.2	0.0	0.0	13.5	1.2	1.5	0.9	1.3	6.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	2.1	0.0	0.1	4.1	0.2	0.0	0.0	0.5
CYB5D2	MGC32124	ENSG00000167740	"Cytochrome b5 domain containing 2"	Q8WUJ1	17	4143168-4187310	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011032, HPA042299"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Endoplasmic reticulum, Plasma membrane"		"HPA011032: , HPA042299: AB_10793879"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.16e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.75e-2)"	"prognostic favorable (4.98e-6)"	"unprognostic (1.57e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.71e-3)"	"prognostic favorable (7.76e-5)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.03e-10)"	"unprognostic (2.01e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.97e-1)"	13.1	17.3	18.7	5.1	26.4	3.6	15.0	20.6	27.5	15.0	8.1	21.8	14.6	13.3	13.9	27.1	9.8	17.4	14.5	10.3	17.8	21.6	22.9	25.3	8.6	7.4	19.7	26.1	19.5	17.0	28.5	18.5	9.9	19.1	12.0	6.8	17.3	17.5	16.8	12.2	11.7	10.3	7.8	21.7	7.9	12.3	54.1	17.1	4.8	20.6	7.1	6.8	12.0	8.6	9.4	13.0	14.7	12.7	5.9	12.5	9.0	7.9	10.7	6.2	6.5	40.1	11.8	2.6	7.7	16.7	5.7	5.8	3.1	5.3	2.6	7.0	8.9	4.8	11.3	2.6	3.6	2.3	8.5	12.9	2.4	6.7	5.3	7.3	1.0	4.9	15.4	8.6	3.1	6.2	11.9	10.2	5.8	2.5	15.8	4.3	9.8	3.7	1.6	2.2	6.8	5.8	4.5	5.5	6.3	13.1	4.2	5.0	4.2	8.7	5.1	11.4	7.2	13.5	1.6	13.7	8.3	2.1	7.6	4.0	3.0	2.3	2.0	10.2	2.2	3.2	0.6	12.7	14.7	7.2	10.4	8.1	9.4	11.4	8.8	12.0	9.4	10.8	9.7	11.7	5.9	9.4	13.0	12.5	9.0	18.7	26.4	20.6	27.5	17.8	21.6	19.7	26.1	19.1	17.1	11.9	9.3	19.5	18.9	47.7	26.3	8.5	56.0	45.5	11.4	29.6	55.0	44.7	44.7	26.6	19.7	31.6	18.6	0.0	23.9	24.3	20.3	8.4	10.5	31.1	17.8	38.1	13.3	29.4	21.3	23.3	26.7	17.5	13.5	14.4	13.8	34.2	24.3	17.3	26.9	34.9	30.0	0.0	21.2	83.1	23.6	37.5	32.3	15.2	15.8	7.8
DEFB108B		ENSG00000184276	"Defensin beta 108B"	Q8NET1	11	71833200-71837710	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"Collecting duct cells: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"HaCaT: 2.8"									HPA042588	Uncertain				"Secreted - unknown location"	NA	NA					"HPA042588: AB_10959523"																		0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.3	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DHRS13	"MGC23280, SDR7C5"	ENSG00000167536	"Dehydrogenase/reductase 13"	Q6UX07	17	28897781-28903071	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 29.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 29.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022991	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA022991: AB_1853865"	"unprognostic (8.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (2.38e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.55e-1)"	2.3	6.0	5.9	5.1	7.9	31.7	5.9	24.9	5.7	6.4	4.5	6.4	9.0	4.1	2.6	6.5	6.7	4.0	3.0	2.7	5.3	10.9	6.9	27.0	4.1	8.6	6.7	5.4	3.6	9.5	8.5	5.3	9.5	9.9	14.9	3.5	5.0	11.8	10.9	1.1	6.8	3.0	3.2	5.6	8.0	5.5	2.8	3.6	4.4	5.5	1.2	8.1	9.2	5.1	4.0	3.1	29.7	3.5	4.6	6.3	3.1	5.6	3.6	8.5	10.8	1.3	1.9	8.3	3.1	4.0	5.7	8.8	11.2	3.4	15.6	5.3	0.6	6.6	5.1	12.0	3.4	2.4	15.7	11.6	8.8	6.7	6.1	3.2	4.4	1.0	1.4	3.1	3.6	3.8	4.0	1.7	11.0	19.7	5.4	1.1	10.2	9.7	7.4	5.2	14.9	0.5	15.5	8.1	12.0	10.5	9.6	12.3	10.3	4.9	34.0	6.6	4.7	22.6	7.2	0.5	1.8	5.6	4.4	4.2	12.6	11.8	9.7	5.4	5.6	4.5	0.4	2.3	1.6	4.8	3.5	5.9	3.6	6.1	6.0	3.1	4.0	6.3	4.6	29.7	4.6	3.3	1.7	5.7	3.1	5.9	7.9	24.9	5.7	5.3	10.9	6.7	5.4	9.9	3.6	3.0	3.4	3.0	11.5	1.3	5.4	0.4	2.5	0.0	3.4	7.0	2.0	21.6	8.3	7.8	10.7	2.9	2.4	46.7	2.4	18.2	1.9	9.4	1.1	3.8	5.2	4.8	2.9	6.7	0.8	3.8	1.1	2.7	5.0	24.4	2.7	6.9	3.2	2.9	0.4	2.9	5.0	6.5	1.4	1.5	12.6	1.5	11.3	5.3	5.7	4.3
DHRS4L2	SDR25C3	ENSG00000187630	"Dehydrogenase/reductase 4 like 2"	Q6PKH6	14	23969874-24006408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Hepatocytes: 186.0;Proximal tubular cells: 502.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"	"Secreted - unknown location"	NA	NA			Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.41e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-3)"	"unprognostic (7.34e-2)"	"prognostic favorable (3.21e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.65e-2)"	6.3	11.2	6.9	12.8	7.9	3.0	11.4	14.6	9.6	7.2	9.9	3.4	2.6	12.1	5.6	10.4	25.5	5.4	4.3	8.9	5.0	4.1	42.0	33.0	16.7	7.2	4.6	2.4	7.1	28.4	6.0	5.2	3.1	7.6	8.3	9.5	5.4	14.2	10.9	18.7	9.8	14.9	6.4	5.6	8.1	7.1	28.2	4.5	13.8	5.9	32.8	14.5	5.3	7.1	10.4	22.3	3.2	27.2	7.9	11.5	14.7	8.5	12.9	2.2	11.0	21.4	22.4	0.2	7.7	15.3	11.3	8.4	3.7	10.1	5.6	5.3	15.5	7.3	9.3	9.9	12.9	9.4	18.2	6.0	1.3	11.2	23.0	15.8	7.1	22.2	23.1	16.4	7.3	10.8	7.8	13.2	17.3	4.3	19.9	12.1	26.9	17.7	7.4	4.4	20.1	14.3	28.0	9.1	17.4	16.2	11.3	12.0	7.2	10.6	9.8	6.4	4.9	11.8	10.7	9.3	6.0	6.2	7.0	3.9	11.6	9.2	1.6	5.2	10.3	8.5	2.3	27.2	3.2	10.1	22.5	10.4	10.4	10.8	11.5	22.3	8.2	11.1	10.1	1.3	7.9	13.2	18.3	10.3	14.7	6.9	7.9	14.6	9.6	5.0	4.1	4.6	2.4	7.6	4.5	14.9	23.5	21.4	38.6	24.6	9.7	15.1	17.8	32.1	23.9	24.4	2.0	16.3	107.8	33.6	16.0	33.7	49.1	23.3	48.9	6.2	41.2	29.1	17.3	186.0	120.7	11.1	35.8	45.4	59.2	31.0	40.6	42.6	49.0	45.9	56.0	58.7	33.6	63.1	35.0	502.2	6.9	32.3	38.1	8.9	1.4	35.1	10.9	27.3	69.8	32.0
EGFL8	"C6orf8, NG3"	ENSG00000241404	"EGF like domain multiple 8"	Q99944	6	32164583-32168281	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;Hep G2: 3.6;NB-4: 3.0;SK-MEL-30: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061173	Uncertain		Approved	"Nuclear speckles,Vesicles"	"Secreted - unknown location"	NA	NA			Vesicles	"Nuclear speckles"	"HPA061173: AB_2684443"	"unprognostic (7.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.60e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.60e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	4.5	6.3	7.3	2.6	7.6	4.5	5.0	6.3	9.4	7.1	6.7	8.4	8.7	4.7	6.4	5.5	4.3	4.8	8.4	4.8	8.2	4.4	4.3	1.8	4.3	2.0	25.7	3.9	14.4	2.9	1.3	2.9	9.2	14.1	6.0	2.7	14.7	3.9	5.3	3.8	12.9	5.8	3.0	11.9	3.5	3.9	2.3	7.0	0.2	3.1	8.3	2.0	5.2	6.8	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.3	1.3	3.2	0.4	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.2	0.0	0.0	2.0	1.3	0.4	0.0	0.0	1.9	0.0	1.0	3.6	1.1	0.0	0.7	0.0	0.3	0.3	0.0	0.1	0.7	2.2	0.3	0.0	0.0	1.7	1.0	3.0	0.0	0.3	0.0	1.1	0.1	0.0	0.2	0.6	0.5	1.2	0.0	0.1	3.7	0.0	1.4	2.2	0.0	0.8	1.7	0.0	0.1	0.0	0.1	0.1	0.1	1.1	1.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.3	7.6	6.3	9.4	8.2	4.4	25.7	3.9	14.1	7.0	6.0	5.5	0.0	0.6	1.3	1.4	0.1	0.0	2.7	2.3	1.8	2.0	0.7	0.0	0.2	0.1	1.0	0.0	0.0	0.2	0.3	0.8	0.6	0.0	0.0	0.2	0.0	0.0	2.5	0.3	0.0	3.4	0.0	0.0	0.0	1.0	1.1	0.2	0.0	1.1	0.0	1.1	0.0	1.2	0.4	0.4	1.9	0.7	0.0	1.2	0.4
EGFLAM	"AGRINL, AGRNL, FLJ39155, PIKA"	ENSG00000164318	"EGF like, fibronectin type III and laminin G domains"	Q63HQ2	5	38258409-38465021	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 54.7"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 113.9;Leydig cells: 143.8;Sertoli cells: 84.1;Smooth muscle cells: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 7.2;HBEC3-KT: 8.7;hTERT-HME1: 11.6;HUVEC TERT2: 11.1;LHCN-M2: 25.6;U-2 OS: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA066577	Approved				"Secreted - unknown location"	NA	NA					"HPA066577: "	"unprognostic (2.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (7.02e-6)"	"unprognostic (2.60e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.04e-2)"	18.6	10.4	0.8	3.1	2.6	0.0	25.9	1.5	0.7	7.8	4.0	1.5	5.1	0.8	9.3	9.2	6.3	3.9	4.0	7.8	0.6	1.1	4.8	3.5	1.5	11.0	1.3	0.6	16.6	1.4	2.1	3.0	25.7	3.5	9.9	1.5	19.8	6.6	11.1	54.7	2.9	2.3	3.5	2.2	8.1	1.8	9.1	1.3	4.9	4.6	19.4	4.2	6.0	6.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	4.6	0.1	0.5	0.1	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.1	7.2	0.0	0.1	0.0	0.0	8.7	0.0	0.0	1.1	0.0	4.1	0.0	2.0	0.0	0.0	3.9	0.0	0.0	11.6	0.0	11.1	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	2.7	0.0	2.6	0.1	1.0	0.0	0.1	0.0	0.1	11.2	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	2.6	1.5	0.7	0.6	1.1	1.3	0.6	3.5	1.3	0.0	0.0	0.0	0.2	2.4	1.0	2.0	0.0	0.0	0.0	0.0	113.9	0.4	3.3	0.4	41.7	3.3	0.0	0.0	0.9	0.4	12.7	0.2	0.0	0.0	0.6	0.0	0.0	1.3	0.0	39.1	143.8	0.6	5.0	0.0	0.0	1.5	0.9	0.0	29.0	2.9	30.1	84.1	78.8	8.1	3.1	1.8	0.5	0.0	0.0	0.3
ENDOD1	KIAA0830	ENSG00000149218	"Endonuclease domain containing 1"	O94919	11	95089810-95132645	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008932, HPA010517"	Enhanced		Approved	"Nuclear membrane"	"Secreted - unknown location"	NA	NA		19000000	"Nuclear membrane"		"HPA008932: AB_2262252, HPA010517: AB_1852351"	"unprognostic (8.81e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.64e-7)"	"unprognostic (5.92e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (3.27e-4)"	14.9	13.8	20.3	7.9	27.9	4.1	15.0	14.3	31.0	17.6	25.4	52.6	9.7	8.4	13.7	12.2	19.0	13.1	12.2	14.4	24.0	22.3	18.9	4.9	10.6	7.3	33.5	20.1	12.0	4.7	48.8	11.8	12.1	40.6	36.5	29.4	15.5	12.5	22.9	34.4	20.6	14.5	16.2	40.4	22.9	8.3	9.3	25.5	0.5	12.6	12.3	6.7	9.0	16.5	7.3	2.9	1.3	5.4	3.1	5.9	6.1	1.1	1.7	2.2	1.3	62.5	20.0	9.2	8.3	1.8	2.2	2.3	8.6	15.1	8.0	10.3	6.6	5.0	11.1	2.1	11.4	0.8	6.3	1.6	17.3	0.8	3.6	6.8	3.1	22.4	18.1	14.9	1.3	4.2	15.3	7.7	7.7	3.5	5.2	8.3	2.9	1.3	0.1	0.5	12.4	5.6	5.8	0.0	3.3	6.6	9.3	1.1	0.9	3.5	3.5	6.2	3.1	3.6	0.9	5.5	12.2	3.6	8.1	3.5	4.3	3.2	0.6	3.7	1.7	27.2	1.3	1.3	0.9	5.9	3.2	5.5	7.2	3.9	5.0	2.9	7.3	3.2	3.8	0.6	3.1	5.4	1.3	2.2	6.1	20.3	27.9	14.3	31.0	24.0	22.3	33.5	20.1	40.6	25.5	8.9	14.2	11.5	14.8	7.1	2.1	4.4	17.8	1.4	11.4	10.4	0.0	4.6	1.7	4.5	2.5	22.4	35.5	23.3	7.7	6.5	8.6	20.7	13.9	2.9	2.9	0.0	15.5	38.1	4.3	2.6	9.5	5.5	27.0	1.0	22.5	1.9	6.1	40.2	14.2	9.3	0.6	38.8	19.1	0.3	3.6	10.9	10.4	5.1	18.4	8.6
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 80.9;Peritubular cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 23.1;LHCN-M2: 13.8;U-138 MG: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	NA	NA		2500000			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	17.2	2.1	0.5	1.9	0.5	0.0	30.5	0.6	0.4	8.5	2.8	1.6	8.3	1.1	25.7	7.1	1.5	6.4	2.6	1.9	0.5	0.7	10.9	19.4	2.0	0.7	1.1	0.0	7.3	17.5	22.2	27.0	28.9	0.8	3.3	1.2	13.4	5.4	6.5	2.1	1.7	2.6	6.8	2.0	1.2	1.7	4.6	0.3	2.0	13.2	6.9	1.4	3.2	7.7	0.6	2.2	1.4	0.3	4.6	1.7	0.1	0.0	0.8	0.8	0.0	23.1	3.6	0.0	6.0	6.1	2.3	6.4	2.6	0.7	0.0	0.5	3.8	4.8	0.0	0.8	0.1	9.9	0.2	1.1	0.0	0.7	7.7	0.7	0.0	2.8	5.9	0.2	6.4	0.2	2.7	2.8	0.5	0.0	1.2	13.8	1.6	0.0	0.0	5.2	1.0	0.9	0.0	6.7	0.1	0.1	0.3	2.3	0.0	0.1	0.8	2.7	4.0	2.5	0.0	1.8	18.5	0.7	1.3	5.8	2.2	0.0	0.0	8.4	0.0	2.3	1.4	0.2	0.3	0.3	0.2	1.7	0.3	0.3	0.3	2.2	0.6	0.3	0.3	1.0	4.6	0.3	0.3	0.2	0.1	0.5	0.5	0.6	0.4	0.5	0.7	1.1	0.0	0.8	0.3	0.0	1.7	1.5	10.5	1.3	4.0	2.8	5.1	0.0	0.0	1.8	0.0	2.0	5.0	0.1	3.9	1.9	7.7	0.0	8.8	1.3	25.4	3.4	0.0	80.9	4.3	1.6	0.0	2.5	3.3	4.7	23.3	1.3	1.7	0.0	8.6	4.4	7.9	3.5	65.7	15.6	0.3	12.9	10.5	1.4	1.3	1.1	5.1	0.0	1.7	1.6
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.0;intestine: 45.4;seminal vesicle: 70.7"	"Cell type enhanced"	"Detected in many"	20	"Enterocytes: 9.0;granulocytes: 33.7;Proximal tubular cells: 8.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	74	"basophil: 18.2"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 18.2"	"Group enriched"	"Detected in some"	18	"HEL: 5.2;Hep G2: 17.0;HMC-1: 7.6"	"Low region specificity"	"Detected in some"							HPA043772	Enhanced				"Secreted - unknown location"	NA	NA		480000			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	0.8	7.9	0.5	2.0	0.5	0.0	4.0	2.1	0.4	19.0	18.5	0.2	29.0	9.3	6.2	7.2	0.5	2.3	1.8	0.2	0.4	0.7	11.9	2.7	1.7	0.2	0.5	0.2	0.9	0.2	0.0	0.5	0.4	0.2	3.7	4.8	0.6	14.9	70.7	0.2	0.8	45.4	1.9	0.4	0.5	0.7	1.0	0.2	4.1	0.5	1.2	0.5	0.9	1.2	0.0	0.0	18.2	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	5.2	0.0	17.0	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.5	2.1	0.4	0.4	0.7	0.5	0.2	0.2	0.2	0.0	1.4	0.0	2.8	0.0	0.0	0.2	0.0	2.7	1.2	0.0	0.0	0.0	1.7	0.0	1.3	0.3	9.0	0.0	0.0	0.0	0.5	4.6	33.7	1.7	0.1	0.0	0.0	0.6	0.6	0.0	1.1	0.2	1.7	0.0	1.1	0.0	0.0	2.3	0.7	8.2	0.0	0.0	0.0	1.8	0.8	0.5	0.1	0.5	5.2	1.1
ERBB3	"HER3, LCCS2"	ENSG00000065361	"Erb-b2 receptor tyrosine kinase 3"	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 180.9;Enterocytes: 163.1;Paneth cells: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 30.9;MCF7: 20.2;OE19: 31.8;RT4: 24.2;SK-BR-3: 28.4;SK-MEL-30: 37.9;T-47d: 31.5;WM-115: 40.2"	"Low region specificity"	"Detected in many"							"CAB025331, HPA045396"	Uncertain		Supported	"Plasma membrane,Actin filaments"	"Secreted - unknown location"	NA	NA		420000	"Plasma membrane"	"Actin filaments"	"CAB025331: , HPA045396: AB_2679312"	"unprognostic (2.97e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.07e-2)"	1.1	1.4	11.6	12.6	16.5	0.6	26.8	2.0	16.7	6.8	40.5	40.3	12.0	37.7	2.8	7.5	29.4	5.7	22.9	3.4	18.6	9.0	16.5	33.9	13.4	0.5	23.5	9.3	0.9	21.5	11.4	1.0	15.4	14.9	16.8	29.7	5.5	36.8	22.3	1.1	30.7	41.3	3.2	27.4	0.5	32.9	1.2	23.8	0.0	4.5	7.4	8.5	11.8	14.4	0.9	0.7	5.3	0.6	1.2	1.2	0.2	10.0	0.6	0.8	0.3	0.0	0.0	16.4	0.8	1.9	1.1	1.1	5.5	18.2	0.0	0.2	0.2	0.1	8.6	1.2	1.9	0.6	0.2	0.8	0.0	0.3	30.9	0.0	0.0	0.1	0.4	2.5	0.2	0.0	0.2	0.0	0.1	0.7	0.3	0.1	20.2	0.1	0.3	2.8	31.8	0.4	0.1	1.9	0.5	2.1	24.2	0.9	0.3	0.7	28.4	37.9	2.7	31.5	0.1	0.0	0.1	1.1	0.6	0.1	0.2	0.1	0.1	0.1	0.0	40.2	5.3	0.4	0.8	0.9	0.4	0.4	0.4	0.7	0.3	0.3	0.9	0.6	1.2	3.3	1.2	0.6	0.7	0.8	0.2	11.6	16.5	2.0	16.7	18.6	9.0	23.5	9.3	14.9	23.8	110.2	61.2	1.3	13.0	16.3	1.5	1.4	180.9	21.4	61.4	33.2	2.0	44.4	1.7	41.9	0.9	2.2	163.1	0.0	77.1	73.6	2.7	83.4	1.1	83.9	5.5	0.0	89.5	6.7	1.9	0.0	1.4	1.7	52.3	2.8	134.3	11.3	75.9	165.5	0.0	31.8	1.1	6.5	1.7	2.4	2.3	32.2	84.1	1.5	124.3	62.5
FAM131A	"C3orf40, MGC21688"	ENSG00000175182	"Family with sequence similarity 131 member A"	Q6UXB0	3	184335926-184348421	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 54.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 31.7;basal ganglia: 23.9;cerebral cortex: 59.8;hippocampal formation: 86.5"	HPA042800	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"	"Secreted - unknown location"	Yes	No			"Nucleoli rim"	"Mitotic chromosome"	"HPA042800: AB_10797023"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.88e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.02e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.28e-2)"	8.1	14.9	18.8	4.6	26.4	2.5	5.0	21.9	54.7	5.4	6.4	8.0	4.8	6.3	7.5	4.9	7.5	7.7	8.4	11.9	28.1	13.0	4.1	3.0	6.0	3.4	9.1	25.9	8.8	11.3	9.2	16.4	5.0	7.8	6.7	3.5	3.3	7.1	11.7	9.3	10.5	5.8	8.7	5.9	5.3	5.5	7.0	7.0	0.8	3.5	3.9	2.7	5.5	4.1	2.1	5.5	11.1	6.5	1.6	2.2	2.5	8.2	3.4	5.5	9.7	7.5	6.2	5.2	3.7	8.4	5.9	4.6	2.6	2.9	1.2	15.5	3.6	12.6	7.8	0.0	6.7	3.8	8.8	9.3	0.0	5.2	5.6	7.6	0.1	6.5	4.6	1.1	5.0	11.6	5.5	11.8	5.7	1.8	1.3	2.2	6.4	3.2	0.2	9.4	5.1	6.9	5.8	2.2	7.9	5.9	0.2	16.9	17.6	2.3	6.5	8.6	3.7	19.1	2.1	11.9	7.2	5.6	5.8	11.6	14.0	8.4	0.8	23.2	1.2	5.1	2.0	4.8	6.0	1.5	6.5	1.6	2.0	1.2	1.6	5.5	2.1	1.2	1.5	11.1	1.6	3.4	2.3	2.2	2.5	18.8	26.4	21.9	54.7	28.1	13.0	9.1	25.9	7.8	7.0	6.0	5.3	6.7	16.9	9.8	21.2	5.1	10.2	16.0	1.2	14.0	13.7	8.2	1.7	5.6	3.9	8.8	13.1	23.3	2.9	2.7	5.4	12.7	6.9	1.5	6.8	22.3	9.2	15.4	5.4	0.7	17.3	8.3	1.7	9.0	6.4	14.1	7.4	8.6	19.4	3.0	16.3	6.5	10.3	11.6	6.8	12.8	27.8	4.4	8.1	13.1
FAM172A	"C5orf21, DKFZP564D172"	ENSG00000113391	"Family with sequence similarity 172 member A"	Q8WUF8	5	93618069-94111699	"Predicted intracellular proteins, Predicted secreted proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012299, HPA045505"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA012299: AB_1845724, HPA045505: AB_2679354"	"unprognostic (1.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.03e-2)"	18.4	15.4	24.2	17.8	21.8	9.8	19.3	28.8	20.8	19.9	14.4	15.5	13.9	11.2	19.1	16.1	17.7	18.8	14.3	14.0	21.0	19.9	18.5	8.0	14.9	22.4	18.9	13.0	23.0	18.2	20.7	28.4	15.1	15.6	19.4	12.3	12.6	14.3	22.6	6.2	11.8	12.9	26.2	20.8	13.6	13.7	8.3	16.6	16.1	22.8	9.5	16.1	19.0	15.7	9.8	7.1	13.1	7.3	12.3	11.9	6.4	4.6	5.4	13.3	14.9	16.0	19.4	6.9	9.9	7.7	4.3	4.3	3.7	6.5	6.7	7.5	11.6	7.7	4.1	4.0	14.0	10.1	4.5	4.8	8.9	11.3	2.5	6.8	6.8	10.3	16.9	8.0	3.9	7.6	15.6	9.8	6.3	1.8	2.0	17.7	5.1	5.7	5.2	2.0	8.6	4.4	6.4	14.0	6.3	6.8	9.0	11.9	21.2	8.0	3.4	7.3	8.7	8.2	8.3	9.7	10.3	9.3	6.7	11.7	8.6	12.5	7.6	16.2	7.6	18.8	13.1	5.4	7.0	11.9	7.3	11.9	9.4	8.9	8.7	7.1	9.8	10.1	10.2	13.0	12.3	5.1	6.8	9.2	6.4	24.2	21.8	28.8	20.8	21.0	19.9	18.9	13.0	15.6	16.6	50.6	23.7	24.4	21.0	10.9	48.1	20.2	28.1	62.9	25.0	10.4	29.5	11.1	51.4	16.4	38.4	23.3	15.8	0.0	18.6	10.7	16.0	19.5	24.3	12.4	10.1	39.7	16.3	17.8	18.0	23.9	35.6	17.5	20.3	22.6	11.5	34.6	17.2	13.9	34.3	27.9	51.6	12.9	17.9	19.0	23.5	8.8	9.2	23.5	16.4	20.4
FAM180A	"HWKM1940, UNQ1940"	ENSG00000189320	"Family with sequence similarity 180 member A"	Q6UWF9	7	135728348-135748846	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.0"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 6.6;Cardiomyocytes: 5.2;Fibroblasts: 5.8;Ito cells: 8.0;Leydig cells: 2.6;Melanocytes: 6.8;Peritubular cells: 3.9;Smooth muscle cells: 2.8;Suprabasal keratinocytes: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"U-2197: 74.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021224	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA			Nucleoplasm		"HPA021224: AB_1851352"	"unprognostic (3.85e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.62e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.88e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.35e-4)"	"unprognostic (6.62e-4)"	9.3	2.6	0.1	1.7	0.5	0.0	5.6	0.1	1.0	7.8	5.7	0.3	0.5	0.7	9.4	2.0	5.1	3.0	21.2	14.7	0.1	0.1	8.7	23.0	4.6	0.0	0.1	0.0	8.1	1.1	0.0	0.3	1.4	0.5	6.1	1.8	1.9	2.2	0.1	3.5	5.5	3.2	8.1	0.4	0.9	1.6	3.9	0.1	0.0	4.6	4.8	0.9	6.6	8.3	0.6	0.2	2.0	0.3	0.4	0.5	0.1	0.0	0.0	0.0	0.0	8.1	8.4	0.0	4.2	16.1	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	10.3	1.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	16.7	0.0	74.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.1	0.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.6	0.4	0.5	0.8	0.4	0.3	0.2	0.2	0.1	0.1	0.5	0.1	1.0	0.1	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	6.6	0.0	5.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	2.6	0.0	6.8	0.0	0.0	0.0	0.1	0.0	3.9	0.0	0.0	0.0	2.8	0.0	0.0	4.3	0.6	0.0	0.0	0.0
FAM198A	"C3orf41, DKFZP434B172"	ENSG00000144649	"Family with sequence similarity 198 member A"	Q9UFP1	3	42979267-43060211	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 11.9;Leydig cells: 9.2;Muller glia cells: 17.2;Peritubular cells: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.9;RPMI-8226: 6.2;SK-BR-3: 4.2;T-47d: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047726	Approved		Supported	Vesicles	"Secreted - unknown location"	NA	NA		440000	Vesicles		"HPA047726: AB_10960554"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.81e-1)"	8.9	3.5	6.2	3.7	8.3	0.1	5.4	4.1	6.8	10.8	3.5	6.1	2.4	1.3	11.7	9.4	4.0	13.8	13.0	2.0	7.2	2.6	1.3	12.1	3.8	1.1	5.1	5.5	9.4	3.0	0.3	2.6	3.2	11.2	2.7	1.8	4.0	4.1	3.8	1.4	1.8	2.5	9.2	5.2	1.2	4.3	3.1	6.8	0.0	2.0	1.1	0.6	3.8	4.2	0.0	1.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	5.9	0.2	0.0	1.7	0.3	0.6	0.0	0.0	0.2	1.8	0.0	1.8	0.0	2.8	0.0	0.7	0.0	0.0	0.0	2.5	0.9	0.0	0.0	1.3	0.5	2.1	1.2	0.0	0.6	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.4	0.0	3.4	0.0	0.0	0.0	0.0	6.2	0.0	0.8	0.1	0.4	0.0	4.2	0.0	0.3	11.9	1.4	0.0	0.8	1.2	2.4	0.0	0.4	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.2	1.2	0.0	0.0	6.2	8.3	4.1	6.8	7.2	2.6	5.1	5.5	11.2	6.8	0.0	0.0	0.0	0.1	0.1	1.2	0.6	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.1	0.6	0.3	0.0	0.0	0.2	1.9	3.1	0.2	0.0	11.9	3.1	3.2	0.0	1.8	0.3	0.0	9.2	0.0	0.0	1.0	0.0	17.2	0.3	0.0	18.7	0.3	1.6	6.5	1.4	0.9	0.9	0.5	2.3	0.0	0.0	0.0
FAM3A	"2-19, DXS560S, XAP-7"	ENSG00000071889	"Family with sequence similarity 3 member A"	P98173	X	154506159-154516242	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025016, HPA035268, HPA056991"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"	"Secreted - unknown location"	Yes	No			"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"CAB025016: , HPA035268: , HPA056991: AB_2683303"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.19e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.71e-2)"	18.9	18.9	18.9	14.7	20.9	13.7	17.3	13.4	25.7	22.3	21.2	31.1	16.3	37.0	18.2	16.2	19.3	19.1	25.3	31.4	21.3	18.7	19.8	28.5	16.1	16.7	23.0	16.4	29.1	35.5	18.2	22.1	21.0	18.5	20.6	9.9	17.3	29.4	34.7	33.4	15.3	33.7	14.4	25.4	18.4	23.6	10.7	16.8	13.5	28.8	16.1	12.2	16.9	16.9	8.0	13.3	21.2	11.5	8.5	13.3	8.9	16.6	16.0	4.0	13.5	12.2	6.2	11.4	8.5	5.9	5.9	7.0	7.3	10.1	10.8	43.4	14.2	11.5	12.1	6.3	7.5	1.4	8.8	8.6	4.2	14.0	5.1	19.1	2.8	6.8	7.7	6.8	12.1	8.5	7.0	4.1	7.0	8.0	8.0	6.7	17.4	5.2	12.3	1.7	18.1	20.1	6.5	4.0	29.7	6.4	6.9	8.0	6.1	3.9	9.5	14.0	3.1	7.2	4.4	4.5	7.9	4.8	21.4	11.5	30.8	16.8	13.2	14.6	7.4	8.1	21.2	9.9	12.5	13.3	11.5	12.9	6.2	8.2	9.3	9.9	8.0	10.2	11.9	5.0	8.5	9.5	13.3	8.5	8.9	18.9	20.9	13.4	25.7	21.3	18.7	23.0	16.4	18.5	16.8	11.9	14.7	8.0	19.3	14.4	23.0	20.5	25.5	8.1	6.8	21.0	13.7	39.7	23.2	22.8	0.6	17.7	66.7	23.3	37.0	40.6	24.2	23.6	5.7	27.2	26.3	20.6	16.8	20.3	14.9	1.6	31.1	13.9	32.1	19.0	45.1	25.5	24.3	49.1	27.6	26.2	15.2	6.5	16.0	3.7	8.6	18.4	59.6	19.3	33.2	20.3
FAM46B	MGC16491	ENSG00000158246	"Family with sequence similarity 46 member B"	Q96A09	1	27005020-27012836	"Predicted secreted proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 55.8;tongue: 42.0"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 59.6;Basal keratinocytes: 91.9;Suprabasal keratinocytes: 129.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 87.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;intermediate monocyte: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 32.4;hTERT-HME1: 16.7;NTERA-2: 17.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"	NA	NA						"unprognostic (1.67e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.44e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	3.3	0.6	0.6	3.9	0.3	0.1	10.4	0.3	0.4	20.6	13.4	0.4	3.6	0.8	8.0	2.8	55.8	5.5	4.0	9.1	0.2	0.0	3.8	0.5	11.6	0.7	0.4	0.9	3.8	1.2	1.0	0.7	7.4	0.9	6.8	1.2	1.5	23.5	11.1	0.9	36.3	3.5	21.5	0.3	0.4	6.8	4.6	0.1	0.6	3.1	42.0	18.7	23.0	13.6	0.0	0.4	1.3	2.5	0.0	0.0	0.0	1.9	0.3	4.0	1.2	0.5	0.6	1.0	2.8	0.9	11.3	4.5	7.7	2.6	0.0	4.8	1.5	2.5	6.3	0.7	10.3	3.0	0.0	0.6	0.1	1.5	1.3	5.7	0.0	0.2	2.6	32.4	3.4	16.7	0.0	0.1	0.0	0.2	0.0	1.4	1.5	0.0	0.6	17.0	1.4	0.8	0.2	0.0	0.1	11.0	0.0	0.4	0.3	5.4	12.2	7.1	8.7	9.6	0.1	0.2	2.7	9.4	0.3	0.6	0.1	0.4	0.0	0.5	0.0	1.7	0.0	0.0	1.3	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.4	0.2	0.0	0.4	0.9	0.9	0.1	59.6	1.9	0.0	24.5	91.9	0.1	0.0	0.0	2.7	0.0	0.0	0.0	1.7	0.0	0.0	1.4	0.5	1.1	0.0	0.0	2.6	2.4	12.8	0.0	0.0	0.5	0.0	7.0	1.8	0.0	1.4	4.6	0.8	6.8	0.0	1.2	5.0	0.0	0.0	1.8	0.0	0.6	0.0	17.8	5.8	3.9	129.2	4.5	0.0	0.9	10.6
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478334-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.8"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 191.1;Club cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 10.8;eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 58.9;BEWO: 19.8;CACO-2: 15.4;HaCaT: 17.8;HAP1: 19.1;NTERA-2: 18.9;T-47d: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		500000	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	2.1	8.8	16.4	3.0	30.3	0.0	9.9	15.8	21.3	6.8	14.1	55.7	5.6	4.2	22.0	6.6	10.2	12.5	12.5	1.4	20.6	11.1	11.4	16.1	13.1	1.0	41.2	13.3	7.4	12.8	25.5	2.5	6.2	30.2	11.7	8.7	16.4	23.8	24.3	0.4	45.4	4.7	18.3	74.8	0.5	9.3	2.9	32.1	0.8	23.4	1.6	3.4	6.9	8.5	0.1	0.1	10.8	0.1	0.1	0.3	0.0	2.2	0.1	9.2	58.9	0.0	0.0	19.8	0.1	0.0	0.0	0.0	15.4	0.3	0.0	4.2	0.9	0.0	17.8	19.1	4.0	0.0	0.0	4.1	0.0	0.0	0.3	0.4	0.0	3.8	0.0	8.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	18.9	2.7	0.0	0.0	0.0	2.3	5.7	5.0	0.1	0.1	0.1	10.8	0.0	11.5	15.8	0.0	0.0	0.1	2.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	10.8	0.1	4.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	16.4	30.3	15.8	21.3	20.6	11.1	41.2	13.3	30.2	32.1	17.9	31.8	0.0	29.5	35.6	0.0	2.7	191.1	18.7	52.4	34.9	0.0	12.6	0.0	4.0	2.9	0.5	2.6	0.0	0.2	2.7	17.5	9.8	0.0	4.3	2.0	0.0	2.4	3.1	0.3	6.5	1.1	1.3	5.0	1.0	32.0	1.6	0.6	1.4	5.6	11.5	0.1	0.0	2.1	0.9	7.7	24.2	3.3	1.5	3.0	27.7
GATD1	"FLJ34283, PDDC1"	ENSG00000177225	"Glutamine amidotransferase like class 1 domain containing 1"	Q8NB37	11	767220-777488	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 41.7;Alveolar cells type 2: 23.2;Collecting duct cells: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 50.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008812	Uncertain		Supported	Nucleoplasm	"Secreted - unknown location"	NA	NA			Nucleoplasm		"HPA008812: AB_10962724"	"unprognostic (3.39e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.23e-3)"	"unprognostic (4.89e-3)"	"prognostic favorable (3.79e-5)"	"unprognostic (2.84e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.61e-3)"	16.7	36.5	26.6	16.3	24.9	10.6	19.1	30.9	29.8	15.1	15.0	20.7	19.8	23.3	17.7	22.4	16.6	18.8	20.0	16.7	27.0	26.2	19.8	18.6	15.3	15.6	25.8	19.4	21.9	16.6	15.5	22.9	16.4	22.0	18.6	10.5	15.8	20.0	23.8	19.2	27.2	21.5	12.6	21.7	17.2	19.1	17.5	21.5	12.8	17.0	13.0	11.5	11.9	14.3	4.0	9.5	1.3	8.7	1.7	4.7	2.8	16.8	9.8	9.4	10.1	4.4	6.8	9.1	10.0	4.4	9.3	8.3	7.0	26.4	9.2	3.7	6.6	10.1	18.1	7.0	8.9	4.7	11.7	50.6	5.6	14.7	14.8	7.6	10.5	12.0	9.7	9.9	4.0	6.1	8.6	7.1	10.7	13.7	8.4	5.2	4.9	11.8	11.3	9.0	5.5	18.0	13.0	6.4	11.5	8.2	3.8	24.4	9.6	9.7	13.9	6.8	2.6	12.0	6.9	13.0	10.1	7.6	5.4	7.7	10.1	5.1	11.7	15.3	14.0	8.2	1.3	7.0	1.3	4.7	8.7	3.4	4.0	4.5	4.4	9.5	3.5	3.9	2.6	0.7	1.7	3.5	5.5	2.1	2.8	26.6	24.9	30.9	27.7	27.0	26.2	25.8	19.4	22.0	21.5	41.7	23.2	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.6	21.0	0.0	11.0	5.0	9.7	0.0	0.0	0.0	0.0	6.5	6.9	0.0	0.0	5.8	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	8.2	0.0	0.0	11.7	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0
GFOD1	"ADG-90, C6orf114, FLJ20330"	ENSG00000145990	"Glucose-fructose oxidoreductase domain containing 1"	Q9NXC2	6	13357830-13487662	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 12.8;NK-cell: 11.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;NK-cells: 11.4"	"Cell line enhanced"	"Detected in many"		"HEL: 18.8;HMC-1: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029096	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted - unknown location"	No	No			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029096: AB_10602320"	"unprognostic (5.00e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.72e-5)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.66e-3)"	15.7	3.8	9.4	4.6	11.5	17.5	8.7	28.5	22.3	5.4	5.0	4.0	0.5	3.5	4.0	2.6	12.1	4.3	11.8	18.5	11.9	7.1	2.1	6.6	8.2	6.6	6.3	14.2	1.7	2.3	3.9	3.3	6.8	6.6	4.4	5.2	1.5	3.4	3.0	15.5	4.7	5.6	8.3	4.2	12.0	8.2	1.5	4.1	1.9	3.9	4.5	6.9	4.7	7.6	2.3	0.2	12.8	0.8	11.4	1.4	0.8	7.4	0.7	0.6	1.3	1.1	1.1	0.8	0.6	0.3	0.4	0.2	0.2	0.5	10.2	10.6	0.7	0.6	6.6	2.0	3.2	0.4	0.7	3.8	18.8	3.9	3.9	1.5	5.4	29.1	0.6	2.5	1.0	2.8	1.6	5.7	2.7	0.6	0.9	0.8	2.4	1.2	3.3	1.0	2.5	2.2	4.1	1.4	5.2	0.3	1.4	3.5	0.6	2.5	0.4	2.4	1.4	0.6	0.5	7.7	0.9	2.0	2.2	3.3	8.5	4.8	12.2	0.8	3.2	0.2	0.1	0.4	12.8	1.4	0.7	0.2	2.3	0.2	0.6	0.2	1.9	0.1	0.5	0.3	11.4	0.8	0.0	0.1	0.8	9.4	11.5	28.5	18.7	11.9	7.1	6.3	14.2	6.6	4.1	0.0	2.6	12.7	4.9	18.0	38.9	87.7	12.7	12.0	0.0	0.0	0.0	0.4	0.0	4.3	0.0	36.2	13.5	46.7	2.7	27.6	5.8	2.3	4.6	16.8	2.4	1.6	8.1	33.2	15.8	0.0	2.3	10.4	11.8	0.0	11.8	2.0	18.1	31.7	1.1	0.5	3.0	12.9	20.8	0.0	1.7	19.6	0.6	34.8	3.3	4.7
GFOD2	"FLJ23802, MGC11335"	ENSG00000141098	"Glucose-fructose oxidoreductase domain containing 2"	Q3B7J2	16	67674531-67719421	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040939, HPA041112"	Uncertain		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA040939: AB_10796564, HPA041112: AB_10794541"	"unprognostic (9.80e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.64e-2)"	9.0	9.4	9.6	7.7	13.8	13.4	8.6	42.9	18.9	10.7	10.6	5.0	9.4	10.7	8.1	5.9	21.8	12.2	8.4	6.8	10.1	12.4	9.8	24.4	7.9	6.9	8.2	11.1	5.6	9.0	14.1	11.7	19.4	10.8	7.4	8.7	6.4	8.7	7.2	6.5	14.1	8.1	8.6	5.7	12.8	7.5	8.3	5.1	6.1	9.7	13.2	12.8	9.0	16.4	9.1	6.5	10.6	5.5	6.4	10.2	4.1	9.3	15.2	9.3	19.2	9.5	7.1	11.0	7.8	10.1	14.6	15.0	12.9	8.6	15.8	7.3	9.0	7.8	11.8	9.6	9.0	12.4	9.4	11.8	4.0	8.1	18.3	7.2	6.5	7.8	5.9	10.4	19.3	5.8	7.2	21.0	16.2	8.2	3.1	8.1	19.9	10.6	7.8	12.6	5.6	8.3	17.0	5.5	12.2	8.9	13.3	19.1	11.2	19.3	6.5	5.9	5.7	9.9	4.3	16.1	11.4	11.4	10.1	7.7	8.0	11.3	17.2	7.0	9.5	8.1	0.7	5.5	5.7	5.6	3.5	9.0	8.0	9.5	9.6	5.6	9.1	8.4	6.6	10.6	6.4	3.4	6.5	10.2	4.1	9.6	13.8	42.9	18.9	10.1	12.4	8.2	11.1	10.8	5.1	0.0	5.9	5.4	11.8	20.4	12.7	3.7	20.4	20.1	10.3	10.4	13.7	8.1	5.0	17.9	77.4	35.6	18.8	0.0	10.2	17.9	10.3	10.3	4.6	39.5	5.8	20.6	41.5	26.4	6.3	21.4	8.1	4.7	8.5	3.6	15.0	11.3	13.3	18.2	10.6	10.1	9.9	6.5	12.3	14.2	17.9	23.8	18.5	10.2	15.6	15.5
GLB1L	MGC10771	ENSG00000163521	"Galactosidase beta 1 like"	Q6UWU2	2	219236606-219245478	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.0"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043058	Enhanced				"Secreted - unknown location"	NA	NA					"HPA043058: AB_10806375"	"unprognostic (4.30e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.48e-3)"	"unprognostic (3.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.50e-2)"	6.9	5.4	2.7	2.0	3.7	2.3	5.6	1.6	3.3	4.0	5.8	4.6	4.5	1.6	5.3	7.9	2.5	14.3	8.6	3.4	3.1	3.5	18.5	3.5	4.1	2.5	2.1	2.1	6.1	3.1	11.7	6.7	7.4	5.6	4.5	2.0	13.2	5.8	3.0	1.4	2.5	4.4	3.4	2.3	3.9	2.1	57.0	1.4	3.1	5.0	1.4	2.4	4.0	2.0	1.7	2.8	3.2	8.9	1.4	1.8	2.2	2.4	4.3	6.7	5.4	7.4	9.1	3.4	4.1	8.7	5.2	4.9	1.6	6.9	0.8	3.7	3.6	3.9	1.3	1.9	4.0	4.1	2.2	3.3	2.5	6.2	3.9	18.3	0.9	4.0	10.8	2.5	4.9	3.0	12.3	4.6	3.8	1.5	4.8	4.8	3.5	2.1	2.5	1.1	0.9	1.2	2.2	3.7	3.4	10.5	1.4	4.3	3.9	3.4	4.8	4.0	4.7	7.5	2.2	3.6	4.4	5.3	2.5	2.2	4.6	1.3	1.3	8.1	1.1	11.0	2.0	7.0	0.5	1.1	8.9	0.6	0.6	0.9	1.1	2.8	1.7	1.8	1.3	3.2	1.4	6.7	1.2	0.3	2.2	2.7	3.7	1.6	3.3	3.1	3.5	2.1	2.1	5.6	1.4	3.0	3.2	0.8	2.5	1.5	4.8	1.7	2.5	24.1	7.9	3.5	11.8	2.9	3.3	3.1	21.1	2.5	2.1	0.0	1.6	1.5	4.4	2.7	0.0	1.0	11.7	3.2	4.7	9.8	6.1	17.2	10.0	4.5	8.5	1.0	2.8	3.5	1.7	2.3	6.0	15.3	9.5	6.5	1.2	80.3	5.4	1.5	1.1	2.1	1.7	1.6
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 36.2"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 158.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 5.8;NK-cell: 5.8"	"Group enriched"	"Detected in many"	23	"NK-cells: 5.8;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.6;HaCaT: 20.7;OE19: 47.6;SCLC-21H: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA054808, HPA059955"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA			Nucleoplasm	Vesicles	"HPA054808: AB_2682608, HPA059955: AB_2684178"	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	0.8	1.2	1.6	4.4	4.2	0.1	4.5	0.3	2.5	6.0	13.5	4.5	8.7	3.6	20.5	6.6	3.0	17.1	15.7	0.8	2.2	2.7	13.8	0.3	4.1	1.3	0.9	1.4	9.5	6.5	22.7	8.6	5.4	11.2	23.5	7.8	36.2	5.2	17.4	0.8	5.9	2.7	5.6	0.7	0.2	5.7	7.0	0.3	1.4	15.0	5.2	2.6	5.1	2.9	0.2	0.0	0.0	0.0	5.8	5.8	0.8	6.0	0.6	3.3	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	5.1	19.6	0.0	6.5	0.0	2.7	20.7	9.9	0.1	0.0	0.0	9.4	0.0	2.6	0.2	0.9	0.0	11.4	0.1	0.3	0.0	0.0	0.0	0.0	3.0	9.9	0.0	0.0	5.8	1.6	1.1	1.8	47.6	7.2	0.0	0.0	0.5	5.6	4.3	14.0	5.2	4.4	5.6	0.0	0.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	1.2	0.0	0.0	0.0	5.8	0.0	2.3	0.0	1.3	2.3	0.0	0.2	1.6	2.6	0.0	5.8	0.0	0.0	0.0	0.8	1.6	4.2	0.3	2.5	2.2	2.7	0.9	1.4	11.2	0.3	0.0	2.6	0.0	4.2	1.9	6.1	1.0	2.5	8.1	3.4	0.0	39.3	0.2	0.0	2.0	1.7	0.6	9.7	0.0	2.1	0.9	1.5	7.6	0.0	0.0	0.2	4.8	8.6	0.0	0.0	4.9	1.1	0.0	5.0	0.0	5.8	8.1	1.7	8.2	0.7	8.1	158.9	0.0	1.9	2.3	4.2	0.6	0.1	1.3	10.7	2.6
GLT1D1	FLJ31978	ENSG00000151948	"Glycosyltransferase 1 domain containing 1"	Q96MS3	12	128853427-128984968	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.1;bone marrow: 25.4;liver: 24.7"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 11.5;Hepatocytes: 7.9;Kupffer cells: 11.4;Late spermatids: 34.0;Muller glia cells: 9.8"	"Group enriched"	"Detected in some"	6	"liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 23.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 23.1"	"Group enriched"	"Detected in some"	6	"MOLT-4: 12.4;NTERA-2: 18.0;SCLC-21H: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039051, HPA039052"			Enhanced	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA039051: AB_10673299, HPA039052: AB_10672839"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.41e-1)"	3.0	0.6	7.0	7.0	12.4	25.4	0.6	7.1	15.5	1.8	0.6	1.2	0.2	0.5	4.1	1.4	0.9	2.1	2.1	1.2	6.3	10.5	1.2	24.7	2.2	4.5	5.8	6.4	0.6	1.2	0.4	1.0	1.0	7.6	1.3	0.7	2.6	0.4	1.9	8.2	1.3	0.6	3.6	1.6	9.2	0.6	14.7	1.3	0.1	2.0	0.0	0.8	1.7	0.6	0.0	1.4	23.1	3.8	0.0	0.3	0.8	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.3	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.1	0.0	1.1	1.4	0.0	0.8	7.0	12.4	7.1	15.5	6.3	10.5	5.8	6.4	7.6	1.3	0.0	0.0	0.5	0.0	0.8	0.4	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	1.5	0.0	0.0	1.8	11.4	34.0	0.3	1.7	1.7	0.0	0.0	9.8	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.6	0.2	0.3	0.1	0.0	0.0	0.0
GLTPD2		ENSG00000182327	"Glycolipid transfer protein domain containing 2"	A6NH11	17	4788959-4790390	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 13.0;kidney: 9.8;liver: 44.4"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 65.2;Proximal tubular cells: 128.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 25.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 3.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.7;CACO-2: 11.8;Hep G2: 15.5;MCF7: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA058295, HPA065267"	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA058295: AB_2683671, HPA065267: AB_2685451"	"unprognostic (4.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (5.62e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.25e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.71e-4)"	"unprognostic (7.59e-3)"	0.2	0.3	0.5	0.2	0.7	0.8	0.2	0.8	1.8	0.2	8.0	0.3	0.2	8.6	0.3	0.2	0.4	0.3	0.2	0.2	0.5	0.7	9.8	44.4	0.6	0.2	0.5	0.4	0.2	0.5	0.2	0.5	0.2	0.4	0.2	0.0	0.5	0.8	0.2	0.8	1.4	13.0	0.2	0.4	0.8	0.9	0.2	0.2	0.4	0.2	1.6	0.3	0.4	0.3	0.0	0.5	0.0	3.2	0.0	0.2	0.2	0.6	2.5	0.2	2.1	0.0	0.0	4.7	0.4	0.0	0.0	0.0	11.8	0.9	1.2	1.3	0.0	0.4	2.3	0.0	0.1	0.0	2.2	1.8	0.1	1.0	15.5	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.7	0.6	0.0	5.4	0.2	0.2	0.3	0.6	1.0	0.9	0.6	0.3	0.0	0.9	1.6	1.0	2.2	0.4	0.6	0.1	1.4	0.1	2.5	0.8	1.0	0.5	0.4	0.2	0.6	0.1	0.3	0.7	0.9	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.2	0.5	0.7	0.8	0.7	0.5	0.7	0.5	0.4	0.4	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.3	0.0	65.2	0.1	0.0	0.0	1.8	1.3	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	128.9	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.5
HHIPL1	KIAA1822	ENSG00000182218	"HHIP like 1"	Q96JK4	14	99645110-99680569	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 14.1"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 11.2;Melanocytes: 3.3;Muller glia cells: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.3;fHDF/TERT166: 9.1;SiHa: 6.1;THP-1: 6.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA		59000				"unprognostic (6.16e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.49e-6)"	"unprognostic (2.52e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.12e-6)"	3.8	1.6	9.8	4.0	12.7	1.1	2.1	5.1	14.1	3.2	2.7	2.5	2.9	2.2	4.8	2.6	3.3	2.7	6.2	3.6	7.3	4.9	1.3	1.6	2.0	4.5	4.8	6.8	2.4	1.2	1.1	1.6	2.5	5.4	4.4	1.7	4.4	2.4	3.8	2.5	1.9	2.2	6.3	3.2	3.3	2.1	1.7	2.7	0.0	1.1	1.6	2.4	2.5	1.8	0.1	0.0	1.2	0.1	0.0	0.1	0.0	0.1	0.4	0.7	0.2	0.2	0.0	2.9	2.6	0.7	0.6	0.2	0.2	0.8	0.3	5.3	9.1	0.1	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.3	0.0	2.9	0.0	0.1	1.6	0.3	2.1	0.3	0.3	2.5	0.1	0.1	0.2	1.6	0.4	0.1	0.4	2.1	0.0	0.1	0.8	0.0	0.3	0.1	0.2	0.3	1.1	6.1	0.1	0.0	1.1	0.1	6.4	1.6	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.6	0.5	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	9.8	12.7	5.1	10.8	7.3	4.9	4.8	6.8	5.4	2.7	0.0	0.0	0.0	0.0	0.0	11.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	1.1	0.1	0.0	0.0	1.5	0.0	0.0	1.3	1.6	0.0	0.3	0.0	3.3	0.0	0.0	12.4	0.0	0.6	1.8	0.0	1.4	0.0	0.8	0.3	0.2	0.0	0.1	0.0	0.0	0.1
HHLA1	PLA2L	ENSG00000132297	"HERV-H LTR-associating 1"	C9JL84	8	132061486-132111159	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"placenta: 1.3"	"Cell type enhanced"	"Detected in some"	26	"Alveolar cells type 2: 13.7;Ciliated cells: 2.7;Club cells: 4.5;granulocytes: 3.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"NTERA-2: 4.8;SuSa: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"	NA	NA											"unprognostic (5.15e-2)"								"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6		0.0	0.0	0.0	0.1	1.3		0.0	0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	13.7	0.0	0.0	0.0	0.0	0.6	0.0	2.7	4.5	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGFL4		ENSG00000204869	"IGF like family member 4"	Q6B9Z1	19	46039748-46077118	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 8.5;skin 1: 13.9"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 40.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 6.6;HaCaT: 5.9;OE19: 10.3"									HPA047655	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA047655: AB_2680113"	"unprognostic (1.22e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.96e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.59e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	0.1	0.8	4.4	0.3	4.4	0.2	0.3	3.9	8.5	0.2	0.3	0.0	0.0	0.9	1.0	2.9	1.9	0.4	1.1	1.9	2.8	2.8	0.3	0.4	0.7	0.9	1.2	6.0	2.0	0.2	3.3	4.5	0.2	2.1	0.9	0.5	4.6	1.1	0.0	0.5	13.9	0.7	0.1	1.6	0.5	0.7	0.8	0.5	0.0	1.5	0.6	0.2	1.2	0.2	0.3	1.6	1.3	0.7	0.2	0.5	0.1	0.1	6.6	0.2	0.5	0.0	1.1	0.4	0.0	0.0	0.0	0.0	1.4	0.3	0.9	0.1	0.1	0.9	5.9	0.0	0.0	0.0	0.7	1.1	0.0	0.8	1.6	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.7	0.0	0.7	0.1	0.5	0.3	10.3	0.3	0.1	2.9	1.4	0.0	0.3	0.4	0.4	0.0	0.1	1.7	0.8	0.4	1.2	0.6	0.8	1.4	0.4	0.4	0.8	0.4	0.2	0.1	0.9	1.8	1.3	0.7	0.7	0.5	0.3	0.3	0.3	0.2	0.1	0.1	0.3	0.1	0.4	0.9	0.2	0.1	1.6	0.4	0.1	4.4	4.4	3.9	8.5	2.8	2.8	1.2	6.0	2.1	0.5	0.0	0.0	0.0	0.0	0.9	5.1	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.4	1.3	1.0	0.0	0.0	0.0	0.0
IGSF10	"CMF608, FLJ25972"	ENSG00000152580	"Immunoglobulin superfamily member 10"	Q6WRI0	3	151425384-151458709	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Osteogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 17.8"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 118.2;Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 1.5"	"Group enriched"	"Detected in some"	5	"HeLa: 25.6;HL-60: 12.4;REH: 9.2;RPMI-8226: 29.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA012655, HPA012921"	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA		280000	Vesicles		"HPA012655: , HPA012921: AB_1851526"	"unprognostic (1.78e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.47e-7)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.84e-4)"	"unprognostic (9.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.52e-4)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.57e-4)"	2.5	2.9	0.6	0.1	0.4	0.0	4.5	0.0	0.2	0.3	0.5			0.0	0.7	0.8	2.0	3.4	7.3	4.1	0.7	0.8	0.0	0.0	6.7	0.5	0.3		17.8	0.1	0.7	1.5	0.0		0.0	0.6		3.7	0.0	0.0	1.2	0.7	0.7	0.3	0.2	0.4	0.3			1.3		1.6	1.5	0.1	0.2	1.5	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.2	4.0	25.6	0.0	0.9	12.4	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	29.6	0.0	0.0	0.5	0.0	3.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.1	3.7	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0											0.0	0.3	0.5	1.2	2.2	14.0	1.1	2.5	13.4	10.3	1.8	3.9	18.9	0.0	0.2	118.2	0.7	0.0	0.0	1.2	2.6	5.4	0.9	0.0	0.0	1.2	57.2	5.8	0.0	0.3	22.0	6.4	1.6	3.3	1.0	0.4	23.5	0.3	0.0	1.1	0.3	2.2	0.0	0.9	6.7	2.4	2.0	25.9	0.0	0.0	0.0
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115694	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.0"	"Cell type enhanced"	"Detected in many"	8	"Kupffer cells: 84.8;Macrophages: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 27.6;NB-4: 24.3;THP-1: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		20000	"Nucleoplasm, Cytosol"		"CAB024996: "	"unprognostic (1.92e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.51e-3)"	17.7	7.6	6.5	13.6	13.8	40.5	24.7	4.0	6.7	8.6	8.1	7.7	4.6	6.2	7.4	9.4	6.8	7.8	7.4	8.8	6.1	4.9	8.3	11.6	16.8	39.2	10.3	2.0	7.7	7.7	6.9	5.4	6.2	8.3	6.9	5.7	5.3	7.0	5.3	5.3	8.6	9.1	8.3	11.2	23.4	7.3	5.3	9.7	50.0	7.9	3.2	11.0	6.3	12.8	0.5	3.6	15.6	6.9	1.4	2.4	2.0	3.6	2.1	1.9	2.5	3.9	2.3	2.5	5.5	3.6	2.6	3.3	2.0	2.4	3.3	2.3	5.5	3.4	6.0	2.7	2.6	1.8	5.4	3.2	0.0	1.2	1.3	4.5	27.6	8.6	3.4	3.8	2.3	1.8	2.5	2.7	2.7	1.4	3.5	2.6	3.1	3.3	24.3	1.1	4.7	2.1	0.7	0.4	0.6	2.4	2.7	1.3	0.0	3.8	3.3	2.7	2.3	2.5	35.0	7.5	2.0	2.9	3.0	2.0	2.8	1.5	1.6	2.9	13.4	2.1	6.7	6.9	6.1	1.1	3.2	0.9	0.4	1.5	1.1	3.6	0.5	2.4	1.8	15.6	1.4	2.9	1.7	0.9	2.0	6.5	13.8	4.0	6.7	6.1	4.9	10.3	2.0	8.3	9.7	11.9	13.1	6.7	5.5	7.8	2.0	4.5	15.3	5.3	3.4	5.2	7.9	5.4	0.0	8.0	2.5	9.3	15.1	0.0	10.8	10.6	8.2	8.5	7.0	9.6	29.2	3.2	12.7	20.9	84.8	1.4	8.3	43.1	8.5	3.6	13.1	3.8	10.5	11.8	4.2	3.1	3.2	12.9	9.0	1.4	14.7	5.9	5.4	20.0	10.6	9.3
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173671-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 63.6;Leydig cells: 199.0;Peritubular cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 33.9;ASC TERT1: 18.2;fHDF/TERT166: 76.1;HSkMC: 13.8;RPMI-8226: 23.3"	"Region enriched"	"Detected in all"	5	"olfactory region: 145.0"	"Low region specificity"	"Detected in many"			"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		110000000	"Plasma membrane"	"Golgi apparatus"	"HPA040326: AB_2676928, HPA050811: AB_2681243"	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	24.6	6.8	3.3	10.4	4.6	0.1	21.4	2.0	12.1	72.8	19.7	2.9	13.2	4.1	67.3	36.3	23.0	22.1	29.6	17.7	1.7	1.7	8.0	2.5	10.2	5.8	3.3	7.2	80.2	3.4	1.2	13.8	31.5	3.9	32.2	4.0	36.4	10.0	17.9	12.5	13.6	8.8	27.5	9.0	9.8	10.3	16.3	0.6	1.3	18.9	17.0	9.9	27.9	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	33.9	18.2	0.1	5.2	0.0	0.0	0.0	0.0	2.1	0.0	0.3	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	4.0	0.0	0.1	0.5	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.6	2.0	12.1	1.7	1.7	3.3	7.2	3.9	0.6	0.0	2.2	0.0	0.1	10.4	0.0	3.1	0.0	2.7	1.2	0.0	0.0	1.1	0.0	0.2	1.7	8.7	0.0	0.0	0.2	1.6	63.6	0.1	0.0	0.0	3.5	0.0	0.0	7.4	0.0	3.2	199.0	0.8	11.8	0.0	0.0	0.1	1.3	0.0	150.3	0.0	0.3	25.8	21.7	0.9	0.5	7.8	0.8	0.0	0.0	0.2
ITGBL1	"OSCP, TIED"	ENSG00000198542	"Integrin subunit beta like 1"	O95965	13	101452593-101720856	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Fibroblasts: 24.6;Ito cells: 14.7;Peritubular cells: 7.8;Spermatocytes: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.2;ASC TERT1: 30.3;fHDF/TERT166: 71.2;LHCN-M2: 65.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (1.70e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.13e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.70e-4)"	16.7	6.3	1.2	1.1	1.7	0.0	24.0	8.3	1.6	17.6	1.4	2.7	2.0	0.3	3.4	1.7	19.5	3.5	25.5	13.6	2.7	2.2	2.0	4.9	17.9	0.7	4.0	4.0	3.6	5.2	3.4	18.8	21.6	5.9	8.4	1.7	15.8	18.1	3.0	6.5	9.9	0.4	19.5	7.7	2.4	5.8	3.8	1.6	0.4	6.2	14.3	2.7	11.9	17.4	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	45.2	30.3	0.0	13.6	14.1	6.2	4.0	0.0	0.5	0.0	0.0	71.2	2.9	14.7	0.0	5.0	9.8	0.0	0.0	4.3	0.1	0.0	4.7	0.0	0.0	12.8	0.3	3.5	10.0	11.8	16.0	0.0	0.3	0.1	65.3	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	5.1	7.1	5.7	0.0	1.7	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.2	1.7	8.3	1.6	2.7	2.2	4.0	4.0	5.9	1.6	3.0	0.3	0.0	0.0	3.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	3.0	0.1	0.0	0.0	0.2	0.4	24.6	0.0	0.0	0.4	0.5	4.8	0.0	14.7	0.0	1.1	0.0	0.3	5.0	0.0	0.0	0.3	0.7	0.0	7.8	0.0	0.4	0.0	6.6	8.6	7.2	2.0	0.7	0.0	0.0	0.1
KIAA0100	"BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488"	ENSG00000007202	KIAA0100	Q14667	17	28614440-28645454	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042781	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted - unknown location"	No	No			"Nuclear speckles, Cytosol"		"HPA042781: AB_10797020"	"unprognostic (1.91e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.43e-1)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (4.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.03e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.24e-3)"	"unprognostic (7.58e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	27.7	31.2	22.3	21.3	34.7	21.9	26.3	28.1	40.1	20.0	24.0	28.2	20.9	15.5	24.7	21.6	25.4	24.0	20.1	21.4	22.0	22.4	38.1	30.7	24.1	26.3	23.1	19.6	25.6	24.6	48.0	27.0	32.7	35.6	22.7	28.5	22.1	27.0	23.3	40.7	25.0	27.9	28.4	21.4	26.4	22.8	24.8	18.6	26.3	28.6	20.2	26.6	22.7	18.8	2.9	7.2	3.5	3.0	2.0	3.3	1.3	19.6	37.6	19.1	18.1	34.8	20.8	13.9	18.4	24.6	22.6	21.3	25.8	9.0	27.4	22.2	33.6	23.6	26.3	28.0	27.3	27.4	30.3	26.2	21.8	29.8	14.1	15.0	38.0	37.9	21.2	21.2	30.5	23.3	17.6	32.2	19.6	20.5	8.9	20.5	28.2	27.7	18.1	8.3	35.7	13.9	21.3	21.4	17.9	13.6	35.4	18.8	14.5	23.2	63.6	15.5	24.8	38.0	26.6	29.7	17.3	19.1	23.1	34.7	8.4	9.7	17.7	19.7	24.7	20.1	0.8	3.0	3.5	3.0	2.5	3.3	2.9	1.5	2.7	3.3	1.7	1.8	1.8	1.8	2.0	2.7	7.2	1.7	1.3	22.3	34.7	28.1	40.1	22.0	22.4	23.1	19.6	35.6	18.6	14.9	19.1	3.9	6.3	9.2	31.3	27.1	15.3	12.0	12.5	12.2	27.5	10.4	5.0	8.4	12.4	10.5	22.7	23.3	9.4	8.0	8.9	11.1	8.1	28.0	9.4	27.0	11.6	21.5	29.7	18.3	8.6	15.0	10.1	14.4	15.6	12.6	9.2	8.6	6.0	13.8	22.8	0.0	7.8	16.9	20.9	9.7	38.1	8.6	16.1	11.2
KIR3DX1	"FLJ00060, LENG12"	ENSG00000104970	"Killer cell immunoglobulin like receptor, three Ig domains X1"		19	54532692-54545771	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 3.9;heart muscle: 3.6;lymphoid tissue: 4.6"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 13.1;Ciliated cells: 2.7;Club cells: 4.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"U-266/84: 10.0"									HPA052110	Uncertain				"Secreted - unknown location"	NA	NA					"HPA052110: AB_2681731"	"unprognostic (5.85e-3)"	"unprognostic (4.13e-3)"	"unprognostic (8.47e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.22e-4)"	"unprognostic (1.36e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.73e-9)"	"unprognostic (1.09e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (6.20e-3)"	1.9	0.0	0.0	1.3	0.6	2.2	0.3	0.0	1.2	0.6	0.2	3.9	0.0	0.0	1.0	0.0	0.5	0.1	0.4	3.6	0.1		0.1	0.2	2.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.2	0.0	0.0	0.0	0.9	0.1	0.1	0.5	0.6	4.6	0.0	0.5	0.1	0.0	0.2	0.0	2.7	0.0	0.0	0.4	0.3	1.7	0.2	1.2	1.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	10.0	0.0	0.0	0.8	0.0	1.7	0.2	0.0	1.1	0.2	0.2	0.2	0.2	0.2	0.0	0.4	0.1	0.2	0.6	1.2	0.0	0.3	0.3	0.0											0.0	13.1	0.9	0.5	0.6	0.0	0.2	0.0	2.7	4.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.3	0.0	0.0	0.0	0.3
LAG3	CD223	ENSG00000089692	"Lymphocyte activating 3"	P18627	12	6772512-6778455	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.1;ovary: 28.4"	"Cell type enhanced"	"Detected in many"	13	"Intestinal endocrine cells: 20.8;Leydig cells: 36.2;Peritubular cells: 65.0;T-cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.7"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 11.3;MAIT T-cell: 9.2;memory CD8 T-cell: 10.0"	"Lineage enriched"	"Detected in single"	56	"T-cells: 11.3"	"Cell line enriched"	"Detected in single"	144	"HDLM-2: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002301, HPA013967"	Enhanced				"Secreted - unknown location"	NA	NA					"CAB002301: AB_564101, HPA013967: AB_1846277"	"unprognostic (9.39e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (8.88e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.74e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (4.62e-11)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	"unprognostic (8.19e-3)"	1.7	0.4	0.3	33.2	0.3	1.0	1.0	0.8	0.7	7.7	4.4	0.5	2.7	2.9	6.4	3.3	2.4	3.8	3.0	2.2	0.3	0.4	1.2	5.9	3.8	12.4	0.4	0.0	28.4	0.4	0.1	1.0	1.3	2.7	2.8	1.8	1.1	2.0	6.8	0.8	0.6	9.6	1.7	0.9	58.1	2.0	6.1	0.1	4.1	1.0	1.3	23.5	2.6	3.6	0.0	0.2	0.0	0.0	0.0	11.3	0.8	0.0	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	9.2	0.0	2.2	10.0	0.0	0.0	0.6	4.0	0.0	0.0	0.0	0.2	1.7	0.8	0.3	0.3	0.8	0.7	0.3	0.4	0.4	0.0	2.7	0.1	0.0	3.5	0.9	0.8	4.5	4.0	1.2	0.0	0.0	5.7	0.0	9.8	0.2	0.0	0.1	0.3	1.9	1.1	0.0	0.0	0.2	2.1	1.9	0.0	2.5	8.7	0.0	20.8	5.5	3.5	1.1	36.2	0.3	1.7	4.6	4.5	1.3	0.3	0.0	65.0	0.2	6.2	6.5	2.5	0.3	2.0	2.6	0.1	29.6	2.5	0.3
LAIR2	CD306	ENSG00000167618	"Leukocyte associated immunoglobulin like receptor 2"	Q6ISS4	19	54497879-54510687	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.8;lymphoid tissue: 19.6;pituitary gland: 7.1;placenta: 15.5"	"Cell type enriched"	"Detected in some"	9	"Extravillous trophoblasts: 233.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"T-reg: 12.8"	"Lineage enriched"	"Detected in single"	21	"T-cells: 12.8"	"Group enriched"	"Detected in some"	5	"BEWO: 6.9;Hep G2: 3.3"														"Secreted - unknown location"	NA	NA						"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.86e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.68e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.40e-5)"	"unprognostic (6.71e-2)"	0.9	0.5	0.6	5.9	1.7	1.6	0.5	0.2	1.3	0.4	0.6	1.3	0.0	0.4	0.5	1.3	0.7	0.5	1.3	0.4	1.4	3.0	0.6	0.8	3.2	12.3	0.6	0.5	0.2	0.9	0.1	7.1	15.5	1.3	0.8	1.3	0.4	0.5	0.4	0.6	0.5	1.2	0.5	1.5	6.6	1.0	1.2	0.4	19.6	0.5	0.0	2.0	0.3	0.3	0.0	0.0	0.1	0.1	0.6	12.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.7	0.3	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	3.0	2.0	0.0	0.0	0.8	2.7	0.1	0.6	0.1	0.0	12.8	1.8	0.6	1.7	0.2	1.3	1.4	3.0	0.6	0.5	1.3	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	233.4	0.5	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	26.9	24.5	0.0	0.0
LDLRAD2		ENSG00000187942	"Low density lipoprotein receptor class A domain containing 2"	Q5SZI1	1	21812265-21825221	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 2: 1.1;Ciliated cells: 1.4;Collecting duct cells: 1.8;Early spermatids: 1.0;Ito cells: 1.3"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"basophil: 1.9;plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;NTERA-2: 2.5;REH: 3.4;THP-1: 2.9;TIME: 6.3"									HPA030478	Approved				"Secreted - unknown location"	NA	NA					"HPA030478: AB_10601541"	"unprognostic (4.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.35e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.80e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.39e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	5.4	1.9	0.2	2.2	0.2	2.7	2.2	0.0	0.1	1.7	3.2			4.7	3.1	0.0	1.3	2.2	1.6	3.6	0.5	1.1	1.5	0.1	1.0	1.8	0.0		0.5	1.1	0.0	0.9	0.2		3.1	0.3		5.7	0.1	2.7	1.3	1.7	0.2	0.0	2.3	3.2	0.8			1.6		0.9	2.2	1.8	0.6	2.5	1.9	0.0	0.7	0.0	0.0	0.5	0.7	0.4	0.6	0.2	0.0	1.3	0.9	0.0	0.0	0.0	0.4	1.5	0.0	2.4	0.2	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.4	1.2	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.9	0.4	0.1	0.3	0.0	0.0	0.2	0.0	1.4	2.5	0.3	0.4	3.4	0.5	0.0	0.0	0.4	0.0	0.3	0.5	0.1	0.1	0.7	0.2	2.9	6.3	0.6	0.6	0.8	0.0	0.0	0.1	0.4	0.1	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.0											0.0	1.1	0.0	0.0	0.5	0.0	0.5	0.0	1.4	0.0	1.8	0.0	0.1	0.0	0.1	1.0	0.6	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.2	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.4	0.2	0.0	0.0	0.0
LRCH3	MGC4126	ENSG00000186001	"Leucine rich repeats and calponin homology domain containing 3"	Q96II8	3	197791226-197888436	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012380, HPA017299"	Uncertain		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA012380: AB_1853260, HPA017299: AB_2669576"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.29e-1)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.32e-1)"	16.4	14.0	19.3	23.4	19.1	11.0	18.0	37.5	19.1	21.9	19.0	28.2	15.6	11.0	24.7	14.8	15.6	18.3	16.7	18.2	15.9	14.5	12.6	14.2	14.8	23.4	19.7	13.1	27.5	12.9	23.7	26.0	15.2	15.4	20.4	16.7	23.6	15.6	22.4	23.0	15.7	15.9	28.3	15.9	18.7	15.0	20.2	20.4	27.0	13.5	9.5	26.0	20.3	18.0	6.9	2.8	22.6	4.8	4.9	6.0	3.3	18.1	6.5	17.5	10.8	21.2	24.1	6.8	13.2	16.0	16.1	18.9	15.3	9.6	9.9	20.7	16.2	22.9	11.9	14.6	12.8	21.7	7.9	9.1	16.5	9.7	13.0	14.5	12.6	13.0	16.5	7.8	15.3	19.6	15.6	19.0	8.8	10.4	16.5	15.2	15.4	9.5	5.5	12.0	9.3	13.6	10.0	10.9	7.1	8.5	10.7	8.7	9.4	16.0	12.1	12.7	16.8	21.2	11.1	18.5	13.4	7.7	16.2	13.2	15.3	13.7	9.0	12.7	18.0	12.6	22.6	3.4	7.0	5.9	4.8	4.5	6.9	4.6	5.0	2.8	5.7	4.3	6.0	2.3	4.9	4.6	2.6	4.4	3.3	19.3	19.1	37.5	19.1	15.9	14.5	19.7	13.1	15.4	20.4	29.8	24.8	15.9	14.0	9.4	55.4	14.2	17.8	16.0	19.4	8.7	53.0	7.0	1.7	10.1	9.5	20.2	6.8	0.0	8.4	5.5	19.9	12.7	10.5	13.0	7.6	36.5	5.8	41.7	13.0	7.1	23.3	15.3	16.9	28.9	8.2	26.6	11.3	7.0	26.9	4.2	44.4	19.4	17.0	16.3	16.6	9.3	5.0	14.0	9.2	13.1
LY6G5B	"C6orf19, G5b"	ENSG00000240053	"Lymphocyte antigen 6 family member G5B"	Q8NDX9	6	31670167-31673776	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	6	"Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Rod photoreceptor cells: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"											HPA048307	Approved				"Secreted - unknown location"	NA	NA					"HPA048307: AB_2680348"	"unprognostic (2.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.85e-3)"	"unprognostic (5.04e-3)"	"unprognostic (8.34e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-4)"	"unprognostic (7.27e-3)"	"unprognostic (1.98e-5)"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.98e-4)"	7.2	2.4	3.7	4.8	3.7	14.7	6.1	17.5	5.5	4.8	5.3	3.7	14.9	3.4	7.8	6.6	3.7	5.8	3.7	3.7	3.7	1.5	3.7	3.7	6.5	6.2	3.7	3.7	8.9	3.7	1.0	5.0	4.3	7.2	5.2	6.6	5.6	4.3	4.1	5.2	13.3	6.5	5.3	3.7	7.7	4.2	10.3	3.7	6.0	6.2	3.7	7.2	3.9	4.7	0.4	0.5	0.0	0.4	0.6	1.4	0.0	4.2	4.7	9.4	12.8	2.2	4.7	12.0	8.4	2.6	6.0	6.0	5.7	5.5	10.3	2.3	10.4	3.9	6.9	2.2	11.0	9.7	4.1	14.6	9.8	5.0	4.4	1.8	12.1	8.1	10.0	6.6	8.8	4.2	8.5	3.2	7.8	5.9	6.2	4.1	3.8	6.6	9.4	5.2	1.2	2.1	9.3	2.9	4.5	2.8	11.8	6.6	10.7	3.8	1.5	2.8	12.1	3.8	8.2	6.1	12.0	6.3	5.4	2.0	11.2	7.8	9.6	4.2	11.7	3.6	0.0	0.4	0.0	1.4	0.2	0.1	0.0	0.3	1.1	0.5	0.4	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	3.7	3.7	17.5	5.5	3.7	1.5	3.7	3.7	7.2	3.7	3.0	0.0	1.5	1.0	0.9	0.8	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.3	0.8	0.6	0.0	0.2	0.4	0.0	1.2	0.6	0.0	0.0	0.6	0.9	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.4	1.1	0.5	0.0	0.8	0.9
LY6G5C	"C6orf20, G5c, NG33"	ENSG00000204428	"Lymphocyte antigen 6 family member G5C"	Q5SRR4	6	31676684-31684040	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.6"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 17.4;Spermatocytes: 12.9;Spermatogonia: 13.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1;HDLM-2: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038690	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA038690: AB_10673286"	"unprognostic (1.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.83e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.74e-5)"	"unprognostic (5.84e-2)"	"unprognostic (3.78e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.39e-2)"	0.4	0.0	0.5	2.1	2.5	1.1	0.3	4.6	3.8	0.0	0.0			0.2	0.3	0.4	0.0	0.5	2.0	0.8	0.4	0.7	0.0	0.9	0.5	1.2	0.3		0.4	2.5	0.0	1.0	0.4		0.1	0.0		0.2	0.0	1.3	0.3	0.3	0.0	0.4	0.8	1.2	2.1			0.2		0.0	0.3	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.4	2.1	3.1	0.1	0.1	0.1	0.3	0.3	0.8	0.0	2.4	1.5	0.1	0.1	0.0	0.6	0.0	0.0	0.9	2.7	1.4	1.1	0.0	0.5	0.0	0.3	1.2	0.0	0.0	0.7	1.7	0.1	0.0	0.9	0.0	1.5	0.1	0.0	2.3	0.4	0.1	0.1	0.0	1.0	0.4	0.8	0.1	0.5	0.3	0.2	0.9	0.0	0.5	0.0	0.1	1.8	0.0	0.2	1.1	1.8	0.1	0.4	0.5	0.5	2.3	1.5	0.6	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0											3.0	1.0	0.0	1.7	1.4	3.1	0.8	2.5	17.4	1.2	1.8	2.0	0.4	3.3	1.5	9.4	4.3	2.9	0.0	4.3	0.1	1.2	2.4	4.7	1.7	5.2	0.0	3.4	7.4	6.5	4.4	1.1	2.2	1.7	1.8	1.7	5.7	3.7	2.5	1.4	3.8	0.9	0.0	1.9	12.9	13.4	0.6	0.2	4.4	2.5	0.9
LYG1	SALW1939	ENSG00000144214	"Lysozyme g1"	Q8N1E2	2	99284238-99304742	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"kidney: 22.5"	"Group enriched"	"Detected in some"	6	"Distal tubular cells: 18.3;Proximal tubular cells: 70.3"	"Cancer enriched"	"Detected in many"	15	"renal cancer: 31.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted - unknown location"	NA	NA						"unprognostic (1.53e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.76e-4)"	"unprognostic (6.94e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-3)"	1.0	0.4	1.0	1.1	1.0	0.7	2.1	2.3	1.0	1.1	1.0	1.0	1.0	1.2	1.4	1.9	1.0	0.7	1.0	1.0	1.0	0.4	22.5	3.1	1.0	1.5	1.0	1.0	1.1	1.0	0.0	1.0	1.0	1.0	1.6	1.1	1.0	1.0	1.0	2.0	1.5	1.2	1.0	1.0	2.6	0.6	2.9	1.0	1.0	1.2	1.0	1.2	1.0	1.0	1.0	0.4	1.2	0.9	0.0	2.4	0.5	0.5	3.9	3.0	4.9	6.9	4.1	3.4	1.5	1.7	1.6	2.7	0.8	3.5	0.8	2.7	0.7	0.4	1.7	4.0	0.6	1.9	2.7	2.4	2.2	2.9	1.3	1.4	0.8	5.4	3.2	4.3	2.6	1.0	3.6	0.8	5.2	1.2	2.6	1.8	0.8	2.0	6.7	0.7	2.0	3.8	4.9	1.7	1.3	6.9	1.5	1.7	1.0	0.6	1.2	1.1	3.8	0.5	0.7	2.2	2.0	2.5	3.6	1.7	3.0	1.8	0.6	0.6	4.0	1.0	0.0	0.9	1.2	1.5	0.1	1.4	0.2	0.2	0.6	0.4	1.0	1.2	0.7	0.0	0.0	0.0	0.0	2.4	0.5	1.0	1.0	2.3	1.0	1.0	0.4	1.0	1.0	1.0	1.0	0.0	0.0	0.0	0.2	0.0	1.0	0.3	0.0	0.0	2.3	1.8	2.0	0.2	18.3	0.5	7.8	0.3	0.3	0.0	0.2	0.1	0.4	0.5	4.6	0.0	0.3	0.0	0.0	1.3	0.3	3.6	0.3	0.4	0.0	1.0	0.3	0.3	0.6	0.0	0.4	70.3	0.5	0.0	0.4	1.8	0.2	0.0	0.5	0.5	0.2	0.1
MEGF6	EGFL3	ENSG00000162591	"Multiple EGF like domains 6"	O75095	1	3489920-3611495	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 37.8"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 19.4;Basal keratinocytes: 16.4;Ito cells: 16.5;Melanocytes: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.8;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 22.5;HeLa: 20.3;hTERT-RPE1: 26.6;U-2197: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052129	Uncertain		Approved	"Microtubules,Cytokinetic bridge"	"Secreted - unknown location"	Yes	No		580000	Microtubules	"Cytokinetic bridge"	"HPA052129: AB_2681739"	"unprognostic (1.95e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.43e-2)"	15.0	2.3	0.5	8.5	1.0	9.2	13.4	0.8	2.0	8.1	5.9	1.8	7.5	2.3	5.1	13.1	6.6	14.6	21.0	6.1	1.4	0.5	2.7	1.9	12.6	12.6	0.7	1.9	8.8	4.8	0.8	1.5	2.8	2.3	12.0	0.9	11.0	8.7	5.5	6.1	37.8	4.2	3.0	0.8	5.7	4.2	4.6	1.4	5.0	5.2	12.0	12.0	6.7	10.1	0.8	0.3	4.8	0.1	0.0	1.9	0.2	4.5	7.2	1.6	3.1	0.1	0.1	0.5	22.5	6.3	1.9	0.6	1.5	5.3	0.0	7.2	7.7	1.3	2.8	0.0	0.2	0.2	0.0	0.1	0.0	20.3	1.3	0.0	0.1	0.4	0.0	0.2	0.1	0.2	26.6	2.4	0.0	0.0	0.0	0.0	2.5	0.0	4.1	1.0	1.0	0.4	0.9	0.9	2.7	0.4	1.4	1.6	1.5	8.1	0.5	2.8	2.3	2.2	0.4	1.0	8.2	0.8	20.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	4.8	0.1	0.0	0.4	0.0	0.4	0.4	0.3	0.8	0.8	0.1	2.2	0.0	0.0	0.0	1.9	0.2	0.5	1.0	0.8	2.0	1.4	0.5	0.7	1.9	2.3	1.4	20.8	19.4	0.0	7.5	16.4	0.8	3.0	5.1	0.0	6.8	1.8	0.0	0.1	0.0	3.0	0.2	8.7	0.3	0.0	1.2	1.0	6.4	3.4	1.1	0.9	1.0	0.0	0.0	16.5	0.8	0.0	10.6	2.8	18.6	0.0	1.3	9.5	3.6	0.0	3.2	1.7	1.0	0.0	2.1	0.5	0.6	9.9	0.3	0.0	0.7	3.0
METTL24	"C6orf186, dJ71D21.2"	ENSG00000053328	"Methyltransferase like 24"	Q5JXM2	6	110245928-110358272	"Predicted secreted proteins"		"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Early spermatids: 4.3;Horizontal cells: 1.6;Late spermatids: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	34	"T-cells: 7.3"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;fHDF/TERT166: 2.6;HHSteC: 3.1;SCLC-21H: 4.6;SH-SY5Y: 2.8;SuSa: 4.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037441, HPA037442"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA037441: AB_10670933, HPA037442: AB_10696931"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.78e-3)"	2.1	1.9	2.4	3.7	2.8	0.0	1.8	2.8	2.1	11.9	10.8	2.9	4.8	1.5	16.2	5.0	5.6	7.0	9.6	3.2	2.1	1.9	5.2	1.1	2.4	0.6	2.1	2.7	9.2	2.3	5.8	4.6	0.3	2.2	8.6	5.0	10.2	1.1	8.6	0.4	1.1	4.0	16.1	2.8	0.6	6.0	2.8	1.5	0.6	2.1	3.0	1.5	13.3	5.1	0.0	0.1	0.0	0.0	0.2	7.3	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	2.8	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	7.3	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	2.4	2.8	2.8	2.1	2.1	1.9	2.1	2.7	2.2	1.5	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
MTRNR2L13		ENSG00000270394	"MT-RNR2-like 13"	S4R3P1	4	116298876-116300320	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 11.5"	"Cell type enriched"	"Detected in some"	39	"Cardiomyocytes: 161.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.9"	"Group enriched"	"Detected in some"	5	"HeLa: 8.3;Hep G2: 4.4"														"Secreted - unknown location"	NA	NA										"unprognostic (6.40e-2)"					"unprognostic (2.88e-1)"			"unprognostic (2.49e-1)"	"unprognostic (1.99e-1)"				1.7	2.5	0.6	0.2	1.1	0.4	0.6	0.6	1.8	0.6	1.2	0.0	2.9	0.5	0.6	1.0	0.6	0.6	0.4	3.3	0.6	0.6	2.3	1.4	0.9	1.7	0.6	0.5	0.6	0.6	0.0	0.6	0.4	2.7	0.6	1.1	0.2	1.2	0.4	11.5	0.6	1.0	1.1	2.6	0.6	0.6	2.0	1.2	0.0	0.6	1.4	0.2	1.0	0.6	0.4	0.2	4.9	0.4	0.3	0.2	0.3	0.3	1.1	0.1	1.1	0.1	0.1	0.4	0.9	0.0	0.0	0.0	0.1	0.5	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.1	8.3	4.4	0.1	0.1	0.4	0.4	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.4	0.0	0.2	0.1	0.2	0.1	0.4	0.3	1.2	0.1	0.4	0.2	0.1	0.5	0.2	0.2	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.0	0.4	1.0	0.1	0.3	0.1	0.3	0.2	0.1	0.2	0.4	0.2	0.2	4.9	0.3	0.2	0.2	0.0	0.3	0.6	1.1	0.6	1.8	0.6	0.6	0.6	0.5	2.7	1.2	0.0	0.0	0.0	4.2	0.1	0.0	161.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.5
MTRNR2L3		ENSG00000256222	"MT-RNR2-like 3"	P0CJ70	20	57358442-57359980	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 13.3"	"Cell type enriched"	"Detected in many"	94	"Cardiomyocytes: 2712.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.0;Hep G2: 1.6"														"Secreted - unknown location"	NA	NA						"unprognostic (1.55e-4)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.44e-6)"	"unprognostic (2.56e-1)"	"unprognostic (6.68e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.52e-3)"	"unprognostic (7.52e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.94e-3)"	0.8	1.0	2.9	0.3	2.4	2.4	0.5	1.0	3.6	0.7	0.9	0.0	2.5	0.6	0.5	1.4	0.7	0.5	1.0	1.3	2.5	0.7	1.2	1.1	0.4	0.5	2.1	2.7	0.8	1.2	0.2	0.5	0.3	2.4	0.5	0.9	0.0	2.4	1.1	13.3	1.1	0.5	0.5	1.7	0.4	0.9	1.2	2.7	0.0	0.6	0.0	0.3	0.3	0.6	1.0	0.8	3.7	0.7	0.1	1.3	0.4	0.3	0.0	0.2	0.9	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	5.0	1.6	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.0	0.6	0.1	0.2	0.1	0.5	0.3	0.6	0.2	0.0	0.2	0.4	0.1	0.2	0.0	0.1	0.4	0.1	0.2	0.2	0.6	0.2	0.3	0.5	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.7	0.7	1.1	0.8	0.2	0.6	0.4	0.5	0.5	0.8	1.0	1.3	0.5	3.7	0.1	0.6	0.2	0.7	0.4	2.9	2.4	1.0	3.6	2.5	0.7	2.1	2.7	2.4	2.7	0.0	0.0	0.9	28.7	2.9	0.0	2712.0	2.5	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	1.3	0.0	0.0	0.0	0.3	5.1	15.0	0.0	2.4	0.6	0.0	0.0	1.8	1.6	0.4	1.4	0.4	6.8	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	8.5	0.2	0.8	2.8	0.5	0.0	0.0	16.2
MTRNR2L5		ENSG00000249860	"MT-RNR2-like 5"	P0CJ72	10	55599303-55600041	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 7.0;skeletal muscle: 16.4;tongue: 6.6"	"Cell type enriched"	"Detected in single"	42	"Cardiomyocytes: 23.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;Hep G2: 2.5;HL-60: 1.0"														"Secreted - unknown location"	NA	NA															"unprognostic (2.11e-2)"				"unprognostic (1.20e-1)"				0.4	1.8	1.5	1.2	2.5	0.2	0.4	0.4	2.3	0.4	0.6	0.4	0.0	0.5	0.4	1.3	0.4	0.4	0.6	0.5	1.0	0.5	0.9	0.4	0.4	0.3	1.4	0.6	0.4	0.7	0.1	0.8	0.1	0.6	0.4	0.3	0.0	4.7	7.0	16.4	0.4	0.8	0.5	0.4	0.4	0.5	0.5	0.9	0.0	0.4	6.6	0.3	1.0	0.4	0.2	0.1	1.8	0.4	0.1	0.1	0.1	0.3	0.0	0.3	0.3	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	1.7	2.5	0.0	1.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.0	0.4	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	1.8	0.1	0.1	0.1	0.0	0.1	1.5	2.5	0.4	2.3	1.0	0.5	1.4	0.6	0.6	0.9	0.0	0.0	0.0	0.1	0.6	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MTRNR2L7		ENSG00000256892	"MT-RNR2-like 7"	P0CJ74	10	37601440-37602974	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.1;heart muscle: 1.6;skeletal muscle: 1.9"	"Cell type enriched"	"Detected in single"	277	"Cardiomyocytes: 171.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.2;Hep G2: 1.6"														"Secreted - unknown location"	NA	NA															"unprognostic (2.28e-1)"				"unprognostic (5.87e-2)"				0.3	0.6	0.1	0.0	0.1	0.2	0.1	0.1	0.4	0.1	0.3			0.0	0.1	0.2	0.1	0.1	0.0	1.6	0.1	0.1	0.9	0.4	0.1	0.0	0.1		0.1	0.1	0.0	0.3	0.0		0.1	0.5		0.1	0.0	1.9	0.1	0.1	0.0	0.1	0.1	0.2	0.2			0.1		0.0	0.1	0.1	0.3	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.3	0.0	0.3	0.2	0.0	0.1	0.0	0.7	0.0	0.6	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	3.2	1.6	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.7	0.0	0.5	0.0	0.1	0.3	0.5	0.4	0.3	0.0	0.2	0.8	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.8	0.0	1.2	0.2	0.6	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.3	0.2	0.2	2.1	0.2	0.1	0.2	0.1	0.2											0.0	0.0	0.0	0.6	0.1	0.0	171.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6
MXRA5	DKFZp564I1922	ENSG00000101825	"Matrix remodeling associated 5"	Q9NR99	X	3308565-3346641	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 49.4;pancreas: 46.6"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 34.2;Collecting duct cells: 29.6;Exocrine glandular cells: 53.2;Pancreatic endocrine cells: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 12.8;BJ hTERT+: 49.0;fHDF/TERT166: 23.0;HaCaT: 20.3;HSkMC: 9.9"									"HPA000508, HPA076518"	Uncertain		Uncertain	Mitochondria	"Secreted - unknown location"	NA	NA		1700000	Mitochondria		"HPA000508: AB_2147995, HPA076518: "	"unprognostic (7.51e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (7.05e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.94e-4)"	6.5	12.1	0.5	10.4	1.2	0.0	7.5	0.4	0.8	49.4	4.4	0.6	18.8	2.1	11.4	6.0	8.7	4.2	5.8	9.2	0.6	0.5	8.0	4.5	5.9	0.9	0.6	0.7	7.9	46.6	0.5	1.4	7.9	0.8	11.0	5.9	10.2	11.5	29.5	1.1	16.6	7.8	8.8	0.5	7.7	5.1	4.0	0.3	5.7	15.0	11.7	6.2	12.7	9.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	12.8	0.0	7.6	49.0	0.0	0.0	0.0	0.2	0.0	0.6	23.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	2.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.4	0.8	0.6	0.5	0.6	0.7	0.8	0.3	0.0	0.0	0.0	3.9	34.2	0.0	1.6	0.0	1.4	5.7	29.6	0.0	0.0	0.0	1.7	0.0	2.2	0.0	0.0	53.2	0.2	19.5	0.1	0.0	0.0	0.3	0.0	0.0	17.2	0.8	0.0	0.0	0.0	16.9	1.0	0.0	0.0	47.4	0.0	1.4	0.0	0.1	0.0	9.2	0.0	0.0	19.1	0.2	0.0	0.0	1.4
MXRA7	"FLJ46603, PS1TP1, TMAP1"	ENSG00000182534	"Matrix remodeling associated 7"	P84157	17	76672551-76711016	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 140.1;Muller glia cells: 291.2;Peritubular cells: 134.7;Rod photoreceptor cells: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 93.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044819, HPA075316"	Uncertain		Enhanced	"Endoplasmic reticulum"	"Secreted - unknown location"	NA	NA			"Endoplasmic reticulum"		"HPA044819: AB_10964134, HPA075316: "	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.67e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.80e-5)"	28.4	46.7	14.7	18.2	43.2	1.8	32.4	15.6	30.5	31.0	44.0	14.6	16.9	6.6	44.5	40.4	33.2	28.0	28.1	93.3	15.1	13.1	14.1	5.1	24.7	13.3	16.2	16.3	36.1	16.4	40.1	7.8	21.1	20.6	32.8	14.5	41.9	15.0	61.7	13.9	10.8	13.3	59.9	15.8	31.4	21.9	20.7	10.0	6.4	51.0	9.3	6.6	44.7	31.4	2.9	3.6	1.9	3.9	7.8	7.0	4.0	2.5	7.6	11.4	21.5	60.5	55.4	5.7	36.1	29.3	26.4	25.8	10.2	0.4	0.0	16.4	49.9	27.6	10.3	12.7	20.0	43.2	0.1	12.6	6.5	5.7	16.9	37.0	3.0	0.8	34.4	23.9	30.6	25.2	59.4	38.8	1.6	4.6	0.1	60.8	0.7	0.3	2.1	3.6	4.0	21.6	5.7	44.9	2.1	21.2	0.6	4.0	29.1	10.7	0.1	20.6	34.0	7.1	3.9	47.5	59.7	12.7	24.3	37.9	3.4	0.6	0.1	93.7	1.3	8.6	1.5	3.9	0.8	6.3	1.2	4.8	2.9	3.5	7.0	3.1	0.7	2.3	4.9	1.9	7.8	0.4	3.6	0.8	4.0	14.7	43.2	15.6	30.5	15.1	13.1	16.2	16.3	20.6	10.0	14.9	10.5	2.9	23.3	9.2	140.1	103.5	2.5	9.4	11.4	29.6	90.3	1.0	1.7	20.9	3.3	36.2	0.9	0.0	3.6	4.2	41.8	16.2	2.3	3.2	2.8	104.9	6.4	54.0	5.6	6.6	93.7	2.2	13.5	1.8	5.6	291.2	7.9	0.0	134.7	5.8	125.1	12.9	36.0	1.2	12.1	7.8	0.7	9.6	1.2	18.1
NENF	"CIR2, SCIRP10, SPUF"	ENSG00000117691	"Neudesin neurotrophic factor"	Q9UMX5	1	212432887-212446379	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026763, HPA028488"	Uncertain				"Secreted - unknown location"	NA	NA		2400000			"HPA026763: AB_1854379, HPA028488: AB_2672638"	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.80e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.99e-3)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.28e-1)"	"unprognostic (2.28e-2)"	21.9	19.9	33.5	10.1	47.7	12.8	44.4	16.2	30.6	41.9	23.9	45.2	24.0	12.7	24.1	42.2	19.4	27.6	19.6	50.6	31.3	31.4	32.0	25.8	18.0	20.4	38.3	21.3	38.3	43.4	21.0	47.1	17.9	23.6	26.7	23.9	19.8	22.1	36.1	53.6	16.5	12.2	29.7	49.5	13.2	16.8	9.6	24.5	6.5	23.6	26.0	16.2	19.3	19.9	7.2	13.3	1.9	6.7	0.8	9.2	2.5	23.0	12.2	6.6	29.9	48.8	36.9	11.8	11.7	28.7	20.9	20.6	14.2	14.8	8.9	9.0	27.8	20.8	15.0	16.4	17.0	17.1	13.5	32.8	5.7	7.9	4.1	18.5	5.7	20.7	26.4	25.1	14.5	12.1	23.6	13.5	16.3	17.6	12.0	18.2	9.5	13.2	26.9	11.5	21.7	38.3	11.7	11.9	14.9	21.3	4.1	13.3	23.2	12.1	27.6	20.9	13.1	21.0	22.3	2.6	16.4	15.2	22.7	21.5	11.3	18.1	6.9	17.9	8.1	12.5	1.0	4.8	1.9	4.1	6.7	7.3	7.2	4.9	9.2	7.7	5.1	6.5	6.5	0.5	0.8	4.5	13.3	5.7	2.5	33.5	47.7	16.2	30.6	31.3	31.4	38.3	21.3	23.6	24.5	11.9	22.9	67.7	184.9	147.7	34.2	125.7	140.1	4.0	13.6	235.5	11.8	249.5	139.3	36.9	4.9	69.1	63.2	93.5	42.5	152.2	182.5	294.0	48.3	169.3	166.2	36.5	130.4	101.9	99.0	12.5	275.5	153.8	177.2	70.3	141.5	167.3	33.6	57.5	210.4	431.6	22.2	116.4	173.1	10.1	130.6	149.2	154.2	56.5	129.6	224.5
NHLRC3		ENSG00000188811	"NHL repeat containing 3"	Q5JS37	13	39038306-39050109	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013738	Uncertain				"Secreted - unknown location"	NA	NA		240000			"HPA013738: AB_1854455"	"unprognostic (7.92e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.90e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.81e-2)"	21.3	14.5	12.3	18.8	14.7	7.3	17.6	13.8	19.1	13.9	14.2	18.2	16.4	12.7	17.8	37.1	9.8	13.8	18.0	13.0	12.4	12.2	20.1	28.2	17.6	17.7	15.5	15.9	21.9	17.2	7.8	16.5	24.4	15.2	13.0	19.0	18.4	15.7	22.9	10.8	13.5	14.8	13.6	17.3	20.1	18.3	14.0	13.1	13.0	21.2	8.9	13.1	14.6	12.6	5.7	7.9	2.0	9.2	5.6	7.3	4.6	3.4	2.2	9.6	4.5	11.1	11.5	14.6	5.4	6.7	5.8	7.6	6.8	15.5	9.4	10.3	3.5	7.3	7.3	3.7	3.1	5.0	13.5	4.2	7.6	4.5	7.5	7.1	7.4	11.1	9.3	4.1	3.9	3.9	8.8	3.6	7.8	2.6	11.7	5.2	2.6	5.8	11.8	2.5	7.9	2.2	6.2	25.5	5.2	8.8	6.9	2.2	4.0	3.4	4.8	12.2	5.6	6.3	12.0	4.2	7.9	3.9	10.3	5.6	9.4	8.0	3.8	10.5	8.1	5.7	2.0	9.0	1.0	6.6	9.2	7.3	5.7	4.8	5.3	7.9	4.6	4.9	7.0	0.8	5.6	8.2	7.3	5.4	4.6	12.3	14.7	13.8	19.1	12.4	12.2	15.5	15.9	15.2	13.1	11.9	19.8	23.0	12.8	7.4	71.9	10.8	17.8	25.4	29.6	33.2	53.0	56.2	8.3	16.4	5.1	23.3	21.0	0.0	14.5	13.2	18.0	9.5	15.1	29.4	37.9	74.7	13.3	43.6	40.6	2.8	56.7	39.9	16.9	16.2	25.9	44.6	14.0	34.0	39.3	13.3	83.5	58.2	11.1	32.5	31.9	7.9	20.3	35.5	26.2	6.8
NPS		ENSG00000214285	"Neuropeptide S"	P0C0P6	10	127549369-127552639	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	8	"head and neck cancer: 4.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"midbrain: 6.5;pons and medulla: 5.3"	"Region enriched"	"Detected in some"	8	"cerebral cortex: 5.8"	CAB020139	Uncertain				"Secreted - unknown location"	NA	NA					"CAB020139: AB_776718"					"unprognostic (2.83e-1)"													0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NRN1L	"MRCC2446, UNQ2446"	ENSG00000188038	"Neuritin 1 like"	Q496H8	16	67884805-67888855	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 20.9"	"Cell type enhanced"	"Detected in some"	29	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 8.1;Bipolar cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"BEWO: 27.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041761	Uncertain				"Secreted - unknown location"	NA	NA					"HPA041761: AB_10961155"										"unprognostic (2.79e-2)"				"unprognostic (3.32e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.85e-1)"	1.9	2.1	3.4	1.9	11.6	7.2	1.8	8.5	5.1	2.0	1.7	6.3	0.4	3.1	2.2	0.9	1.5	2.5	1.7	4.8	5.9	5.3	1.6	1.8	4.4	4.4	5.7	3.1	4.9	2.6	3.6	6.5	1.6	6.4	2.6	1.4	20.9	4.4	2.0	4.5	6.8	2.6	1.6	3.5	4.3	2.2	2.6	6.1	0.4	2.4	1.5	1.5	3.9	1.9	1.6	0.5	2.1	1.9	0.8	3.8	0.9	0.1	0.4	0.6	0.7	0.3	0.8	27.1	0.4	0.0	0.3	0.2	0.0	0.4	0.3	0.5	0.1	0.1	0.3	0.0	0.2	0.2	0.3	0.6	0.2	1.1	1.5	0.6	0.1	1.1	0.5	0.9	0.0	0.0	0.4	0.0	1.1	0.7	0.6	0.2	1.4	0.5	3.3	5.1	0.0	0.3	1.3	0.0	0.5	0.2	0.4	0.8	0.3	0.4	0.4	0.4	5.3	0.9	1.1	0.5	0.3	0.2	0.0	0.0	0.2	0.3	0.7	0.1	0.4	0.1	0.0	1.9	0.0	3.8	1.1	2.0	1.6	2.3	1.2	0.5	1.3	2.0	1.1	2.1	0.8	1.3	0.4	1.3	0.9	3.4	11.6	8.5	5.1	5.9	5.3	5.7	3.1	6.4	6.1	3.0	8.1	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0
NT5DC3	"FLJ11266, TU12B1-TY"	ENSG00000111696	"5'-nucleotidase domain containing 3"	Q86UY8	12	103770453-103841197	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.0"	"Cell type enhanced"	"Detected in many"	9	"Intestinal endocrine cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.0"					"Low region specificity"	"Detected in all"			HPA041634			Approved	Mitochondria,Cytosol	"Secreted - unknown location"	NA	NA			Mitochondria	Cytosol	"HPA041634: AB_10795597"	"unprognostic (2.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.72e-6)"	"unprognostic (8.60e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (8.11e-4)"	4.2	5.4	14.8	3.2	10.5	23.9	5.4	2.7	16.2	12.2	52.0	2.9	9.4	2.0	17.9	8.4	8.9	3.5	2.6	2.2	13.3	5.7	2.2	4.0	2.8	2.3	2.8	11.7	3.8	3.5	1.8	4.2	4.5	10.4	9.8	12.5	3.7	3.9	9.1	7.0	2.8	4.2	32.9	2.1	1.9	6.6	3.5	2.7	0.0	2.9	0.9	2.4	22.4	5.2	4.1	4.9	2.4	1.6	1.5	3.3	0.8	3.3	6.0	3.5	4.0	4.9	3.9	6.5	5.5	3.3	3.9	2.5	4.1	0.9	5.6	1.1	6.5	4.3	3.8	4.9	10.9	5.7	4.1	4.0	7.0	2.2	4.7	2.8	3.7	1.9	3.4	2.4	5.0	22.0	8.0	2.3	2.9	11.0	2.9	8.7	3.0	3.2	6.0	4.3	4.8	6.5	4.5	6.1	2.1	6.2	2.3	4.7	1.9	4.6	5.2	6.5	3.3	2.9	3.5	3.0	3.9	4.7	5.3	11.0	2.6	3.1	4.2	3.7	5.7	5.6	0.8	1.5	0.1	1.7	1.6	3.3	3.5	2.4	1.4	3.8	4.1	2.1	1.8	2.4	1.5	1.0	4.9	0.6	0.8	14.8	10.5	2.7	16.2	13.3	5.7	2.8	11.7	10.4	2.7	0.0	2.9	0.8	17.0	3.9	1.5	2.8	2.5	9.4	2.3	1.8	0.0	4.2	0.0	1.8	8.8	1.6	1.6	0.0	1.8	4.4	3.9	10.0	0.0	4.3	1.7	9.5	39.5	1.3	3.5	7.4	4.6	2.5	0.0	2.8	9.1	0.8	2.3	0.0	7.8	1.5	4.9	0.0	8.0	0.5	3.1	3.9	3.4	0.9	9.0	8.6
NXPE3	"FAM55C, MGC15606"	ENSG00000144815	"Neurexophilin and PC-esterase domain family member 3"	Q969Y0	3	101779202-101827392	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.6"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 37.8;Horizontal cells: 46.1;Ito cells: 40.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036259	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA		7600	Vesicles	Nucleoplasm	"HPA036259: AB_10671838"	"unprognostic (3.30e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-5)"	"unprognostic (4.98e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.76e-6)"	"unprognostic (2.89e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.75e-3)"	6.1	4.7	7.2	7.6	16.6	7.8	5.3	6.1	16.2	6.3	5.2	29.5	6.0	2.4	7.9	2.6	4.5	8.2	4.8	12.6	9.8	5.9	3.0	2.5	6.9	10.7	24.0	8.6	5.5	2.6	15.8	6.9	4.7	22.0	6.2	3.4	3.4	4.2	7.5	44.6	2.5	4.9	7.6	9.4	8.7	4.6	5.1	17.2	6.6	5.3	4.1	9.8	7.3	5.0	8.9	11.6	15.9	13.6	6.7	19.5	11.1	7.8	12.0	10.4	3.7	11.2	11.7	2.3	8.7	11.1	10.5	15.3	2.8	0.8	11.5	25.8	9.8	12.7	1.7	11.5	9.4	13.0	14.3	3.6	8.9	7.6	7.4	14.8	7.5	8.3	6.7	1.6	8.7	3.2	13.7	11.3	11.2	1.8	37.8	17.3	4.1	10.0	1.8	5.9	0.4	7.4	4.6	12.6	4.9	7.7	2.0	8.2	9.8	3.7	0.9	6.5	6.5	1.7	10.8	9.8	11.7	13.9	1.3	9.0	18.0	17.8	13.6	10.0	33.3	2.2	6.3	13.6	15.9	12.7	10.4	8.8	8.9	14.2	13.2	11.6	5.8	19.5	15.5	6.9	6.7	9.9	7.4	16.3	11.1	7.2	16.6	6.1	16.2	9.8	5.9	24.0	8.6	22.0	17.2	23.8	6.1	9.7	1.9	3.3	23.7	37.8	5.1	2.7	3.4	0.0	7.9	0.7	0.0	2.6	1.0	11.7	0.0	0.0	2.2	1.2	7.8	0.8	12.7	1.6	6.3	46.1	6.9	40.5	18.4	1.3	8.6	9.5	6.8	10.8	0.5	22.7	2.0	0.0	7.1	0.5	15.7	19.4	7.6	9.3	15.2	2.6	0.6	10.9	0.4	1.0
OAF	MGC52117	ENSG00000184232	"Out at first homolog"	Q86UD1	11	120210767-120230332	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 187.7;Muller glia cells: 261.4;Urothelial cells: 195.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.2;intermediate monocyte: 2.9;myeloid DC: 4.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 4.6;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 35.0;Hep G2: 54.7;NB-4: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047412	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		65000000	Nucleoplasm		"HPA047412: AB_10960631"	"unprognostic (1.59e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.11e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-1)"	16.2	22.5	8.6	6.9	15.4	3.5	24.9	1.2	10.3	18.7	16.8	4.0	8.0	19.4	14.3	17.2	10.7	13.4	20.6	13.7	8.7	1.4	21.5	93.4	5.6	8.1	5.4	6.4	26.2	43.7	2.4	7.4	4.6	3.2	10.3	13.5	18.2	26.5	5.8	3.7	3.0	22.1	11.7	3.3	15.3	9.9	5.5	5.5	1.2	6.8	8.6	3.6	11.2	10.9	0.1	4.6	0.3	6.2	0.0	0.4	1.3	7.0	2.2	8.4	4.2	13.1	14.8	0.5	13.8	14.3	5.6	8.2	2.2	11.0	0.0	35.0	9.3	9.2	7.4	2.3	3.5	2.2	5.1	5.7	5.8	1.4	54.7	11.7	12.8	2.3	18.4	2.1	5.3	14.9	10.8	16.0	3.5	3.7	6.7	1.3	2.6	0.0	36.7	3.4	1.9	11.2	3.3	0.2	6.8	8.4	3.9	0.4	3.0	4.0	4.5	11.4	2.4	1.4	21.3	9.7	12.0	4.4	12.2	1.3	0.2	0.1	0.1	9.2	21.4	4.1	0.0	6.2	0.0	0.2	2.9	0.1	0.1	0.0	0.0	4.6	0.0	0.1	0.4	0.3	0.0	0.6	0.9	0.3	1.3	8.6	15.4	1.2	10.3	8.7	1.4	5.4	6.4	3.2	5.5	0.0	1.1	1.5	19.1	8.4	3.2	3.6	33.1	0.0	2.3	68.0	2.0	1.8	23.2	14.3	0.1	24.8	97.4	23.3	24.3	4.7	46.2	12.2	1.1	187.7	5.5	0.0	21.9	11.1	10.6	0.0	15.5	9.7	15.1	1.8	55.8	261.4	23.5	41.9	4.2	64.1	8.0	51.8	45.3	0.5	6.7	8.9	5.1	3.2	42.0	195.3
OLFML1	UNQ564	ENSG00000183801	"Olfactomedin like 1"	Q6UWY5	11	7485388-7511377	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Fibroblasts: 33.2;Leydig cells: 36.8;Peritubular cells: 37.1;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 24.3;HSkMC: 3.8;SuSa: 5.3;U-2197: 16.1"									HPA039735	Uncertain				"Secreted - unknown location"	NA	NA		270000			"HPA039735: AB_10673148"	"unprognostic (3.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (3.13e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.72e-3)"	16.8	3.0	0.8	6.2	1.3	0.0	9.4	1.8	2.1	32.2	6.4	2.5	7.6	2.0	28.0	19.9	17.1	10.5	15.3	11.8	1.7	0.8	4.2	5.1	12.4	5.3	1.6	1.8	32.1	2.8	0.6	2.6	3.1	4.5	27.9	4.8	14.6	5.1	11.8	5.4	5.4	6.9	12.9	1.2	8.3	4.5	8.0	0.6	0.7	6.8	14.3	5.4	12.9	15.4	2.7	0.6	0.9	3.0	0.2	0.5	0.1	0.0	0.0	0.3	0.0	1.5	1.5	24.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.1	16.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.9	0.3	0.9	0.3	1.7	0.3	0.0	0.2	2.7	0.5	0.5	0.9	0.2	3.0	0.6	0.1	0.1	0.8	1.3	1.8	2.1	1.7	0.8	1.6	1.8	4.5	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.8	33.2	0.1	0.0	0.2	0.6	0.0	0.0	6.7	0.0	0.2	36.8	0.3	6.8	0.0	0.0	0.0	0.1	0.0	37.1	0.1	0.0	25.8	7.7	0.3	0.1	3.1	0.2	0.0	0.0	0.0
OLFML2A	FLJ00237	ENSG00000185585	"Olfactomedin like 2A"	Q68BL7	9	124777158-124814885	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 12.1;Endothelial cells: 14.2;Fibroblasts: 13.1;Sertoli cells: 12.9;Smooth muscle cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 58.3;GAMG: 12.1;HeLa: 14.7;hTERT-RPE1: 13.5;WM-115: 22.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021180, HPA022254"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Cytosol"		"HPA021180: AB_1854790, HPA022254: AB_1854791"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.05e-2)"	17.3	2.1	1.0	7.4	1.7	0.1	10.9	1.9	3.4	34.2	18.9	3.1	6.3	2.3	29.2	8.3	11.8	4.2	7.6	12.5	1.2	1.0	3.0	0.6	10.3	1.5	2.1	1.5	13.2	3.4	3.6	2.1	5.0	4.0	16.1	4.6	18.9	4.7	9.5	9.8	11.6	5.0	33.7	1.6	23.8	4.0	3.1	0.6	3.7	20.0	11.9	5.0	22.0	10.4	1.4	0.7	2.6	0.9	0.6	0.6	0.4	0.3	5.2	0.4	0.1	6.1	58.3	0.0	0.8	2.9	1.2	1.2	0.0	0.7	0.0	1.5	0.0	12.1	9.7	0.1	0.3	1.4	0.0	0.0	0.0	14.7	0.0	0.3	0.0	0.0	4.1	0.9	3.6	0.5	13.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	1.3	0.0	0.5	0.0	3.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	1.5	10.6	1.4	0.1	0.0	1.8	1.9	2.0	0.2	0.7	0.0	0.0	5.6	0.3	22.8	1.9	0.9	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.7	1.4	0.4	0.6	2.6	0.6	0.3	0.6	0.3	0.4	1.0	1.7	1.9	3.4	1.2	1.0	2.1	1.5	4.0	0.6	0.0	2.2	0.0	3.7	10.6	0.5	12.1	0.0	1.4	0.0	0.0	2.0	0.2	0.0	0.1	0.6	14.2	0.0	0.0	0.6	0.2	13.1	1.0	0.0	0.0	0.1	0.0	0.0	3.1	2.4	1.2	2.6	0.5	10.1	0.0	0.0	0.2	0.0	0.0	1.4	0.0	3.9	12.9	28.8	0.2	0.7	7.3	0.0	0.0	0.0	1.6
OLFML2B	DKFZP586L151	ENSG00000162745	"Olfactomedin like 2B"	Q68BL8	1	161983192-162023854	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 56.2;Hofbauer cells: 31.7;Kupffer cells: 20.4;Leydig cells: 19.2;Peritubular cells: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 8.8;non-classical monocyte: 6.5"	"Lineage enriched"	"Detected in single"	10	"monocytes: 8.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.0;HSkMC: 45.3;RH-30: 34.6"	"Region enriched"	"Detected in many"	6	"hippocampal formation: 45.1"	"Low region specificity"	"Detected in many"			"HPA054136, HPA062739"	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA054136: AB_2682397, HPA062739: AB_2684858"	"unprognostic (2.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (5.97e-3)"	"unprognostic (7.32e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.01e-12)"	"unprognostic (1.64e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.97e-2)"	19.6	6.6	1.7	12.8	3.0	0.3	12.3	0.6	4.1	13.0	14.5	2.9	6.5	1.5	14.2	21.8	3.2	9.8	33.7	25.4	2.9	1.6	3.9	1.2	12.8	24.1	2.9	1.2	7.0	2.3	3.2	2.6	27.6	2.2	6.6	2.2	14.5	9.0	6.1	6.1	8.9	5.0	15.1	3.6	22.4	3.4	12.5	2.1	1.9	18.3	13.7	8.5	12.4	7.3	0.0	0.8	0.3	8.8	0.0	0.1	0.2	0.0	0.1	2.6	0.8	8.4	16.0	0.0	0.8	4.1	1.7	4.6	0.0	0.0	0.0	0.1	9.7	1.7	0.0	0.2	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	45.3	0.0	2.0	0.0	0.8	0.2	0.0	0.0	0.4	7.4	0.0	0.0	0.1	0.8	0.0	0.4	0.0	34.6	3.3	0.6	0.0	0.3	0.1	3.4	0.0	0.2	8.0	0.0	0.0	0.0	1.0	0.2	1.5	1.3	0.0	0.0	0.0	9.9	1.0	0.5	0.0	0.6	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.3	0.0	6.5	0.0	0.0	0.2	1.7	3.0	0.6	4.1	2.9	1.6	2.9	1.2	2.2	2.1	0.0	1.1	0.0	0.0	3.0	0.0	2.5	0.0	0.0	1.2	1.8	0.0	0.2	0.0	0.0	56.2	0.0	0.0	0.0	0.0	0.3	9.3	0.1	1.1	0.0	31.7	0.0	0.0	1.8	20.4	4.5	19.2	9.9	1.7	1.0	0.0	0.9	0.0	0.0	27.6	0.0	0.0	6.5	12.6	1.5	0.9	1.9	0.2	0.0	0.0	0.0
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860694	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 383.4;pancreas: 677.5"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 1160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	No	No		140000000	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	18.0	34.7	6.3	15.4	8.4	35.0	16.1	6.1	6.5	22.1	40.5	9.0	45.0	42.6	14.7	29.1	40.3	12.8	42.3	20.7	6.3	5.9	27.2	383.4	20.9	29.1	7.9	4.5	14.3	677.5	6.4	23.4	58.5	7.2	22.5	8.5	12.3	251.9	42.5	31.0	24.3	112.8	11.0	5.2	36.7	31.6	9.1	7.2	10.5	29.7	50.7	46.4	16.5	20.5	21.6	71.3	45.8	60.8	38.8	55.9	70.8	58.4	50.9	18.9	60.8	51.0	60.1	44.7	114.3	73.7	49.8	67.5	37.4	51.3	23.6	50.3	73.4	30.1	41.5	20.7	44.7	28.9	15.2	35.1	35.3	53.6	152.0	67.1	111.5	58.5	45.3	30.4	39.9	42.3	64.5	82.1	16.9	25.0	102.0	35.5	53.4	31.9	88.6	14.8	62.0	46.4	26.1	33.8	46.8	38.7	70.7	22.7	25.1	57.0	164.5	59.3	32.6	74.4	131.4	63.7	93.6	46.9	53.1	55.7	73.4	53.1	22.3	123.0	43.0	71.3	45.8	60.8	38.3	53.5	38.7	55.9	21.6	36.4	42.8	43.4	18.7	21.2	31.5	20.0	38.8	27.6	71.3	25.7	70.8	6.3	8.4	6.1	6.5	6.3	5.9	7.9	4.5	7.2	7.2	95.3	135.6	82.0	139.4	106.7	53.8	19.6	234.4	58.9	83.0	106.4	31.4	682.3	34.9	562.2	31.8	104.1	635.2	0.0	930.3	1160.9	218.5	265.2	99.1	768.8	403.4	58.8	191.7	211.1	166.1	51.9	130.9	120.0	129.9	349.9	361.7	113.5	636.3	443.3	105.4	92.7	40.7	155.2	103.8	85.8	107.3	126.5	837.3	139.5	385.8	170.2
PAMR1	"DKFZP586H2123, RAMP"	ENSG00000149090	"Peptidase domain containing associated with muscle regeneration 1"	Q6UXH9	11	35431823-35530300	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	24	"Basal keratinocytes: 16.9;Fibroblasts: 47.8;Suprabasal keratinocytes: 8.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.9;ASC TERT1: 74.1;BJ hTERT+: 72.1;fHDF/TERT166: 17.1;HSkMC: 25.5;U-87 MG: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"	NA	NA		3300000				"unprognostic (3.38e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.00e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (5.08e-5)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.08e-1)"	"unprognostic (9.98e-2)"	"unprognostic (8.25e-2)"	14.1	9.9	11.9	0.7	10.5	0.4	10.2	0.7	12.8	40.1	6.6	9.7	5.1	3.1	37.0	12.7	6.8	12.1	12.7	11.1	9.5	7.3	2.6	8.0	3.5	1.1	9.9	5.4	4.4	3.4	0.8	3.4	34.0	18.1	12.7	4.6	0.8	2.7	12.1	3.1	12.5	4.7	14.6	13.8	3.7	3.1	5.8	5.7	0.6	3.4	6.0	2.9	18.8	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	74.1	0.0	9.1	72.1	1.0	1.7	6.4	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	10.8	0.0	0.0	25.5	0.3	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	10.5	0.7	12.8	9.5	7.3	9.9	5.4	18.1	5.7	0.0	0.0	0.0	1.5	16.9	0.0	1.2	0.0	1.4	3.4	1.8	0.0	1.5	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.9	47.8	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	8.2	2.9	0.0	0.0	0.2
PAPLN	MGC50452	ENSG00000100767	"Papilin, proteoglycan like sulfated glycoprotein"	O95428	14	73237497-73274640	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 31.9;Muller glia cells: 21.2;Peritubular cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"neutrophil: 4.4;plasmacytoid DC: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 8.8;granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 13.1;HSkMC: 24.7;hTCEpi: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA048682, HPA053453"	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		46000000	Nucleoplasm		"HPA048682: AB_2680492, HPA053453: AB_2682155"	"unprognostic (1.97e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.56e-3)"	"unprognostic (7.42e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.46e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.69e-2)"	"unprognostic (5.58e-2)"	9.3	6.1	13.6	11.8	14.8	2.9	11.0	4.1	11.1	10.8	7.0	6.0	3.8	4.1	14.2	19.5	4.6	12.1	8.0	4.8	15.7	3.0	24.9	1.9	7.8	23.3	4.1	9.7	10.9	2.7	1.0	11.1	5.2	5.7	8.1	6.2	14.9	4.7	10.2	1.8	16.2	10.3	8.6	6.0	17.6	7.4	6.5	8.9	5.1	15.3	2.2	16.5	6.8	5.6	1.1	8.8	4.4	0.8	0.5	0.5	0.2	2.0	2.0	0.8	0.3	1.5	1.9	4.6	0.4	0.0	0.1	0.1	2.6	0.6	0.4	2.1	0.0	0.1	3.3	2.1	1.5	0.2	2.3	3.1	0.9	3.2	0.3	13.1	0.3	1.7	24.7	9.1	0.4	1.4	0.1	0.4	1.9	0.6	0.3	0.0	1.0	0.2	2.2	0.5	0.2	0.6	0.3	0.3	2.1	1.8	0.4	0.2	0.4	4.8	5.5	0.9	6.6	0.1	3.7	0.4	0.6	1.9	0.2	0.2	1.1	0.1	0.2	1.1	1.1	0.5	1.1	0.8	0.6	0.4	0.5	0.2	0.7	0.3	0.5	0.2	1.1	0.5	0.5	4.4	0.5	0.4	8.8	0.5	0.2	13.6	14.8	4.1	11.1	15.7	3.0	4.1	9.7	5.7	8.9	0.0	1.6	0.0	0.5	1.8	1.0	1.3	2.5	1.4	5.7	5.2	7.9	0.5	0.0	3.0	0.3	1.1	0.1	0.0	0.0	0.9	6.1	1.7	0.0	0.0	1.2	0.0	0.0	1.8	0.3	1.4	31.9	0.9	1.7	2.8	0.0	21.2	0.4	0.0	41.4	13.4	3.0	6.5	1.0	0.6	0.1	2.6	0.3	0.0	0.9	0.4
PCDHA1		ENSG00000204970	"Protocadherin alpha 1"	Q9Y5I3	5	140786136-141012347	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 7.1;testis: 3.1"	"Cell type enhanced"	"Detected in some"	24	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ito cells: 1.3;Sertoli cells: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"T-47d: 14.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035969	Enhanced		Approved	"Plasma membrane"	"Secreted - unknown location"	NA	NA			"Plasma membrane"		"HPA035969: AB_10673492"	"unprognostic (2.76e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-4)"	"unprognostic (7.38e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.01e-5)"	"unprognostic (2.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.29e-1)"	0.2	1.5	4.6	0.2	4.4	0.1	0.2	3.3	7.1	0.2	0.3			0.7	0.5	0.1	0.2	0.2	0.4	0.1	5.0	3.7	0.6	0.1	0.2	0.3	3.4		0.2	0.2	1.0	1.4	0.1		0.2	0.2		0.1	0.1	0.1	0.1	0.6	0.2	3.4	0.2	0.3	3.1			0.2		0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.4	1.0	0.0	0.2	1.8	0.3	14.4	0.5	0.0	1.6	1.0	0.7	0.1	0.0	0.1	0.0	0.4	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
PCDHA10	"CNR8, CNRN8, CNRS8, CRNR8, PCDH-ALPHA10"	ENSG00000250120	"Protocadherin alpha 10"	Q9Y5I2	5	140855883-141012344	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 7.0;Cone photoreceptor cells: 7.9;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"EFO-21: 20.2"	"Low region specificity"	"Detected in all"												"Secreted - unknown location"	NA	NA						"unprognostic (4.24e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.70e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.24e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.14e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	2.1	1.7	6.1	1.1	6.6	0.6	2.4	8.0	20.3	3.0	0.9	4.9	0.9	1.1	4.5	6.3	0.5	2.7	3.1	0.8	7.1	2.7	4.3	0.6	2.1	0.7	7.2	3.6	2.8	7.8	0.8	11.2	0.5	6.1	1.6	0.9	1.9	3.2	1.0	0.5	0.7	1.8	4.0	6.9	0.7	1.1	1.9	8.2	0.0	5.0	0.0	0.5	0.7	0.7	0.6	0.4	1.5	0.3	0.6	0.3	0.0	0.0	0.2	0.4	2.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.3	1.6	0.8	0.0	0.1	0.0	4.1	0.3	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.1	0.3	0.3	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.6	0.2	0.3	1.5	0.6	0.2	0.4	0.1	0.0	6.1	6.6	8.0	6.9	7.1	2.7	7.2	3.6	6.1	8.2	0.0	1.0	0.0	0.3	0.0	7.0	0.5	2.5	0.0	0.0	0.0	7.9	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	7.9	1.7	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	1.7	0.0	0.0	0.4	2.6	0.0	0.3	1.0	0.2	0.0	0.0	0.0	0.0	0.2
PCYOX1L	MGC3265	ENSG00000145882	"Prenylcysteine oxidase 1 like"	Q8NBM8	5	149358007-149369653	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 11.1;Rod photoreceptor cells: 12.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037463, HPA038402"	Approved		Approved	Nucleoplasm,Mitochondria	"Secreted - unknown location"	NA	NA		930000	"Nucleoplasm, Mitochondria"		"HPA037463: AB_10673632, HPA038402: AB_2675997"	"unprognostic (1.34e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.83e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.77e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.28e-1)"	4.8	6.6	4.5	7.2	13.5	6.9	4.0	15.9	19.0	6.5	4.4	8.2	2.7	2.3	6.2	2.7	4.6	7.9	5.8	5.2	4.6	8.9	3.7	1.2	4.2	9.6	5.5	9.9	7.9	6.7	27.0	6.4	6.2	13.7	6.4	2.1	9.4	3.4	6.6	1.6	6.6	5.6	6.0	4.6	6.3	5.8	11.5	2.4	5.8	3.3	3.1	7.4	5.0	4.7	1.8	13.5	3.9	9.6	4.5	7.2	4.5	2.1	1.5	2.9	6.3	2.4	1.5	2.1	5.1	1.0	2.5	5.3	0.4	3.5	9.7	15.4	1.6	14.7	4.3	3.2	7.2	0.3	4.7	4.7	4.5	0.0	0.3	7.0	2.9	4.2	6.4	1.2	5.0	4.4	3.4	7.9	8.4	2.6	19.2	0.2	3.4	2.7	4.2	2.7	3.2	9.2	5.2	2.3	25.7	1.0	0.6	5.9	7.7	10.0	3.6	7.9	1.4	9.5	5.5	4.6	2.9	3.1	7.2	2.0	11.3	15.2	5.5	6.1	17.8	7.4	3.0	7.1	3.9	3.0	9.6	4.0	1.8	5.7	2.3	13.5	1.2	6.8	4.7	1.2	4.5	9.1	1.3	7.2	4.5	4.5	13.5	15.9	19.0	4.6	8.9	5.5	9.9	13.7	2.4	8.9	1.7	0.0	1.1	0.9	4.5	4.5	5.1	1.4	2.3	1.8	0.0	4.0	0.0	2.2	2.8	3.8	0.9	0.0	2.1	6.2	2.8	0.7	2.3	0.0	6.4	11.1	0.0	2.5	4.7	1.1	3.1	4.8	1.7	3.6	1.7	6.8	1.7	1.1	2.5	0.3	12.8	0.0	1.2	0.9	3.3	1.4	1.0	2.1	2.2	0.6
PDCD1LG2	"B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2"	ENSG00000197646	"Programmed cell death 1 ligand 2"	Q9BQ51	9	5510570-5571254	"Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 15.1;monocytes: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 25.9;BJ hTERT+: 40.8;HDLM-2: 31.1;TIME: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013411	Approved		Uncertain	Cytosol	"Secreted - unknown location"	NA	NA		34000000	Cytosol		"HPA013411: AB_1855102"	"unprognostic (3.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (6.68e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.37e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-3)"	15.2	1.8	1.2	7.7	1.4	0.2	9.5	0.7	1.2	7.0	1.9	2.3	0.0	0.8	2.9	7.2	3.9	3.8	4.0	5.8	1.2	1.3	2.5	6.4	13.3	10.8	1.6	0.5	4.1	1.8	0.5	1.1	12.9	1.9	5.0	2.5	2.4	2.9	1.7	5.5	3.6	2.5	4.6	3.7	19.5	1.9	4.2	1.2	8.1	3.5	3.5	8.1	6.0	5.4	0.5	0.9	4.1	3.6	0.0	3.0	0.7	2.1	0.0	0.0	0.0	1.8	2.1	0.0	25.9	40.8	12.5	15.2	0.0	0.1	0.0	0.1	10.5	1.8	0.2	0.0	3.5	12.5	31.1	0.0	0.0	0.0	0.0	10.1	0.0	0.0	1.9	0.0	5.8	6.9	3.6	8.2	0.0	0.0	3.1	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	18.0	9.0	0.5	4.3	7.1	0.4	0.0	0.0	5.1	0.0	1.1	4.1	0.9	0.0	1.4	3.6	1.9	0.5	2.2	0.9	0.9	0.3	0.0	1.0	2.0	0.0	0.5	0.0	3.0	0.7	1.2	1.4	0.7	1.2	1.2	1.3	1.6	0.5	1.9	1.2	6.0	0.3	0.8	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.0	0.0	0.2	15.1	2.1	0.1	3.5	0.0	2.8	0.0	0.0	6.7	4.3	0.0	5.5	2.2	1.7	45.9	0.0	0.0	2.1	0.0	2.1	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.7	0.0	0.0	0.0
PDGFRL	PRLTS	ENSG00000104213	"Platelet derived growth factor receptor like"	Q15198	8	17576433-17644071	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 14.3"	"Cell type enhanced"	"Detected in many"	11	"Fibroblasts: 36.0;Leydig cells: 69.0;Peritubular cells: 66.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"AN3-CA: 49.5;BJ hTERT+: 40.1;HSkMC: 21.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052801			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted - unknown location"	NA	NA			"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA052801: AB_2681956"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.00e-3)"	7.7	0.4	0.5	0.1	0.9	0.0	14.3	0.6	0.5	8.0	1.3			0.0	3.6	2.0	0.3	5.8	2.6	1.2	0.3	0.4	0.4	0.3	0.7	0.0	0.4		11.6	1.6	2.3	2.0	1.5		0.9	0.0		1.4	1.1	3.3	1.8	0.6	6.3	0.5	0.2	1.0	0.9			8.3		0.0	0.9	2.0	0.0	0.9	1.4	1.4	0.0	0.0	0.1	0.0	4.5	0.2	49.5	1.5	0.6	3.2	0.9	40.1	1.8	8.0	0.2	0.0	0.0	0.2	0.6	6.0	0.0	2.7	0.2	1.0	0.0	3.0	0.0	1.4	1.0	3.8	0.0	0.0	21.9	0.0	2.2	0.0	0.0	3.3	0.4	0.0	0.6	0.2	3.2	0.0	0.1	2.4	0.2	0.7	0.0	0.0	0.1	0.2	2.9	0.1	0.3	0.3	0.3	0.8	3.0	0.1	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1											0.0	2.2	0.0	0.4	11.7	0.4	2.2	0.0	0.0	3.4	0.0	0.0	14.1	0.0	2.5	19.2	2.7	0.1	0.0	6.4	17.2	36.0	1.7	0.0	0.0	2.7	0.0	1.2	2.5	0.0	3.1	69.0	0.3	10.1	2.8	1.0	1.3	4.9	0.0	66.4	0.0	0.4	0.0	6.1	0.5	1.0	8.7	8.1	0.0	0.2	0.3
PLA2G2C		ENSG00000187980	"Phospholipase A2 group IIC"	Q5R387	1	20161253-20177424	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 4.2;intestine: 4.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 2.6;Late spermatids: 7.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HL-60: 4.5;NB-4: 1.4;SK-BR-3: 1.3;U-698: 5.0;U-937: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"	NA	NA						"unprognostic (3.02e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-4)"	"unprognostic (9.44e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (8.16e-2)"	0.1	0.1	0.3	0.0	0.3	1.0	0.1	0.2	0.2	0.1	4.7			0.4	0.9	0.3	4.2	0.2	0.0	0.1	0.3	0.4	0.2	0.2	0.1	0.3	0.4		0.3	0.0	0.4	0.1	0.0		1.0	0.7		0.2	0.7	0.5	1.2	0.8	0.0	0.2	0.1	1.1	0.9			0.1		0.0	0.9	0.1	0.7	2.4	2.3	1.4	1.3	1.4	0.5	0.2	0.0	0.4	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.0	4.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.5	0.0	0.1	0.7	1.4	0.4	0.0	0.1	0.2	0.2	0.4	0.1	0.3	0.2	0.1	0.4	1.3	0.1	0.3	0.3	0.1	0.2	0.6	0.2	0.2	0.2	0.2	0.1	5.0	0.4	4.8	0.1	2.3	1.4	0.5	0.7	0.5	1.4	0.6	0.7	0.9	2.4	0.7	0.6	0.5	2.3	1.3	0.4	0.8	0.3	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
PLA2G2D	sPLA2S	ENSG00000117215	"Phospholipase A2 group IID"	Q9UNK4	1	20111939-20119566	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 39.9"	"Group enriched"	"Detected in some"	10	"Kupffer cells: 2.2;Melanocytes: 5.0"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 25.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.6;naive B-cell: 5.6;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.6;dendritic cells: 3.4"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 13.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA						"prognostic favorable (4.35e-4)"	"prognostic favorable (8.15e-5)"	"unprognostic (3.88e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.82e-5)"	"unprognostic (7.51e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.60e-1)"	0.4	0.3	0.3	38.8	0.3	0.0	0.4	0.3	0.3	0.3	0.9	0.0	0.0	0.3	0.3	0.2	0.4	0.5	0.4	0.3	0.3	0.3	0.4	0.4	1.0	39.9	0.3	0.0	0.3	0.3	0.0	0.3	0.2	0.0	0.4	1.2	0.1	5.0	0.3	0.3	0.3	7.7	0.0	0.3	18.1	0.6	0.3	0.0	6.6	0.7	0.5	33.0	2.5	0.3	6.6	3.4	1.0	0.2	0.3	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	13.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.3	0.2	2.1	0.1	0.2	0.1	0.1	0.0	1.0	0.2	0.2	0.1	0.1	0.1	6.6	0.1	0.1	0.1	5.6	0.1	0.1	0.4	0.3	0.1	3.4	0.0	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
PLA2G2E		ENSG00000188784	"Phospholipase A2 group IIE"	Q9NZK7	1	19920009-19923617	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"lymphoid tissue: 7.7;skin 1: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;CAPAN-2: 1.2;OE19: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064085	Uncertain				"Secreted - unknown location"	NA	NA					"HPA064085: AB_2685188"														"unprognostic (9.56e-2)"		"unprognostic (3.71e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.2			0.0		7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091190	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 48.3;retina: 58.3"	"Cell type enhanced"	"Detected in some"	21	"Cardiomyocytes: 79.9;Cone photoreceptor cells: 66.8;Leydig cells: 75.4;Peritubular cells: 68.9;Sertoli cells: 258.7"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;HaCaT: 1.1;hTEC/SVTERT24-B: 1.5;hTERT-RPE1: 1.4;U-138 MG: 3.1;U-2197: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053361	Approved				"Secreted - unknown location"	NA	NA					"HPA053361: AB_2682127"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	2.6	0.5	2.8	2.0	6.7	0.2	1.9	1.9	5.2	0.3	10.5	2.1	2.5	1.2	0.5	2.1	5.7	1.9	3.0	48.3	2.6	2.4	0.2	1.8	3.2	1.0	6.1	2.0	17.3	1.2	0.2	0.1	8.3	6.8	6.9	3.2	58.3	1.0	10.3	0.4	0.4	1.0	19.3	1.0	0.8	2.3	3.3	1.3	0.0	0.7	0.0	1.7	7.3	2.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	3.1	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.8	6.7	1.9	5.2	2.6	2.4	6.1	2.0	6.8	1.3	0.0	0.3	0.0	0.0	0.3	9.3	79.9	0.0	0.0	0.0	0.0	66.8	0.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.1	2.1	1.5	0.0	0.0	0.2	0.0	0.0	8.6	0.8	3.6	75.4	0.0	0.0	0.0	0.0	25.1	0.0	0.0	68.9	0.0	27.8	258.7	2.4	0.5	0.6	0.4	0.2	0.0	0.0	0.0
PLAC9		ENSG00000189129	"Placenta specific 9"	Q5JTB6	10	80131682-80145359	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 709.2;Leydig cells: 808.9;Peritubular cells: 620.2;Sertoli cells: 291.1;Smooth muscle cells: 378.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"eosinophil: 3.7;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 41.2;ASC TERT1: 36.0;BEWO: 13.2;HSkMC: 11.9"					"Low region specificity"	"Detected in all"			HPA043469	Uncertain				"Secreted - unknown location"	NA	NA					"HPA043469: AB_10795770"	"unprognostic (1.72e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.57e-3)"	"unprognostic (5.88e-3)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-3)"	43.8	5.5	2.1	4.9	1.9	0.8	38.7	0.7	2.0	38.8	7.3	2.1	16.1	2.5	9.7	27.8	20.3	7.4	20.7	32.5	2.6	1.4	3.8	1.4	15.1	8.5	1.7	0.7	6.0	3.0	0.9	1.0	7.3	6.4	27.8	2.9	46.8	6.4	8.1	7.8	13.0	5.9	25.3	3.3	1.6	5.7	8.4	1.0	0.6	12.3	24.5	6.0	14.1	23.0	0.3	0.6	3.7	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	41.2	36.0	13.2	4.2	3.5	0.3	0.5	0.0	0.3	0.0	0.1	2.3	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	6.8	0.0	0.9	11.9	0.0	0.8	0.4	4.3	1.3	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.8	0.1	0.6	0.0	0.0	0.6	0.0	0.2	0.0	0.8	0.0	0.5	0.3	0.0	0.0	0.1	1.3	2.7	1.5	8.3	0.0	0.2	0.3	0.0	0.7	0.1	0.0	0.3	0.2	3.7	0.0	0.3	0.5	0.3	0.3	0.6	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.6	0.4	0.0	2.1	1.9	0.7	2.0	2.6	1.4	1.7	0.7	6.4	1.0	3.0	2.6	0.0	0.5	112.4	0.2	17.3	0.0	1.4	0.0	0.0	0.0	5.5	0.0	0.4	3.6	61.2	0.0	0.0	0.2	10.6	709.2	0.7	1.1	0.2	12.4	0.0	1.7	90.9	0.0	10.0	808.9	1.1	129.9	0.0	0.0	50.0	0.7	0.0	620.2	0.0	1.6	291.1	378.1	2.6	2.5	110.4	9.6	0.0	0.0	1.8
PLOD3	LH3	ENSG00000106397	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3"	O60568	7	101205977-101218420	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Dioxygenase, Glycosyltransferase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 13.4;monocytes: 14.3;T-cells: 9.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 105.8;WM-115: 102.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001236	Uncertain				"Secreted - unknown location"	NA	NA		370000			"HPA001236: AB_1855474"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.91e-5)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.11e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.87e-2)"	23.9	16.1	11.9	19.5	24.0	14.6	35.4	7.2	19.2	17.8	20.0	31.2	16.6	22.7	22.9	15.1	11.0	17.4	16.7	22.1	14.8	11.6	20.2	54.1	21.0	18.2	36.3	8.9	16.1	23.2	18.5	16.5	33.1	22.4	14.4	14.2	11.1	11.3	19.6	8.8	14.0	23.2	23.2	29.0	20.4	16.7	10.1	30.6	5.1	16.8	6.0	6.9	17.3	42.6	2.6	13.4	2.8	14.3	2.5	9.2	5.3	10.1	9.2	3.8	25.8	18.4	13.3	7.9	18.7	21.0	19.2	13.9	14.8	13.2	0.8	21.1	32.3	14.8	12.4	7.7	11.0	4.9	5.5	3.5	1.0	11.1	14.4	25.4	4.6	8.7	14.3	10.5	11.2	8.9	18.2	17.0	0.7	9.8	105.8	12.9	29.0	0.4	10.9	8.1	17.5	14.0	3.2	5.2	15.7	6.5	3.0	2.9	17.5	11.6	17.0	41.7	10.7	3.2	15.9	14.8	29.1	14.2	35.2	22.9	5.9	10.8	0.6	17.2	11.1	102.0	0.0	10.8	2.8	9.2	14.3	8.1	2.6	6.8	6.1	10.4	1.8	3.2	3.4	1.0	2.5	14.3	13.4	4.3	5.3	11.9	24.0	7.2	19.2	14.8	11.6	36.3	8.9	22.4	30.6	20.8	8.3	9.0	8.8	7.9	5.1	12.3	17.8	12.0	7.9	24.4	13.7	16.7	1.7	35.7	0.4	23.6	35.9	0.0	27.6	62.3	31.0	7.5	19.6	16.6	45.4	7.9	15.5	27.0	21.6	1.5	24.2	16.4	59.1	20.8	16.2	10.8	29.4	28.1	13.8	10.5	5.9	19.4	17.6	7.2	12.6	4.3	15.8	8.6	21.1	4.2
PNLIPRP3		ENSG00000203837	"Pancreatic lipase related protein 3"	Q17RR3	10	116427867-116477957	"Enzymes, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.5;breast: 15.9;esophagus: 12.0;skin 1: 15.5"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 1.0;Late spermatids: 1.6;Melanocytes: 1.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"hTCEpi: 86.9"					"Not detected"	"Not detected"			"HPA046202, HPA052009"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA046202: AB_10959739, HPA052009: AB_2681692"					"unprognostic (2.62e-4)"	"unprognostic (1.60e-1)"			"unprognostic (6.97e-2)"									8.5	0.1	0.0	0.0	0.2	0.0	15.9	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.4	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	8.1	1.9	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0
PODNL1	"FLJ23447, SLRR5B"	ENSG00000132000	"Podocan like 1"	Q6PEZ8	19	13931187-13953392	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.5"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 34.2;Leydig cells: 17.0;Peritubular cells: 35.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 8.8;HSkMC: 16.2;hTERT-RPE1: 25.7;SiHa: 13.0;U-2 OS: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA042807	Approved				"Secreted - unknown location"	NA	NA					"HPA042807: AB_10795514"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (5.61e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.94e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (4.49e-4)"	2.4	1.6	2.2	3.5	4.1	2.2	4.5	7.9	3.2	6.7	2.3	3.0	2.2	1.9	1.7	2.5	8.7	1.7	5.9	4.4	2.0	7.5	1.4	1.0	3.8	1.3	4.2	2.3	3.1	2.5	0.7	4.7	24.5	5.0	6.1	1.5	11.1	4.2	4.1	3.7	12.7	2.7	2.6	3.8	1.3	3.0	7.6	2.1	0.8	2.4	14.9	3.9	4.8	9.9	0.9	3.4	1.3	1.7	1.0	0.8	0.6	0.4	0.5	0.5	0.3	0.8	2.1	0.1	5.5	3.3	1.1	2.2	0.4	0.6	0.3	0.4	8.8	0.2	2.1	0.2	0.2	0.6	2.0	0.9	1.1	0.4	0.1	6.8	0.3	0.7	16.2	1.0	1.5	0.2	25.7	0.0	0.1	0.5	0.4	2.2	3.5	0.3	0.3	0.2	0.4	0.5	0.2	0.1	0.0	0.4	0.1	1.0	0.6	13.0	0.1	0.4	0.6	0.1	0.6	1.0	2.7	9.4	0.7	0.3	0.4	0.0	0.1	1.1	1.2	0.2	0.7	1.7	0.7	0.8	1.4	0.3	0.9	0.6	0.3	3.4	0.5	0.4	0.3	1.3	1.0	0.2	0.5	0.2	0.6	2.2	4.1	7.9	3.2	2.0	7.5	4.2	2.3	5.0	2.1	0.0	0.3	0.0	0.8	1.1	34.2	1.2	0.0	0.0	1.2	0.0	2.0	0.4	0.0	0.1	1.2	1.0	1.1	0.0	0.0	0.1	7.7	0.4	0.0	0.0	7.5	1.6	0.0	0.6	1.5	1.6	17.0	1.1	1.7	0.0	1.3	1.6	0.4	6.2	35.7	0.0	4.0	0.0	0.5	0.7	0.5	3.8	0.7	0.0	1.1	1.2
PRLH	PRH	ENSG00000071677	"Prolactin releasing hormone"	P81277	2	237566574-237567175	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.1;heart muscle: 4.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;MCF7: 4.4;RPMI-8226: 3.7;SK-BR-3: 1.8;T-47d: 2.1;U-87 MG: 2.4"	"Group enriched"	"Detected in some"	58	"hypothalamus: 13.4;pons and medulla: 22.5"	"Region enriched"	"Detected in single"	13	"pons and medulla: 5.1"	HPA014976	Approved				"Secreted - unknown location"	NA	NA					"HPA014976: AB_2732413"	"unprognostic (8.28e-4)"			"unprognostic (3.22e-2)"						"unprognostic (5.42e-2)"								0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	1.8	0.0	4.5	0.0	0.6	0.0	0.0	0.5	0.0	0.0		0.0	0.0	0.0	0.5	0.0		0.1	0.0		1.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.3	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	1.8	0.4	0.0	2.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.5;testis: 31.3"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 84.3;Club cells: 46.6;Cytotrophoblasts: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 20.8;SH-SY5Y: 66.0;THP-1: 29.5"	"Group enriched"	"Detected in many"	5	"amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0"	"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"	NA	NA			"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.9	0.5	2.1	4.1	1.4	0.0	1.9	0.5	2.8	16.5	6.0	2.0	1.3	2.2	3.0	2.7	3.6	9.8	27.5	0.3	2.2	0.9	1.1	0.8	8.0	0.0	0.7	2.4	1.9	9.8	0.0	0.9	20.4	4.1	2.0	5.8	20.0	3.1	3.2	0.3	5.9	8.6	1.0	0.5	0.3	8.1	31.3	0.2	0.3	0.6	7.7	7.7	3.1	16.2	0.3	0.4	0.0	0.1	0.0	0.7	0.0	1.5	0.0	0.5	0.0	0.0	4.2	0.0	13.7	12.5	2.9	4.9	0.0	5.6	0.0	0.0	20.8	1.5	0.2	9.3	2.8	3.9	0.0	2.1	0.0	1.1	0.0	0.4	0.0	0.0	1.3	5.3	1.0	3.0	9.6	0.0	0.1	0.0	0.0	2.4	0.0	0.1	2.8	0.6	10.7	0.9	0.0	11.8	0.0	0.0	2.0	1.5	66.0	0.0	0.0	0.8	9.9	0.0	29.5	0.0	5.9	0.8	3.7	2.7	0.3	0.0	0.0	0.3	0.9	3.4	0.0	0.1	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.4	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.1	1.4	0.5	2.8	2.2	0.9	0.7	2.4	4.1	0.2	6.0	2.9	0.0	0.8	7.4	0.4	1.2	12.7	84.3	46.6	1.8	0.0	36.7	0.0	0.4	7.1	0.7	9.7	0.0	8.8	2.7	5.6	0.3	6.9	0.0	3.2	0.0	5.1	0.0	0.0	11.8	0.0	1.1	5.0	0.0	2.2	0.0	6.5	8.0	0.0	0.3	0.2	0.0	2.1	8.0	13.8	3.8	10.0	0.0	4.2	4.2
PRSS36	FLJ90661	ENSG00000178226	"Serine protease 36"	Q5K4E3	16	31138925-31150094	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 22.2;Hofbauer cells: 15.2;Paneth cells: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 2.2;HeLa: 6.5;HMC-1: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036079	Uncertain				"Secreted - unknown location"	NA	NA					"HPA036079: AB_10602290"	"unprognostic (3.74e-2)"	"prognostic favorable (2.97e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.31e-5)"	"unprognostic (4.18e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.13e-1)"	3.0	2.0	0.4	1.0	1.2	1.1	6.2	0.4	1.8	1.6	1.8	0.4	0.4	3.2	0.4	1.8	1.2	0.5	0.4	2.1	0.4	0.5	0.5	0.7	2.3	0.4	0.4	0.4	1.7	0.4	0.4	6.5	2.5	0.4	1.0	0.9	0.4	3.5	0.4	1.3	3.4	2.1	1.2	0.4	0.4	1.0	0.7	0.4	0.4	0.6	0.4	1.0	2.0	0.4	0.0	2.1	4.3	0.8	0.2	0.4	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.3	0.3	0.2	0.1	0.4	1.4	0.0	0.9	0.4	0.4	1.4	0.1	0.2	0.0	0.2	0.6	2.2	6.5	1.2	0.1	0.3	2.9	0.2	0.1	0.2	0.2	0.2	0.2	0.4	0.1	0.0	0.2	0.5	0.0	0.3	0.4	0.8	0.1	0.5	0.1	0.0	0.0	0.2	0.3	0.0	0.6	0.7	0.0	0.0	0.1	1.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8	4.3	0.2	0.1	0.1	0.0	0.0	0.0	2.1	0.0	0.1	0.4	2.6	0.2	0.0	0.6	0.1	0.1	0.4	1.2	0.4	1.8	0.4	0.5	0.4	0.4	0.4	0.4	0.0	1.4	0.0	2.5	1.6	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.6	0.0	1.4	1.3	0.6	22.2	0.0	2.5	1.0	0.4	2.1	0.0	2.6	15.2	0.0	0.0	1.3	4.1	0.4	2.6	2.3	0.0	7.2	2.0	0.5	1.3	17.5	2.5	1.1	0.0	0.0	0.3	0.7	2.5	2.3	0.5	0.0	2.3	1.7
PRSS42	TESSP2	ENSG00000178055	"Serine protease 42"	Q7Z5A4	3	46829542-46834095	"Enzymes, Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"heart muscle: 12.9;skeletal muscle: 19.2"	"Cell type enriched"	"Detected in single"	4	"Cardiomyocytes: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.3;Daudi: 4.0;Karpas-707: 2.5;NTERA-2: 3.7"									HPA046925	Uncertain				"Secreted - unknown location"	NA	NA					"HPA046925: AB_10961401"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.26e-1)"		"unprognostic (2.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.98e-2)"	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2			0.0	0.2	3.4	0.0	0.2	0.0	12.9	0.0	0.0	1.3	0.5	0.2	0.0	0.0		0.2	0.2	1.6	0.0	0.1		0.4	0.0		0.3	0.2	19.2	0.0	0.0	0.0	0.0	0.4	0.0	0.7			0.8		0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.8	0.2	1.6	0.0	0.0	0.0	0.7	0.2	2.3	4.0	0.4	0.0	0.1	0.0	0.0	0.2	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.4	3.7	0.5	0.0	1.3	0.0	0.0	0.1	0.0	0.6	0.5	0.5	0.0	0.3	1.2	0.0	0.5	0.0	1.0	0.7	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1
PRSS51		ENSG00000253649	"Serine protease 51"	A0A1B0GVH4	8	10482878-10547585	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"brain: 1.4;breast: 3.4;liver: 1.5;testis: 2.3"	"Group enriched"	"Detected in some"	27	"Early spermatids: 3.2;Late spermatids: 2.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.7;CAPAN-2: 1.6;OE19: 1.7;T-47d: 1.9;U-2 OS: 5.1"														"Secreted - unknown location"	NA	NA						"unprognostic (2.52e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-3)"	"unprognostic (2.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	0.0	0.0		0.0		0.4	3.4		1.4	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	1.5	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0		0.1	0.0	2.3			0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS53	POL3S	ENSG00000151006	"Serine protease 53"	Q2L4Q9	16	31083425-31089628	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"liver: 10.9"	"Cell type enhanced"	"Detected in some"	10	"Leydig cells: 1.7;Peritubular cells: 1.1;Suprabasal keratinocytes: 1.3"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034955, HPA034956"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA034955: AB_2674380, HPA034956: AB_10696365"	"unprognostic (3.13e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.53e-12)"	"unprognostic (1.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	0.3	0.0	0.0	0.5	0.3	0.0	0.1	2.9	0.4	0.2	0.3			1.4	1.0	0.0	0.1	0.3	0.6	0.2	0.1	0.3	0.6	10.9	0.5	0.9	0.1		0.3	2.2	0.0	0.8	0.2		1.2	0.0		0.0	0.8	0.0	3.9	0.5	0.4	0.2	1.0	1.3	0.0			0.3		0.0	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.8	0.3	0.0	0.3	0.0	0.0	0.0	1.0	0.5	1.2	1.0	0.0	0.2	0.0	0.3	0.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.0	0.0	0.0	0.0	1.7	0.1	0.3	0.1	1.3	0.3	1.6	0.8	0.0	2.0	1.6	0.0	0.0	0.0	0.0	10.0	0.8	0.9	0.0	1.0	0.0	0.8	0.1	0.7	1.0	0.7	2.5	0.2	1.4	0.1	0.3	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8											0.0	0.0	0.0	0.2	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.1	0.0	0.3	0.0	0.3	0.0	0.0	1.3	0.0	0.7	0.1	0.3
PRSS8		ENSG00000052344	"Serine protease 8"	Q16651	16	31131433-31135762	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 123.2;salivary gland: 143.7"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 330.0;Extravillous trophoblasts: 497.6;Syncytiotrophoblasts: 376.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"pons and medulla: 3.4"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 58.3;CACO-2: 38.3;CAPAN-2: 26.3;hTCEpi: 37.6;SK-BR-3: 44.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030436	Uncertain				"Secreted - unknown location"	NA	NA		3500000			"HPA030436: AB_10602291"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (2.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.63e-3)"	0.3	0.2	0.3	11.5	0.3	0.0	7.6	0.7	0.4	8.0	72.6	0.6	12.8	31.6	3.4	46.7	37.2	2.8	45.3	0.3	0.4	0.3	48.0	20.3	30.0	0.3	0.3	0.3	1.3	46.3	2.7	2.6	93.1	3.4	11.4	14.7	1.1	143.7	7.4	0.3	29.7	123.2	0.5	0.3	0.3	37.0	1.8	0.3	11.3	33.4	18.4	26.7	2.6	13.4	0.2	0.0	1.0	0.3	0.0	0.2	0.0	14.4	0.0	0.0	0.0	0.0	0.0	58.3	0.0	0.0	0.0	0.0	38.3	26.3	0.0	0.3	0.0	0.0	17.3	0.0	16.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	37.6	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	15.5	0.1	0.3	4.8	18.3	0.0	0.1	0.0	0.2	1.8	3.0	0.2	0.1	0.0	44.2	0.0	4.7	10.1	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.4	0.3	0.3	0.3	3.4	0.3	92.3	62.1	0.9	60.6	33.7	0.6	0.3	53.5	9.4	53.4	40.1	0.0	127.8	24.9	145.8	0.0	0.7	330.0	23.3	197.1	497.6	3.6	80.0	6.9	12.8	20.5	0.0	9.2	0.0	0.3	0.0	0.6	2.5	3.3	7.2	109.4	0.3	182.1	150.8	0.0	24.9	0.0	0.0	3.1	0.0	0.1	47.2	376.9	1.3	110.4	79.5
PSAPL1		ENSG00000178597	"Prosaposin like 1 (gene/pseudogene)"	Q6NUJ1	4	7430294-7434973	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"skin 1: 42.2;stomach 1: 23.9;testis: 19.9"	"Cell type enriched"	"Detected in single"	14	"Suprabasal keratinocytes: 2.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 11.9;OE19: 23.0;RPMI-8226: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA038013: AB_10673652, HPA038482: AB_2676037"		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	1.4	0.6	0.0	1.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	42.2	0.1	0.1	0.1	0.1	23.9	19.9	0.1	2.5	0.1	0.1	2.1	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863113-87971930	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 29.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: AB_2797221"	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	42.4	24.1	17.7	20.9	17.7	13.5	32.8	39.9	19.7	43.1	26.7	9.9	19.0	15.1	29.8	22.8	26.8	30.3	21.0	19.1	16.0	17.4	19.6	32.4	27.2	30.4	15.7	19.5	29.1	21.3	16.4	23.6	36.4	14.2	35.3	17.7	21.6	16.8	20.8	16.8	20.4	25.4	26.0	11.7	40.9	17.8	18.7	12.5	49.7	25.2	13.3	18.6	29.6	30.9	4.3	5.1	29.6	11.0	4.3	4.7	2.0	10.2	4.8	5.5	5.0	12.8	8.8	5.0	5.5	12.2	6.5	9.1	4.9	12.6	12.1	3.7	9.0	3.8	6.2	7.4	6.3	10.3	6.0	2.1	4.0	12.5	6.0	13.7	13.5	6.9	6.0	17.6	8.2	10.6	27.6	9.1	7.7	3.0	32.9	5.9	7.8	7.6	24.6	2.0	8.9	0.0	11.8	2.9	8.9	10.1	5.8	2.0	9.0	7.3	3.5	9.2	4.6	9.7	19.6	7.9	21.4	5.0	8.3	4.4	10.8	14.0	13.8	6.6	12.8	1.2	8.3	7.9	12.2	3.6	11.0	3.9	4.3	4.0	3.5	5.1	3.7	4.7	4.5	29.6	4.3	7.2	4.2	3.5	2.0	17.7	17.7	39.9	19.7	16.0	17.4	15.7	19.5	14.2	12.5	32.8	55.3	40.2	50.0	49.8	113.3	39.2	40.8	25.4	28.4	27.9	37.3	22.6	28.2	23.2	57.0	44.4	33.9	0.0	25.8	44.5	52.3	36.9	25.3	58.6	31.3	42.9	30.0	47.9	167.4	70.7	52.6	69.1	59.1	27.9	44.1	54.1	30.2	24.6	51.2	30.8	55.8	90.5	118.8	24.9	24.0	52.6	47.9	35.7	39.2	51.2
PTPRS		ENSG00000105426	"Protein tyrosine phosphatase, receptor type S"	Q13332	19	5158495-5340803	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 54.1;Melanocytes: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	82	"plasmacytoid DC: 13.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 13.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.4;HaCaT: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054747			Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		92000000	"Plasma membrane, Cytosol"		"HPA054747: AB_2682591"	"unprognostic (8.14e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.46e-2)"	59.1	17.3	14.4	9.4	14.8	3.1	32.0	27.6	53.3	28.7	11.4	29.6	14.4	4.6	21.4	15.4	13.3	24.0	22.2	18.6	15.9	15.1	10.7	6.9	13.9	8.6	20.5	12.1	29.2	38.4	10.5	16.6	4.3	12.0	23.1	3.6	28.9	21.5	20.1	11.9	23.8	6.5	17.5	13.8	8.3	12.7	10.8	18.7	4.4	21.1	7.2	7.5	19.1	22.7	0.0	13.4	0.0	0.0	0.0	0.1	0.0	3.7	21.3	19.2	41.4	8.8	7.2	2.5	6.4	7.7	7.8	6.4	0.2	2.0	0.0	15.3	10.8	6.2	42.1	5.1	0.0	3.5	0.4	8.2	0.0	8.7	13.2	4.0	0.0	4.8	7.6	1.8	1.6	0.3	10.2	0.2	2.6	5.9	0.0	3.1	15.7	1.6	4.0	10.8	0.1	9.1	0.0	4.2	0.0	1.6	7.5	14.8	20.3	6.1	1.1	11.7	3.9	7.4	1.6	0.9	7.0	12.1	16.0	7.8	2.1	0.0	12.2	3.6	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	14.4	14.8	27.6	17.6	15.9	15.1	20.5	12.1	12.0	18.7	6.0	0.6	3.2	32.4	54.1	33.8	10.9	12.7	1.4	2.3	12.2	2.0	0.5	8.3	1.4	2.3	10.2	0.0	0.0	0.8	23.7	30.9	35.7	0.0	18.3	1.5	11.1	2.9	28.3	0.3	2.9	43.1	1.4	75.9	0.0	0.0	37.3	0.5	0.0	33.9	2.4	7.7	12.9	39.2	7.2	5.3	32.0	0.8	0.0	0.0	21.1
PTX4	C16orf38	ENSG00000251692	"Pentraxin 4"	Q96A99	16	1485886-1488981	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.0;bone marrow: 4.0;testis: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	21	"intermediate monocyte: 1.1;non-classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	31	"monocytes: 3.0"	"Group enriched"	"Detected in some"	6	"HL-60: 19.5;NB-4: 14.5"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Low region specificity"	"Detected in all"			HPA073694	Supported				"Secreted - unknown location"	NA	NA					"HPA073694: AB_2732237"	"unprognostic (1.04e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.84e-4)"	"unprognostic (3.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.23e-3)"	"unprognostic (4.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.03e-1)"	0.2	1.0	0.6	0.2	0.8	4.0	0.2	0.8	0.5	0.4	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.4	0.3	0.2	0.8	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.4	0.0	0.4	0.4	0.2	0.9	0.1	3.9	0.2	1.5	0.2	0.2	0.2	0.4	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.5	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	14.5	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.6	0.8	0.8	0.3	0.8	1.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PVR	"CD155, HVED, Necl-5, NECL5, PVS, Tage4"	ENSG00000073008	"Poliovirus receptor"	P15151	19	44643798-44663583	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 65.6"	"Cell type enhanced"	"Detected in many"	5	"Pancreatic endocrine cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.6;monocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"TIME: 53.4"									"HPA012568, HPA064739"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted - unknown location"	NA	NA		940000000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA012568: AB_1846248, HPA064739: "	"unprognostic (2.90e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (2.75e-4)"	10.0	13.9	7.4	7.5	8.1	4.7	9.2	11.0	11.0	6.5	10.6	6.5	4.1	13.7	11.3	5.7	6.6	8.8	9.2	23.5	5.8	10.0	10.6	65.6	14.8	2.4	6.0	6.5	10.4	15.9	9.9	20.7	15.5	9.7	10.4	7.7	6.6	8.5	6.9	19.8	5.5	13.0	11.1	7.0	4.8	12.3	6.0	7.2	2.3	8.5	10.8	3.7	8.3	6.7	0.0	5.6	1.2	8.1	0.6	0.4	2.2	21.8	15.3	1.5	6.1	1.9	2.3	2.6	36.9	10.3	12.1	13.9	8.9	9.3	0.0	21.2	10.7	21.2	14.4	5.2	14.0	8.1	2.6	10.1	3.9	9.6	6.0	12.9	1.5	8.4	2.9	6.9	10.7	21.0	12.1	13.1	2.3	1.8	0.0	5.6	1.9	1.3	1.3	3.4	7.4	11.3	0.0	7.0	2.0	26.0	6.7	6.6	7.7	23.4	14.7	5.2	1.7	8.3	3.7	53.4	14.7	18.1	10.8	28.8	0.0	2.1	0.0	11.7	7.5	8.3	0.0	6.4	0.0	0.2	6.6	0.0	0.0	0.0	0.4	5.6	0.0	0.2	0.1	1.2	0.6	8.1	0.5	0.0	2.2	7.4	8.1	11.0	11.0	5.8	10.0	6.0	6.5	9.7	7.2	14.9	28.0	4.5	12.8	3.2	6.9	11.2	20.4	2.7	18.2	1.8	2.0	2.4	3.3	43.0	8.5	13.5	11.9	0.0	30.3	30.1	5.4	11.3	1.1	36.5	7.4	1.6	12.6	7.4	9.2	10.2	5.2	7.8	1.7	25.2	9.7	1.3	48.8	14.4	14.9	2.8	3.3	0.0	17.8	3.4	1.5	4.8	0.8	0.0	10.6	6.5
R3HDML	dJ881L22.3	ENSG00000101074	"R3H domain containing like"	Q9H3Y0	20	44336986-44351235	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.4;intestine: 5.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.7;CACO-2: 3.6;OE19: 3.6;U-2 OS: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA070264	Enhanced				"Secreted - unknown location"	NA	NA					"HPA070264: AB_2686244"	"unprognostic (1.89e-1)"		"unprognostic (2.23e-1)"				"unprognostic (9.86e-2)"	"unprognostic (9.12e-2)"	"unprognostic (6.06e-3)"		"unprognostic (2.64e-1)"			"unprognostic (6.32e-2)"	"unprognostic (4.95e-3)"			0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.0	1.5			5.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.4	0.5	0.2	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.8	1.4			0.1		0.0	0.0	0.0	0.3	0.5	0.9	0.0	0.2	0.2	0.0	0.0	0.3	1.7	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	3.6	0.8	0.5	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.6	0.4	0.2	1.2	0.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.1	0.0	0.2	3.6	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.4	0.2	0.0	0.3	0.3	0.2	0.0	0.0	0.4	2.7	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.5	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.5	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAET1G	ULBP5	ENSG00000203722	"Retinoic acid early transcript 1G"	Q6H3X3	6	149916878-149923121	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.2;tongue: 18.4"	"Cell type enhanced"	"Detected in some"	17	"Basal glandular cells: 4.2;Basal keratinocytes: 2.7;Melanocytes: 3.3;Urothelial cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 23.4;hTCEpi: 18.7;SiHa: 9.2;U-87 MG: 7.6"									HPA062673			Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA062673: "	"unprognostic (4.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.85e-2)"	"unprognostic (9.11e-2)"	2.5	10.0	0.3	0.6	0.3	0.0	2.5	0.2	1.0	5.6	0.6	0.5	1.4	0.2	0.8	4.3	21.2	0.5	1.2	0.9	0.4	0.2	2.3	0.2	1.3	0.1	0.3	0.1	1.9	0.1	0.1	1.2	0.1	0.5	2.9	0.1	0.8	3.9	2.2	0.4	4.3	0.5	1.8	0.9	0.2	0.6	0.5	0.2	0.2	0.7	18.4	10.7	2.8	5.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	1.0	0.0	1.3	1.9	1.8	0.0	0.6	2.4	1.1	1.5	0.0	1.2	0.0	0.5	1.3	1.1	2.0	0.7	4.1	0.8	0.2	1.3	0.4	23.4	0.0	0.5	0.0	0.0	2.7	18.7	2.8	1.3	1.3	0.4	0.6	0.2	0.2	0.4	1.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.8	2.5	0.3	0.2	9.2	0.4	0.0	0.1	0.3	0.3	1.3	0.5	0.4	1.1	0.6	0.0	0.0	0.0	7.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.0	0.4	0.2	0.3	0.1	0.5	0.2	0.0	0.0	0.0	4.2	2.7	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.2	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.3	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	9.5
RGMA	"RGM, RGMa"	ENSG00000182175	"Repulsive guidance molecule BMP co-receptor a"	Q96B86	15	93035273-93089204	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.0;skeletal muscle: 85.5"	"Group enriched"	"Detected in many"	5	"Leydig cells: 110.1;Peritubular cells: 110.0;Spermatogonia: 37.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 26.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 31.0;BEWO: 9.1;MOLT-4: 9.2;NTERA-2: 13.9;REH: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012343, HPA039880, HPA044222"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		1400000	Nucleoplasm	Cytosol	"CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861"	"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (4.72e-3)"	"unprognostic (2.53e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.59e-4)"	"unprognostic (8.11e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.98e-5)"	12.2	3.3	17.4	17.6	24.7	1.8	9.3	11.0	59.0	21.0	22.2	22.2	0.9	9.1	21.8	9.4	23.1	12.1	9.5	7.7	19.3	16.2	2.3	1.6	2.8	3.1	23.0	12.8	16.6	9.1	1.9	2.1	2.5	30.9	5.5	6.5	2.3	16.2	7.0	85.5	4.9	12.3	46.9	36.8	2.2	26.6	15.8	23.1	0.2	2.9	12.2	5.6	4.1	8.8	1.3	0.7	1.7	1.0	0.7	0.5	0.2	1.2	0.2	31.0	0.5	6.5	3.6	9.1	0.2	0.0	0.0	0.0	0.3	0.4	0.1	0.1	0.2	0.0	2.0	5.2	0.1	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.1	0.1	3.8	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.6	9.2	0.1	13.9	0.0	0.0	8.0	7.1	0.0	0.0	0.3	3.3	1.8	0.3	0.1	0.0	1.7	2.5	1.6	0.1	0.0	6.7	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.8	1.4	0.7	0.6	0.4	1.0	0.3	0.6	0.5	0.5	0.1	1.3	0.4	0.5	1.7	0.7	0.4	0.7	0.3	0.2	17.4	24.7	11.0	21.3	19.3	16.2	23.0	12.8	30.9	23.1	0.0	1.0	0.0	15.6	4.8	0.2	3.2	0.0	1.4	2.3	0.0	2.0	3.8	0.0	4.7	0.8	1.1	0.0	0.0	0.6	1.0	7.4	13.3	0.0	0.0	1.8	0.0	0.0	3.1	3.7	2.6	110.1	1.1	3.3	0.0	0.0	4.1	0.6	0.0	110.0	0.0	1.1	12.9	12.3	0.7	37.2	2.5	2.1	0.7	0.0	12.0
RNPEP	APB	ENSG00000176393	"Arginyl aminopeptidase"	Q9H4A4	1	201982372-202006147	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 12.1;granulocytes: 12.3;monocytes: 17.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036074, HPA036075, HPA061487"	Approved		Approved	"Golgi apparatus"	"Secreted - unknown location"	NA	NA		6600000	"Golgi apparatus"		"HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537"	"unprognostic (8.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.68e-1)"	18.5	22.0	6.4	14.9	8.2	9.5	16.7	9.2	11.0	17.8	34.2	13.5	21.2	31.1	17.4	18.7	33.2	19.2	21.8	11.5	6.1	4.6	22.5	18.3	21.5	14.1	7.0	5.4	18.0	19.5	11.6	10.4	26.3	9.0	18.4	26.8	16.4	25.1	13.6	10.0	18.3	66.6	12.8	8.1	22.7	15.7	21.2	6.0	13.9	28.4	19.1	24.7	17.6	17.5	2.3	12.1	12.3	17.0	1.6	3.1	2.2	19.1	20.9	12.5	18.7	20.4	19.2	31.4	14.8	28.8	18.6	21.0	15.0	24.6	4.2	19.1	26.1	11.5	34.9	15.9	29.0	13.0	11.4	20.5	10.5	10.0	14.0	17.4	26.7	37.1	17.5	30.0	16.6	19.1	23.1	33.4	10.4	23.8	6.2	18.8	17.5	3.6	11.4	17.6	30.6	10.4	14.0	17.6	29.6	38.6	17.5	14.4	12.2	36.7	45.8	14.8	25.3	34.8	15.2	23.8	8.7	11.8	8.5	18.0	13.9	11.2	3.8	8.7	22.7	17.4	10.8	9.2	12.3	1.9	15.7	2.6	1.6	2.0	2.2	12.1	2.3	1.8	2.1	6.7	1.6	17.0	4.5	3.1	2.2	6.4	8.2	9.2	11.0	6.1	4.6	7.0	5.4	9.0	6.0	8.9	19.2	23.6	35.3	25.5	11.5	9.0	43.3	13.4	15.9	24.4	9.8	99.1	16.6	59.5	4.4	20.4	152.6	0.0	44.9	74.5	19.0	29.0	15.0	46.6	92.1	11.1	43.1	27.0	67.5	3.8	23.6	48.7	23.6	85.6	66.6	10.8	41.4	81.6	21.5	50.1	7.7	25.8	18.6	15.7	8.2	18.9	73.2	17.5	73.0	31.8
SBSN	"HLAR698, UNQ698"	ENSG00000189001	Suprabasin	Q6UWP8	19	35523367-35528351	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 105.1;skin 1: 241.3;tongue: 338.1"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 889.6"	"Group enriched"	"Detected in many"	9	"cervical cancer: 76.5;head and neck cancer: 355.2;melanoma: 153.1"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 20.2;ASC TERT1: 35.2;HSkMC: 47.6;U-2197: 16.3;U-87 MG: 38.5"					"Low region specificity"	"Detected in some"			"HPA062568, HPA067734"	Enhanced		Approved	Vesicles	"Secreted - unknown location"	NA	NA		62000000	Vesicles		"HPA062568: AB_2684794, HPA067734: AB_2685894"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.83e-4)"	"unprognostic (4.31e-4)"	"unprognostic (6.97e-2)"	"unprognostic (9.08e-14)"	"unprognostic (6.37e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-3)"	0.3	0.0	0.2	0.2	1.6	0.1	11.2	0.2	0.2	65.1	0.2	0.2	0.2	0.0	3.5	0.2	105.1	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.7	0.2	0.2	0.0	0.2	26.8	0.2	1.3	241.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.8	0.2	338.1	51.7	0.4	51.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	20.2	35.2	0.0	1.6	2.2	0.7	0.2	0.0	0.0	0.0	0.3	1.4	0.5	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	47.6	2.6	9.5	2.3	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	5.9	1.2	16.3	0.4	0.1	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	79.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	3.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	13.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	889.6	0.2	0.0	0.0	0.1
SCGB1C1	RYD5	ENSG00000188076	"Secretoglobin family 1C member 1"	Q8TD33	11	193080-194573	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 7.0;pancreas: 5.9;salivary gland: 7.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"basophil: 5.0;neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.1;RPMI-8226: 1.8;SK-BR-3: 2.2;U-266/70: 2.0;U-266/84: 1.0"														"Secreted - unknown location"	NA	NA															"unprognostic (5.09e-3)"								0.1	0.7	0.1	0.1	0.1	2.5	0.4	0.3	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.1	0.1	0.0	1.8	0.1	0.3	0.1	0.1	0.1	0.1	5.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.7	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.1	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	5.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	7.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SCGB1C2		ENSG00000268320	"Secretoglobin family 1C member 2"	P0DMR2	17	137526-139067	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	6	"blood: 4.5;pancreas: 3.6"	"Cell type enhanced"	"Detected in single"	34	"Muller glia cells: 2.8"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"					"Group enriched"	"Detected in some"	18	"basophil: 2.2;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"	"Group enriched"	"Detected in some"	6	"PC-3: 1.4;U-266/70: 2.2"														"Secreted - unknown location"	NA	NA															"unprognostic (4.65e-2)"								0.0	0.0		0.7		0.6	0.1		0.0	0.0	0.0			0.0	0.0	0.0	0.4	0.0	0.0	0.6			0.0	0.0	0.1	0.0			0.0	3.6	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.7			0.0		0.0	0.0		0.0	0.0	2.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SCGB2B2	"SCGB4A2, SCGBL"	ENSG00000205209	"Secretoglobin family 2B member 2"	Q4G0G5	19	34593329-34675699	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	7	"epididymis: 4.1;pancreas: 12.7;skin 1: 5.9;testis: 15.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 7.3;Late spermatids: 26.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 4.4"									HPA046806	Uncertain				"Secreted - unknown location"	NA	NA					"HPA046806: AB_10962373"	"unprognostic (9.99e-2)"	"unprognostic (3.62e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.38e-5)"	"unprognostic (4.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	0.6	0.7	0.7	0.6	0.6	0.0	1.2	0.6	0.9	0.6	0.6	0.6	0.6	0.7	0.6	4.1	1.3	0.7	0.6	0.6	0.7	0.7	0.6	0.7	0.7	0.6	0.6	0.6	0.6	12.7	0.3	0.6	0.6	1.0	0.6	0.2	0.6	0.6	0.6	1.1	5.9	0.6	0.6	0.9	0.6	0.4	15.9	0.6	0.6	1.0	0.6	0.6	1.0	0.6	0.6	0.3	1.4	0.3	0.3	0.8	0.1	0.7	1.4	1.2	0.7	0.8	0.4	1.4	0.8	0.8	0.3	0.4	4.0	0.6	0.5	0.7	0.1	0.6	0.7	1.4	1.2	0.3	1.5	0.6	0.7	2.2	1.0	0.4	0.3	0.9	0.5	1.3	0.1	0.7	1.4	0.0	2.1	0.2	4.4	0.4	1.3	0.6	2.0	0.5	1.1	0.7	1.0	1.0	0.5	0.8	1.5	1.2	1.1	0.8	0.7	0.6	0.7	1.3	0.5	0.8	1.5	1.1	1.0	0.3	3.9	1.8	1.4	0.5	0.2	2.3	1.4	0.3	0.1	0.8	0.0	0.4	0.3	0.5	0.3	0.3	0.6	0.8	0.5	0.3	0.3	0.1	0.1	0.3	0.1	0.7	0.6	0.6	0.9	0.7	0.7	0.6	0.6	1.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0
SECTM1	K12	ENSG00000141574	"Secreted and transmembrane 1"	Q8WVN6	17	82321024-82334074	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.9;intestine: 103.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 42.8;Kupffer cells: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 45.9"	"Group enriched"	"Detected in many"	13	"granulocytes: 45.9;monocytes: 16.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.3;BJ hTERT+: 27.5;BJ hTERT+ SV40 Large T+: 21.2;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;PC-3: 21.8;SiHa: 37.5;SK-BR-3: 20.4;U-2197: 28.6"									HPA051214	Approved				"Secreted - unknown location"	NA	NA		26000000			"HPA051214: AB_2732565"	"unprognostic (2.42e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.55e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.17e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.31e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.01e-1)"	13.5	1.8	1.1	15.7	2.1	3.7	10.6	0.7	2.1	6.4	33.2	1.0	1.3	26.2	6.1	4.9	6.1	6.5	4.7	6.1	2.3	0.8	16.8	3.9	11.2	21.7	1.5	0.6	7.8	2.5	0.0	1.3	6.1	3.5	8.6	9.4	2.1	20.2	2.2	4.9	6.6	103.1	5.5	4.2	24.0	9.4	2.1	1.4	2.3	5.1	7.0	7.7	7.8	16.2	0.0	2.3	45.9	16.2	0.0	0.1	1.1	6.0	1.3	0.0	0.4	10.7	27.3	0.5	3.0	27.5	21.2	20.9	0.6	12.5	0.0	0.1	8.9	0.3	18.5	0.0	1.2	0.8	1.9	0.0	2.5	9.5	1.7	8.3	0.0	0.0	11.6	2.8	1.1	0.5	1.5	0.6	0.0	0.0	0.0	13.4	0.2	0.0	0.0	0.0	1.6	21.8	0.0	0.1	0.3	6.1	0.0	1.4	0.1	37.5	20.4	0.4	0.0	1.6	0.5	0.1	2.3	0.2	28.6	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	9.6	0.0	0.1	16.2	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.0	45.9	0.0	14.8	1.0	0.0	1.1	1.1	2.1	0.7	2.1	2.3	0.8	1.5	0.6	3.5	1.4	11.9	3.7	3.9	4.6	8.4	0.0	0.8	0.0	2.7	2.3	1.8	0.0	0.1	0.0	5.2	0.0	1.6	42.8	0.0	8.3	0.7	6.8	16.9	1.1	0.0	6.9	0.0	0.0	1.8	39.9	0.2	4.9	17.6	1.7	1.8	2.3	0.0	8.7	17.5	0.0	2.2	0.0	0.0	3.3	0.0	0.2	3.0	0.2	0.0	1.0	12.0
SHE		ENSG00000169291	"Src homology 2 domain containing E"	Q5VZ18	1	154469772-154502113	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Endothelial cells: 54.7;Ito cells: 72.4;Spermatocytes: 36.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 33.8;TIME: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037417	Approved				"Secreted - unknown location"	NA	NA					"HPA037417: AB_10672384"	"unprognostic (3.24e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.33e-2)"	22.0	6.5	4.7	4.3	4.9	1.0	28.4	2.3	4.2	7.7	7.1	3.2	5.2	3.3	12.3	8.4	6.9	7.6	6.8	14.1	3.7	2.4	6.1	5.5	19.0	11.6	4.8	2.0	8.8	2.2	6.6	2.5	16.3	4.3	9.6	4.3	5.0	3.5	4.6	7.6	4.1	5.4	8.3	3.1	17.3	3.5	15.8	2.5	2.0	26.8	6.2	3.3	7.6	17.7	1.9	7.7	4.6	2.8	3.3	3.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	3.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.4	0.0	0.7	9.2	0.0	0.2	0.9	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.8	0.6	0.4	3.1	2.8	2.3	1.9	1.4	1.3	0.2	1.9	1.8	2.0	4.6	3.3	2.0	7.7	0.0	0.9	4.7	4.9	2.3	4.2	3.7	2.4	4.8	2.0	4.3	2.5	0.0	18.9	0.0	0.5	3.0	0.0	2.9	0.0	0.0	2.3	1.8	0.0	0.0	0.0	0.0	10.0	54.7	0.0	0.0	0.0	0.0	2.2	0.5	3.5	1.1	1.1	0.0	0.0	72.4	20.1	13.1	1.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.0	36.3	16.4	1.4	0.1	0.0	0.0	0.1
SMIM31	LINC01207	ENSG00000248771	"Small integral membrane protein 31"		4	164754064-164803795	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in some"	4	"intestine: 42.7"	"Group enriched"	"Detected in some"	5	"Exocrine glandular cells: 81.2;Pancreatic endocrine cells: 87.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 3.3;RPTEC TERT1: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"	NA	NA						"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.87e-4)"			"unprognostic (2.95e-2)"	"unprognostic (1.78e-1)"			"unprognostic (4.17e-2)"	"unprognostic (4.82e-1)"		"unprognostic (9.47e-2)"			"unprognostic (5.63e-3)"	0.0	0.0	0.1	4.0	0.0	0.2	0.6	0.0	0.0	3.1	25.4	0.0	0.0	13.7	0.7	0.2	0.1	0.0	6.9	0.0	0.0		0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	9.8	9.8	0.0	2.1	0.0	0.0	0.0	42.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	1.1	1.4	3.1	0.5	1.3	0.5	0.0	0.4	3.3	0.2	0.8	0.2	0.4	0.9	0.3	0.1	0.3	0.3	1.2	0.4	0.6	0.3	0.2	0.2	0.8	0.1	0.4	0.1	0.3	0.4	0.1	0.4	0.3	0.4	0.6	0.9	0.3	0.3	0.2	0.2	0.1	0.0	0.5	0.5	1.5	0.0	0.6	0.4	1.4	0.4	1.7	0.1	0.6	0.2	1.4	4.5	0.6	0.5	0.2	0.4	0.5	0.6	0.5	0.4	0.7	0.4	0.5	0.2	0.8	0.5	1.8	0.4	0.7	0.8	0.7	1.2	3.1	0.5	0.6	0.4	0.3	0.4	0.4	0.4	0.4	0.2	1.1	0.5	0.5	2.8	1.3	0.4	1.4	0.3	0.0											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	18.7	17.0	3.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	81.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SNED1	"FLJ00133, Snep, SST3"	ENSG00000162804	"Sushi, nidogen and EGF like domains 1"	Q8TER0	2	240998838-241095568	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Ito cells: 27.6;Leydig cells: 88.1;Peritubular cells: 66.8;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 5.3"	"Group enriched"	"Detected in many"	28	"B-cells: 5.3;monocytes: 1.7;T-cells: 1.3"	"Group enriched"	"Detected in some"	5	"ASC TERT1: 94.4;HSkMC: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA036414, HPA036415"	Uncertain				"Secreted - unknown location"	NA	NA		15000000			"HPA036414: AB_10960852, HPA036415: AB_10964128"	"unprognostic (1.41e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.62e-2)"	"unprognostic (7.77e-4)"	"unprognostic (3.49e-2)"	"unprognostic (4.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.51e-3)"	"unprognostic (4.95e-3)"	18.8	8.3	4.6	10.3	3.7	1.3	23.7	21.9	7.4	21.7	7.0	7.6	19.1	4.9	19.1	23.9	6.8	17.4	19.2	8.4	5.6	2.5	6.0	5.4	9.5	6.3	5.8	3.9	23.2	7.8	2.4	5.5	2.2	11.8	12.9	3.9	15.6	11.0	11.1	14.3	9.0	6.8	8.2	7.7	11.0	4.2	11.9	7.3	2.7	29.1	8.4	5.7	9.0	17.1	5.3	0.0	0.0	1.7	0.0	1.3	0.2	0.0	0.1	0.0	1.0	13.9	94.4	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.9	0.0	0.5	0.0	0.1	47.8	0.0	0.1	0.0	6.3	2.0	0.0	0.0	0.6	2.5	0.5	0.3	0.0	0.1	0.0	0.0	0.0	1.8	0.0	1.2	0.1	0.1	0.0	0.4	1.8	0.9	0.1	0.3	0.1	5.1	1.9	0.1	11.1	0.3	0.1	0.0	0.3	2.6	0.0	0.5	0.0	0.1	0.0	0.0	0.9	1.0	5.3	1.3	0.7	0.0	2.0	0.7	0.7	0.0	0.0	1.7	0.0	1.3	0.2	4.6	3.7	21.9	7.4	5.6	2.5	5.8	3.9	11.8	7.3	6.0	8.3	3.2	0.8	3.2	2.6	2.0	2.5	5.3	14.8	5.2	0.0	0.1	0.0	0.7	1.1	7.0	0.0	0.0	1.1	0.2	6.6	3.6	0.0	4.9	0.2	1.6	2.4	27.6	1.9	1.9	88.1	0.5	1.7	0.0	0.0	9.9	0.6	0.0	66.8	0.1	1.4	25.8	2.7	0.5	1.9	2.3	0.3	0.0	0.0	0.4
SPINK14	SPINK5L2	ENSG00000196800	"Serine peptidase inhibitor, Kazal type 14 (putative)"	Q6IE38	5	148169733-148175398	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"breast: 2.7;intestine: 3.6;liver: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA						"unprognostic (4.98e-2)"		"unprognostic (3.44e-1)"				"unprognostic (1.94e-2)"	"unprognostic (2.96e-2)"				"unprognostic (5.69e-1)"		"unprognostic (1.48e-3)"				0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.5	1.4			0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.5	0.0	0.0		0.0	0.1	0.0	0.0	0.5		0.3	3.6		1.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.1			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SPINK6	"BUSI2, MGC21394, UNQ844"	ENSG00000178172	"Serine peptidase inhibitor, Kazal type 6"	Q6UWN8	5	148202794-148215137	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;cervix, uterine: 7.2;tongue: 7.1;vagina: 8.6"	"Cell type enhanced"	"Detected in some"	19	"Basal keratinocytes: 1.3;Hofbauer cells: 2.6"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.4;head and neck cancer: 21.0"	"Region enriched"	"Detected in single"	78	"cerebellum: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	84	"HeLa: 244.9;SiHa: 117.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011039	Uncertain				"Secreted - unknown location"	NA	NA					"HPA011039: AB_2668412"		"unprognostic (2.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.87e-2)"	"prognostic favorable (7.16e-4)"		"unprognostic (2.49e-2)"	"unprognostic (4.04e-1)"		"unprognostic (1.80e-2)"	"unprognostic (2.09e-2)"		"unprognostic (2.22e-2)"		"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	1.9	1.1	0.1	0.1	0.1	0.0	0.9	10.6	0.1	7.2	1.6	0.1	0.1	0.0	0.1	3.7	5.9	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.6	0.1	0.1	0.8	0.1	5.0	0.2	0.1	0.5	0.1	0.9	0.1	0.1	0.0	0.2	0.1	1.6	0.1	7.1	0.1	0.4	8.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	244.9	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	10.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	2.6	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1
SPINK7	"ECG2, ECRG2"	ENSG00000145879	"Serine peptidase inhibitor, Kazal type 7 (putative)"	P58062	5	148312419-148315922	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 161.8;tongue: 124.0;vagina: 79.6"	"Cell type enhanced"	"Detected in single"	34	"Urothelial cells: 1.8"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.5;head and neck cancer: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;HeLa: 2.2;hTCEpi: 3.9;PC-3: 3.2;SiHa: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036294	Enhanced				"Secreted - unknown location"	NA	NA		90000			"HPA036294: AB_10671243"		"unprognostic (2.82e-1)"				"unprognostic (8.99e-3)"		"unprognostic (8.52e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.12e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.24e-2)"	"unprognostic (4.22e-2)"	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	39.1	0.1	0.0	0.0	0.1	2.8	0.1	161.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	16.9	0.1	0.2	1.1	0.1	0.1	0.0	0.1	1.3	0.1	0.0	0.6	0.1	124.0	30.6	0.2	79.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.3	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8
SRPX	ETX1	ENSG00000101955	"Sushi repeat containing protein, X-linked"	P78539	X	38149336-38220924	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 82.4"	"Cell type enhanced"	"Detected in many"	19	"Fibroblasts: 130.2;Ito cells: 322.8;Leydig cells: 102.1;Melanocytes: 70.9;Peritubular cells: 89.5"	"Group enriched"	"Detected in all"	6	"glioma: 64.2;melanoma: 70.1;pancreatic cancer: 14.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	56	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	56	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 285.2;ASC TERT1: 63.7;HSkMC: 95.9;HUVEC TERT2: 59.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA		310000				"unprognostic (2.35e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (6.48e-2)"	"unprognostic (3.83e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (7.80e-13)"	"unprognostic (6.94e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (3.36e-4)"	56.2	11.9	2.2	8.5	5.0	0.0	82.4	6.6	4.8	14.1	23.1	7.7	10.1	3.1	17.7	35.5	15.1	37.1	23.3	28.9	5.3	2.9	4.1	6.6	14.2	27.7	9.6	1.9	11.6	7.8	1.4	1.5	34.1	13.4	22.1	10.2	4.7	9.5	6.6	9.9	8.7	14.4	27.8	18.9	0.6	13.3	14.9	7.3	0.9	17.8	5.3	5.1	29.6	54.6	0.0	10.5	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.9	0.0	285.2	63.7	0.0	2.5	5.0	0.8	1.5	0.0	0.2	0.0	0.0	5.3	8.9	0.1	0.1	2.2	0.7	0.0	1.0	0.0	0.0	0.0	12.8	0.2	0.0	95.9	0.2	8.5	4.3	9.9	59.1	0.1	0.0	0.0	9.5	0.1	0.0	0.0	0.7	0.1	1.8	0.0	3.2	0.4	0.0	0.1	0.1	0.1	0.1	0.0	11.9	2.4	0.0	0.0	25.3	6.2	3.2	8.0	7.4	0.0	0.0	0.0	17.9	0.2	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5	0.0	0.1	2.2	5.0	6.6	3.2	5.3	2.9	9.6	1.9	13.4	7.3	3.0	2.2	0.0	2.5	13.6	0.1	10.0	0.0	0.0	0.0	1.8	0.0	3.2	0.0	0.3	0.4	25.6	0.5	0.0	0.3	3.5	130.2	1.2	0.0	1.0	5.4	0.0	0.0	322.8	15.8	1.9	102.1	1.6	70.9	0.0	1.4	0.2	1.0	0.0	89.5	0.1	0.1	25.8	30.6	0.5	0.7	6.4	5.9	0.0	0.4	0.7
SSC4D	"S4D-SRCRB, SRCRB-S4D, SRCRB4D"	ENSG00000146700	"Scavenger receptor cysteine rich family member with 4 domains"	Q8WTU2	7	76389334-76409695	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 9.3;seminal vesicle: 9.5;thyroid gland: 8.6"	"Cell type enhanced"	"Detected in some"	14	"Collecting duct cells: 10.4;Distal tubular cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.6"	"Group enriched"	"Detected in some"	12	"EFO-21: 5.9;Hep G2: 8.1;SuSa: 9.9;U-2 OS: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA062611	Uncertain				"Secreted - unknown location"	NA	NA					"HPA062611: AB_2684807"	"unprognostic (3.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (2.83e-6)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (3.52e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.18e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.73e-2)"	1.1	0.5	0.1	0.1	0.1	0.0	0.4	0.0	0.2	1.0	0.2	0.3	3.0	0.2	0.3	0.8	0.0	0.4	0.1	0.0	0.2	0.2	7.7	0.7	0.2	0.1	0.2	0.8	2.3	4.4	7.8	7.2	0.7	0.4	0.1	0.0	0.8	9.3	9.5	0.4	0.0	0.0	0.2	0.7	0.3	0.1	0.3	0.0	0.0	8.6	0.0	0.2	0.0	0.0	0.3	0.1	0.0	1.6	0.0	0.2	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.8	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.1	0.9	0.4	0.0	0.0	9.9	0.1	0.0	0.0	0.0	23.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.1	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.8	0.4	0.0	0.0	0.3	0.0	0.4	0.0	0.2	1.5	0.0	0.0	0.0	10.4	0.0	0.2	3.3	1.7	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.3	0.0	2.1	2.7	1.6	0.0	1.3	1.2	0.0	0.9	0.8	0.0	0.0	0.0	2.0	0.4	0.0	0.4	1.0	0.1	0.0	0.0	0.5	3.0	0.0	0.2	0.0	0.0	0.3
TEX264	"FLJ13935, ZSIG11"	ENSG00000164081	"Testis expressed 264"	Q9Y6I9	3	51662693-51704323	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 310.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005002, HPA017739"	Enhanced		Approved	Nucleoli,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoli, Cytosol"		"CAB005002: AB_425976, HPA017739: AB_1857910"	"unprognostic (2.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.79e-3)"	"unprognostic (8.11e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.95e-9)"	"unprognostic (4.99e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.67e-2)"	15.7	34.6	15.1	15.3	18.7	9.0	20.0	8.6	22.8	17.5	21.3	15.0	36.0	18.7	20.1	25.5	17.7	21.9	24.8	19.0	14.6	15.6	35.9	30.7	17.0	22.6	15.7	17.9	15.8	29.0	29.9	12.3	24.5	12.2	20.3	16.7	22.6	43.6	44.3	16.3	29.5	20.8	16.6	15.8	18.6	19.0	90.8	11.5	16.6	33.9	18.5	15.9	16.7	16.3	33.1	34.5	24.7	36.7	22.8	50.7	41.1	11.8	21.8	3.9	20.1	40.7	19.8	8.0	10.2	24.2	17.0	17.2	11.6	28.2	17.1	7.5	14.6	28.8	11.6	11.0	20.6	8.3	13.7	17.6	16.3	13.6	15.4	36.3	10.2	18.3	26.1	32.9	19.2	19.7	15.5	12.4	13.0	8.5	29.9	17.5	13.7	16.3	23.8	4.3	19.6	24.5	7.9	5.2	32.2	26.8	16.5	5.6	9.2	12.5	34.5	15.7	5.6	16.8	21.7	9.1	17.2	7.2	18.0	13.5	20.9	22.5	8.4	21.0	21.6	17.1	24.7	36.7	21.7	41.9	36.7	41.9	32.2	43.5	39.7	34.5	33.1	36.5	37.0	7.7	22.8	34.7	30.5	50.7	41.1	15.1	18.7	8.6	22.8	14.6	15.6	15.7	17.9	12.2	11.5	32.8	15.0	27.5	46.0	30.9	30.1	22.8	53.5	25.4	28.4	94.2	55.0	125.5	53.0	63.6	30.2	49.7	69.9	0.0	67.2	73.8	45.6	36.2	16.1	51.7	92.2	39.7	31.6	28.3	36.7	48.4	47.2	49.0	62.4	55.9	51.0	59.8	56.9	65.4	46.0	101.0	46.9	25.8	20.0	310.0	58.8	30.9	63.8	52.4	81.7	32.5
THEM6	"C8orf55, DSCD75"	ENSG00000130193	"Thioesterase superfamily member 6"	Q8WUY1	8	142727203-142736927	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 28.9;RT4: 40.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023255	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted - unknown location"	NA	NA			"Nuclear speckles, Cytosol"		"HPA023255: AB_1845782"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.76e-2)"	"prognostic favorable (6.66e-7)"	"unprognostic (7.02e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (4.49e-4)"	11.9	13.9	9.4	5.6	13.4	6.0	21.6	9.0	20.7	10.8	11.8	12.8	16.6	14.4	5.6	7.1	14.9	12.5	15.0	12.6	10.7	11.5	16.7	35.2	11.0	7.4	8.8	11.7	4.5	30.7	13.4	10.0	10.7	11.6	9.8	6.7	10.0	18.5	15.3	11.3	11.7	14.3	4.8	9.3	8.7	15.1	3.0	7.5	10.3	14.4	15.6	10.6	19.7	7.9	6.5	3.8	4.5	7.4	8.4	14.6	7.5	9.9	8.3	1.2	8.7	4.1	1.4	6.1	5.1	4.3	7.9	5.5	5.0	15.0	4.2	11.8	1.9	2.9	23.2	3.7	11.1	1.3	3.4	10.2	3.2	4.7	10.1	4.5	1.8	3.4	2.0	4.0	1.5	2.2	1.6	6.7	6.0	1.5	2.1	1.3	28.9	7.5	0.4	2.0	18.7	27.1	8.8	0.9	9.6	9.4	40.7	19.6	7.7	7.9	23.7	6.5	1.2	11.6	1.5	3.8	3.4	2.5	9.8	0.9	1.4	1.9	1.8	3.5	9.1	4.2	4.5	4.0	2.0	9.7	7.4	14.6	4.6	10.3	12.5	3.8	6.5	12.5	11.5	0.5	8.4	7.1	2.9	9.1	7.5	9.4	13.4	9.0	20.7	10.7	11.5	8.8	11.7	11.6	7.5	8.9	4.3	2.7	7.4	3.2	9.8	5.3	12.7	0.0	3.4	17.4	5.9	12.1	5.0	10.2	1.7	8.1	19.3	0.0	10.2	9.4	4.1	8.0	0.0	18.1	10.2	15.9	30.6	11.6	1.2	12.4	2.6	2.6	5.0	1.8	12.9	14.6	8.4	3.5	3.9	12.3	11.5	0.0	4.2	2.3	7.2	6.8	2.9	8.5	20.4	21.1
THNSL2	"FLJ10916, SOFAT, TSH2"	ENSG00000144115	"Threonine synthase like 2"	Q86YJ6	2	88170295-88186636	"Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 49.7;Proximal tubular cells: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 16.8;hTCEpi: 10.3;MCF7: 10.7;SuSa: 16.9;T-47d: 15.7"	"Low region specificity"	"Detected in all"							HPA035395	Approved				"Secreted - unknown location"	NA	NA					"HPA035395: AB_10601600"	"unprognostic (1.51e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (6.64e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.24e-2)"	8.6	9.5	5.5	6.0	8.1	0.7	12.0	3.3	10.8	8.7	10.5	17.3	16.3	7.8	11.5	27.0	11.2	11.1	15.1	10.9	5.0	7.1	24.0	29.9	11.7	3.6	7.2	8.6	10.4	8.7	32.4	16.2	14.4	11.3	12.5	3.7	21.1	15.4	9.6	28.7	7.0	12.8	13.7	7.5	4.7	6.6	13.6	1.0	0.9	18.0	9.3	3.8	6.5	5.8	3.4	1.5	0.9	1.1	0.5	1.3	0.8	0.9	0.0	0.0	0.0	2.0	1.3	1.6	4.6	3.4	5.5	6.9	7.0	5.4	0.0	2.1	0.0	0.0	0.2	0.0	0.1	4.7	0.0	0.0	0.0	0.2	0.0	16.8	0.0	0.9	3.1	10.3	1.7	0.0	0.3	0.0	0.0	0.0	0.0	3.2	10.7	0.0	0.0	4.2	8.0	0.7	0.0	0.0	0.0	3.3	0.3	2.0	0.0	5.4	0.8	8.8	16.9	15.7	1.0	0.0	4.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.6	0.9	1.3	1.0	0.9	1.6	0.4	1.0	1.5	3.4	0.7	0.3	0.4	0.5	1.1	0.0	0.0	0.8	5.5	8.1	3.3	10.8	5.0	7.1	7.2	8.6	11.3	1.0	3.0	12.4	3.2	7.8	6.0	10.9	17.3	20.4	4.0	2.3	14.0	0.0	33.4	49.7	12.1	1.3	1.8	8.8	0.0	2.6	14.3	8.0	7.3	0.0	39.2	4.1	12.7	2.4	7.4	9.4	3.4	8.3	2.2	13.5	19.0	7.2	34.2	8.4	7.0	9.2	73.9	6.9	0.0	6.1	2.8	11.0	4.4	20.0	0.0	8.9	5.7
THSD4	"ADAMTSL6, FLJ13710, FVSY9334, PRO34005"	ENSG00000187720	"Thrombospondin type 1 domain containing 4"	Q6ZMP0	15	71096952-71783383	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 60.5"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 104.8;Cardiomyocytes: 53.7;Glandular cells: 73.8;Peritubular cells: 70.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 19.3;ASC TERT1: 18.1;BJ hTERT+: 23.0;T-47d: 18.8;TIME: 28.5;U-2197: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"	NA	NA						"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.01e-3)"	2.4	4.6	1.5	3.6	2.7	0.2	8.5	1.4	3.0	60.5	8.7	2.4	5.1	4.3	19.9	12.8	36.9	20.3	18.7	17.4	2.1	2.0	5.1	3.3	5.0	2.3	2.7	4.2	8.0	8.7	1.2	4.5	12.4	5.3	19.0	4.0	29.7	6.5	8.8	1.6	4.4	8.4	10.6	6.4	1.2	6.2	3.9	1.4	0.0	6.6	13.3	5.3	7.2	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	19.3	0.3	5.6	3.0	18.1	0.0	9.4	23.0	4.9	2.5	0.1	3.7	0.0	7.8	3.3	17.0	7.2	0.7	3.9	3.0	0.8	0.8	0.0	2.0	0.0	1.9	0.0	0.0	1.3	2.9	2.9	11.8	13.4	8.9	0.0	0.0	0.2	4.0	3.8	0.0	0.0	1.7	0.0	3.4	0.0	0.3	0.3	13.0	2.6	0.3	2.4	3.7	4.7	0.0	2.3	18.8	0.0	28.5	0.1	0.4	19.4	5.0	0.0	0.1	0.0	4.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.7	1.4	3.0	2.1	2.0	2.7	4.2	5.3	1.4	17.9	7.0	0.0	104.8	12.4	2.6	53.7	45.9	13.4	5.7	5.2	5.9	0.3	1.7	16.1	6.1	11.9	10.5	0.0	1.6	0.2	10.3	73.8	0.0	10.6	0.2	0.0	2.9	6.7	0.0	11.4	16.1	0.9	8.5	0.0	3.6	0.0	8.6	5.8	70.0	0.3	0.8	0.0	3.8	1.0	1.5	9.5	0.7	0.0	10.9	25.5
TLL2		ENSG00000095587	"Tolloid like 2"	Q9Y6L7	10	96364606-96513918	"Enzymes, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 7.4"	"Cell type enhanced"	"Detected in some"	8	"Cardiomyocytes: 4.8;Early spermatids: 5.2;Late spermatids: 3.4;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"RPTEC TERT1: 21.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (1.28e-2)"	"unprognostic (7.54e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.31e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.52e-4)"	"unprognostic (7.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-4)"	"unprognostic (2.90e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.95e-4)"	"unprognostic (2.30e-1)"	0.7	1.1	3.2	1.4	4.9	1.6	0.7	0.7	5.8	0.8	1.1	5.7	2.5	1.7	1.2	1.1	0.9	0.7	2.6	7.4	3.3	3.8	0.7	0.6	0.5	1.8	3.4	2.1	1.4	1.5	0.4	2.8	1.1	4.6	1.1	1.1	0.0	3.9	2.7	4.1	1.0	2.1	0.9	6.1	0.9	2.1	1.1	5.7	0.0	1.5	4.0	0.7	0.8	0.5	0.9	0.3	0.6	0.2	0.3	0.2	0.0	0.2	0.1	0.4	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.3	1.1	0.1	0.2	0.1	0.2	0.1	0.0	2.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	1.3	0.7	0.1	0.1	0.4	0.0	21.7	0.1	0.8	0.1	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.9	0.2	0.1	0.0	0.9	0.2	0.2	0.6	0.3	0.2	0.3	0.1	0.0	3.2	4.9	0.7	4.0	3.3	3.8	3.4	2.1	4.6	5.7	0.0	0.6	0.0	0.4	0.1	0.0	4.8	2.5	0.0	1.2	0.0	0.0	2.2	0.0	0.3	5.2	0.5	0.0	0.0	0.5	0.0	0.6	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.3	3.4	0.3	1.0	0.0	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.0	0.4	2.9	0.0	0.0	0.4
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6461151-6466195	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1"	"Cell type enhanced"	"Detected in many"	7	"Suprabasal keratinocytes: 25.0;T-cells: 36.2;Undifferentiated cells: 28.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	11	"cerebellum: 19.2"	"Cell type enhanced"	"Detected in many"		"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.2;NB-4: 8.0;RPMI-8226: 19.7"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"	NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"	Nucleoplasm	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"	2.2	1.6	1.2	20.3	1.6	0.4	1.4	19.2	1.8	1.4	13.4	0.7	0.6	2.8	1.2	0.6	4.1	2.4	2.1	2.3	1.8	0.9	1.4	2.3	6.3	13.9	1.1	0.6	1.1	0.6	1.4	14.0	4.1	1.3	1.9	1.3	1.1	10.5	2.3	0.8	24.1	11.2	0.6	0.6	18.9	0.8	1.0	0.8	11.7	1.1	3.2	26.0	3.2	1.5	0.0	0.4	0.0	0.9	0.6	9.5	1.3	1.4	0.3	0.8	1.6	0.0	0.4	0.8	0.6	0.4	0.2	0.0	1.3	2.2	0.0	3.0	0.0	1.0	3.2	0.4	3.7	0.0	20.2	1.5	0.8	1.1	0.0	0.6	0.0	0.0	0.0	2.4	1.2	3.2	1.9	3.2	0.9	0.0	0.0	0.0	1.6	0.0	8.0	1.0	1.1	5.5	0.6	0.2	19.7	0.8	0.5	3.9	5.4	0.0	1.9	0.1	0.3	1.7	2.2	1.7	1.0	1.5	0.0	1.5	0.0	3.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.7	0.3	8.0	0.0	6.9	3.2	0.4	0.0	6.4	1.1	0.0	0.6	0.9	0.0	9.5	1.3	1.2	1.6	19.2	1.8	1.8	0.9	1.1	0.6	1.3	0.8	3.0	5.3	0.5	1.8	21.9	0.8	0.8	2.5	2.7	2.3	1.8	2.0	0.4	0.0	0.1	0.3	5.5	16.9	0.0	0.4	1.6	3.2	1.1	6.9	1.1	3.2	4.8	6.4	9.8	1.6	0.0	2.6	2.1	6.8	1.0	17.6	11.2	0.9	11.5	8.9	0.3	9.3	0.0	0.8	0.5	1.1	25.0	0.1	36.2	28.4	6.7
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228324-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"blood: 10.3;bone marrow: 3.1;lung: 3.1;lymphoid tissue: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 5.4;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.3"	"Cell line enriched"	"Detected in some"	4	"HEL: 4.6"									HPA065044	Uncertain				"Secreted - unknown location"	NA	NA					"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.3	0.1	0.1	1.2	0.3	3.1	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.6	0.3	0.2	0.1	0.2	0.1	0.2	3.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.4	9.5	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	1.3	0.9	10.3	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.4	0.0	0.5	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	10.3	0.0	0.4	0.9	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSKU	"E2IG4, LRRC54, TSK"	ENSG00000182704	"Tsukushi, small leucine rich proteoglycan"	Q8WUA8	11	76782251-76798154	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 86.8"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 427.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 41.4;ASC diff: 70.9;OE19: 44.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA008164	Approved		Approved	"Nucleoplasm,Nuclear bodies"	"Secreted - unknown location"	NA	NA		2100000	Nucleoplasm	"Nuclear bodies"	"HPA008164: AB_1853327"	"unprognostic (1.07e-2)"	"unprognostic (2.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.05e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.81e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (2.87e-4)"	"prognostic favorable (1.66e-4)"	"prognostic unfavorable (2.80e-8)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.88e-2)"	33.1	2.8	1.0	3.6	1.4	0.6	26.9	1.5	2.0	38.8	16.1	1.8	6.4	11.5	13.2	25.5	17.8	15.3	8.6	9.3	1.2	0.3	31.8	86.8	5.1	3.7	1.7	1.3	27.8	12.2	2.6	4.3	43.0	3.4	15.7	4.5	48.5	9.3	10.8	7.0	15.0	21.4	13.0	0.8	3.0	8.7	9.0	0.8	1.5	12.2	16.0	12.4	18.2	27.9	1.8	0.7	2.1	0.4	0.7	1.3	0.2	0.8	41.4	4.6	4.5	70.9	9.1	8.5	1.4	7.8	3.1	3.0	5.3	11.4	0.1	8.1	5.1	13.2	16.6	2.6	10.2	0.9	8.5	1.4	2.0	10.7	14.8	13.4	0.7	3.1	9.3	11.2	5.5	4.5	5.9	3.8	1.5	4.5	0.3	2.8	19.1	0.1	1.5	6.1	44.7	1.8	1.3	4.4	6.5	7.3	7.2	4.2	6.9	7.9	6.2	3.8	4.1	8.3	0.6	1.1	8.7	6.9	21.1	3.3	0.3	0.1	0.3	4.1	2.1	1.5	1.8	0.4	0.5	0.9	0.2	0.4	1.8	0.8	0.7	0.4	1.8	0.9	1.3	2.1	0.7	0.4	0.7	0.8	0.2	1.0	1.4	1.5	2.0	1.2	0.3	1.7	1.3	3.4	0.8	0.0	0.3	0.0	13.0	15.3	3.2	3.9	15.3	2.7	5.7	1.8	0.0	42.8	0.0	5.8	0.2	3.6	20.6	23.3	19.6	58.8	39.7	6.5	1.1	427.8	8.4	0.0	7.5	8.6	9.5	1.2	34.5	1.6	5.0	2.8	14.2	10.4	17.7	20.1	42.5	21.9	0.5	0.0	13.4	0.4	2.3	19.7	36.6	4.4	11.3	17.0
TUFT1		ENSG00000143367	"Tuftelin 1"	Q9NNX1	1	151540305-151583583	"Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 54.9"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 61.5;Suprabasal keratinocytes: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 72.2"	"HPA028112, HPA054301"	Approved	Approved	Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA028112: AB_10603224, HPA054301: AB_2682442"	"unprognostic (6.16e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-2)"	"unprognostic (8.29e-3)"	"unprognostic (9.06e-2)"	"unprognostic (6.70e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (4.53e-2)"	3.4	4.0	2.7	3.3	2.5	3.8	11.6	8.5	4.5	13.3	8.1	1.1	6.7	4.6	5.9	6.9	23.4	3.1	9.7	3.0	2.0	4.0	9.4	3.9	5.3	2.2	1.9	3.9	5.4	9.3	7.8	5.7	33.1	3.3	7.5	8.3	3.3	18.8	9.4	1.7	54.9	9.8	9.6	1.8	1.1	7.4	5.0	1.5	0.5	3.6	12.0	14.4	11.9	12.2	1.2	1.6	6.5	1.1	0.2	6.0	0.9	14.6	5.0	3.7	4.3	0.8	0.7	23.9	3.9	3.5	15.7	15.1	15.9	11.7	1.3	24.6	4.6	7.4	17.2	6.5	6.0	11.5	9.7	3.2	0.8	8.5	2.4	12.5	0.3	1.8	2.5	7.1	12.3	27.4	9.3	1.2	1.8	1.3	10.1	4.8	6.0	0.7	0.2	4.4	10.8	4.3	0.0	10.6	5.0	13.0	22.7	7.4	3.0	25.2	17.2	3.0	11.7	13.7	0.7	3.2	2.8	19.8	17.4	26.1	2.5	4.8	0.1	2.4	0.3	1.7	6.5	1.1	1.1	0.7	0.3	1.4	1.2	1.9	1.0	1.6	0.6	1.7	0.6	4.5	0.2	0.6	0.2	6.0	0.9	2.7	2.5	8.5	4.5	2.0	4.0	1.9	3.9	3.3	1.5	23.8	1.3	0.0	41.3	61.5	1.8	8.9	7.6	1.4	9.1	14.0	0.0	22.2	11.6	15.0	2.1	0.7	37.6	0.0	13.3	12.0	7.4	24.8	4.6	9.3	3.5	0.0	30.9	1.8	0.0	1.9	2.3	2.6	8.5	2.8	21.4	2.0	31.3	21.6	4.9	9.1	0.5	6.5	5.6	0.7	3.4	58.2	47.5	3.2	17.0	26.9
TULP3	TUBL3	ENSG00000078246	"Tubby like protein 3"	O75386	12	2877223-2941140	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015285, HPA018496"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA015285: AB_1858460, HPA018496: AB_2669889"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.80e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.19e-2)"	14.0	12.0	8.1	6.9	12.9	2.4	13.0	21.2	11.1	22.7	13.6	19.6	12.6	5.3	27.7	11.7	14.1	20.9	11.5	12.7	12.1	5.3	12.1	6.5	9.5	7.2	11.0	7.7	37.1	6.8	13.5	15.4	12.7	10.9	12.5	8.1	17.2	9.8	14.0	9.9	19.8	7.0	17.5	9.7	7.3	11.7	13.2	13.8	4.4	13.3	6.3	9.2	11.6	28.4	3.5	2.8	0.6	1.5	4.8	6.3	1.7	9.1	7.8	14.9	12.3	15.0	22.4	14.1	14.4	24.2	15.6	17.3	9.9	8.5	6.8	2.2	21.2	13.3	7.7	8.8	9.3	18.1	8.8	6.5	4.1	9.7	6.3	19.4	4.3	4.7	13.1	11.0	23.6	32.3	19.2	12.0	8.7	3.8	6.4	13.0	8.2	6.4	3.8	20.1	7.3	5.8	6.9	14.6	2.5	9.8	7.7	3.8	10.0	12.6	7.5	8.2	28.4	9.4	4.3	9.6	11.5	13.9	23.3	13.9	2.0	2.4	5.9	11.6	2.4	17.5	0.0	1.5	0.5	4.0	1.5	6.3	2.9	3.1	4.0	1.3	3.5	3.8	5.2	0.6	4.8	0.8	2.8	5.5	1.7	8.1	12.9	21.2	11.1	12.1	5.3	11.0	7.7	10.9	13.8	6.0	8.0	4.2	14.7	18.0	5.6	5.0	12.7	52.2	17.0	1.8	2.0	7.8	19.9	14.2	2.5	13.6	3.2	0.0	6.4	8.8	23.1	19.1	0.0	3.8	4.6	38.1	3.5	19.0	2.2	2.4	37.7	4.7	18.6	9.0	5.0	46.7	9.7	0.0	23.3	13.5	9.5	38.8	23.7	30.7	52.5	17.7	9.7	5.3	5.6	11.1
TWSG1	TSG	ENSG00000128791	"Twisted gastrulation BMP signaling modulator 1"	Q9GZX9	18	9334767-9402420	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 91.3;Peritubular cells: 89.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014898	Uncertain		Supported	Centrosome,Cytosol	"Secreted - unknown location"	No	No		6600000	"Centrosome, Cytosol"		"HPA014898: AB_1858467"	"unprognostic (2.55e-1)"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	13.0	8.9	8.3	6.9	8.5	2.9	17.3	5.0	6.2	21.9	17.4	9.3	56.2	4.7	33.0	21.5	19.0	14.4	16.4	9.2	8.4	7.1	19.8	4.8	12.6	6.6	11.0	6.1	20.4	4.4	12.7	11.4	10.7	9.1	26.5	10.2	10.6	9.4	34.8	6.1	7.6	8.6	36.0	12.3	9.4	12.0	13.0	8.1	4.3	20.5	8.7	6.8	26.0	17.9	3.3	7.8	7.5	4.1	4.1	7.5	3.1	15.0	5.5	15.8	7.8	31.3	28.3	7.3	28.9	36.0	15.9	22.8	5.8	19.9	2.1	14.7	38.1	10.3	5.3	15.5	11.4	29.3	5.9	4.3	3.9	4.7	2.8	27.8	2.8	8.1	28.7	9.4	13.3	6.4	21.8	24.6	2.1	5.9	4.0	40.6	4.6	3.0	3.4	5.1	8.9	4.5	5.4	16.2	1.3	18.0	20.2	2.1	5.5	22.7	6.3	6.0	6.9	7.1	6.6	20.3	29.2	14.6	27.3	17.9	5.8	5.1	4.1	17.9	3.9	10.2	7.5	4.1	5.8	6.7	2.2	4.4	3.3	3.2	6.8	7.8	2.8	3.8	7.5	2.0	4.1	0.7	7.8	1.4	3.1	8.3	8.5	5.0	6.2	8.4	7.1	11.0	6.1	9.1	8.1	23.8	20.2	4.8	20.9	35.1	4.7	6.5	10.2	6.7	18.2	71.5	0.0	5.0	1.7	8.5	91.3	12.0	2.6	0.0	6.8	11.9	72.5	30.5	5.8	7.4	13.6	3.2	5.8	14.1	6.2	20.4	34.8	9.2	21.9	19.0	7.2	15.6	8.5	10.5	89.5	10.7	4.7	71.1	66.9	21.6	4.9	23.5	3.9	7.5	14.3	15.0
TXNDC16	KIAA1344	ENSG00000087301	"Thioredoxin domain containing 16"	Q9P2K2	14	52430590-52552522	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 49.1;Rod photoreceptor cells: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002543	Approved		Approved	Mitochondria	"Secreted - unknown location"	NA	NA			Mitochondria		"HPA002543: AB_1079199"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.95e-3)"	"unprognostic (2.36e-1)"	"unprognostic (5.95e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.04e-1)"	7.0	5.2	10.2	5.9	12.5	5.4	8.6	20.5	15.0	12.1	7.0	7.4	16.1	5.1	8.5	18.4	4.8	5.4	6.5	5.6	9.2	9.4	6.4	8.9	6.1	5.0	9.5	11.3	13.4	7.8	8.6	9.4	7.0	8.9	32.8	7.4	8.1	5.6	24.2	4.2	6.5	5.9	5.6	14.0	11.5	7.4	8.2	10.5	9.7	5.1	3.4	4.8	7.8	7.3	1.2	5.3	3.6	6.3	1.1	4.7	2.2	6.1	0.6	6.9	3.8	5.1	3.8	5.4	2.0	2.7	3.5	6.8	2.2	5.0	10.0	6.9	1.6	2.1	5.8	7.9	2.8	5.4	4.1	10.3	4.6	5.1	2.0	3.7	5.4	2.2	7.0	2.6	4.4	3.3	3.1	3.8	4.4	5.8	15.6	3.0	2.9	6.7	3.8	7.6	4.1	3.7	13.6	13.0	9.0	4.4	6.3	22.5	7.8	9.9	10.4	2.8	6.0	6.6	4.0	2.1	4.7	2.4	5.3	3.4	4.3	5.8	10.1	1.3	5.7	2.7	2.4	6.3	2.5	2.7	4.8	2.9	1.2	2.8	2.0	5.3	0.8	1.4	1.4	3.6	1.1	5.2	2.2	4.7	2.2	10.2	12.5	20.5	15.0	9.2	9.4	9.5	11.3	8.9	10.5	8.9	5.4	5.2	5.3	6.0	35.7	7.9	7.6	5.3	6.8	7.0	7.9	1.7	1.7	3.1	3.3	6.3	5.2	23.3	3.5	1.5	3.3	19.5	2.3	10.5	3.0	9.5	17.7	12.9	15.9	2.7	25.6	5.0	1.7	1.0	17.2	8.4	1.5	9.5	49.1	2.6	45.5	0.0	4.4	9.8	8.4	7.3	0.9	5.7	8.7	3.5
UTS2B	"U2B, URP, UTS2D"	ENSG00000188958	"Urotensin 2B"	Q765I0	3	191267168-191330536	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 19.0"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Early spermatids: 5.1;Late spermatids: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"amygdala: 19.0"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.2;naive B-cell: 3.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"PC-3: 7.2"									HPA026992	Uncertain				"Secreted - unknown location"	NA	NA					"HPA026992: AB_1858703"	"unprognostic (1.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.10e-2)"	1.1	1.5	19.0	0.7	0.8	0.2	1.6	0.5	2.5	0.6	0.6	0.8	0.5	7.7	1.5	0.5	0.6	1.0	3.0	0.9	1.5	1.2	0.5	4.8	0.6	0.9	0.8	0.5	1.7	4.1	0.0	0.5	0.5	1.0	0.5	0.1	0.5	0.5	0.5	0.5	1.3	4.2	0.5	1.1	1.1	1.9	2.9	0.5	0.5	0.5	0.5	0.8	0.9	0.7	6.2	1.2	0.1	0.1	0.0	0.1	0.1	0.9	2.1	2.9	1.4	0.8	3.7	0.9	2.1	1.2	0.8	0.4	1.5	1.1	1.4	1.1	1.0	5.8	1.1	0.9	0.0	3.5	1.4	1.0	1.3	2.8	6.1	0.7	1.6	0.8	1.5	0.4	0.5	0.6	1.9	0.8	1.2	0.9	1.4	1.1	1.2	0.4	1.2	1.6	2.7	7.2	1.8	3.4	0.5	0.4	3.6	1.6	1.0	1.3	1.5	0.8	1.3	1.2	1.0	3.0	1.6	0.9	2.8	0.8	2.3	1.3	1.4	1.9	1.1	1.0	0.0	0.0	0.1	0.1	0.0	0.0	6.2	0.1	0.0	0.0	3.0	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.1	19.0	0.8	0.5	2.5	1.5	1.2	0.8	0.5	1.0	0.5	3.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.7	0.9	0.3	0.2	0.0	0.0	0.0
VASN	SLITL2	ENSG00000168140	Vasorin	Q6EMK4	16	4371848-4383528	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 108.9;Peritubular cells: 57.3;Sertoli cells: 97.0;Smooth muscle cells: 96.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"U-2197: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011246, HPA016992"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted - unknown location"	NA	Yes		2400000000	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA011246: AB_1858720, HPA016992: AB_2732418"	"unprognostic (2.20e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.35e-3)"	"unprognostic (8.91e-3)"	"unprognostic (3.15e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.82e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.95e-3)"	"unprognostic (5.27e-2)"	22.4	10.2	4.9	7.7	6.7	3.8	28.6	1.6	6.5	19.9	5.1	5.6	6.4	5.1	14.3	13.6	16.2	9.9	10.2	12.9	4.4	1.8	21.6	14.1	17.2	5.2	2.7	2.9	21.0	9.8	1.7	5.9	30.2	4.8	12.9	2.0	33.6	7.9	13.1	7.0	16.0	4.0	9.4	3.6	7.9	6.5	14.7	3.5	0.0	15.2	5.5	8.2	16.6	19.0	0.3	0.2	0.4	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	2.8	3.2	1.2	5.3	5.2	1.6	2.7	0.3	0.6	0.0	1.9	3.5	0.2	0.0	0.0	0.1	0.2	1.2	0.1	0.1	1.5	1.6	10.2	0.0	0.0	3.3	0.0	4.0	0.1	2.7	0.0	0.0	0.2	0.0	0.2	1.8	0.0	0.4	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.1	0.9	2.5	4.2	0.0	0.2	0.9	0.2	0.0	4.9	1.3	126.7	0.6	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.9	6.7	1.6	6.5	4.4	1.8	2.7	2.9	4.8	3.5	6.0	12.5	0.9	6.0	8.5	0.0	12.9	35.7	1.4	3.4	22.7	0.0	3.0	6.6	10.3	1.0	3.3	0.2	0.0	2.6	6.4	108.9	7.4	3.5	12.9	2.8	0.0	0.0	4.9	0.3	1.8	46.3	1.2	13.5	0.0	0.4	16.3	17.4	0.0	57.3	12.5	0.7	97.0	96.8	0.5	5.1	6.6	8.4	1.8	0.2	3.3
VSTM2L	"C20orf102, dJ1118M15.2"	ENSG00000132821	"V-set and transmembrane domain containing 2 like"	Q96N03	20	37903104-37945350	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.8"	"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 26.6;Cholangiocytes: 66.2;Ciliated cells: 34.8"	"Group enriched"	"Detected in all"	5	"lung cancer: 23.6;pancreatic cancer: 34.4;prostate cancer: 72.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 26.9;HDLM-2: 36.8;hTCEpi: 9.5;SH-SY5Y: 8.9;SK-BR-3: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043832	Uncertain				"Secreted - unknown location"	NA	NA					"HPA043832: AB_10968449"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (4.96e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.68e-1)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (8.14e-4)"	1.6	7.5	29.3	1.6	22.7	0.8	1.4	7.0	44.8	14.0	1.8	1.8	21.4	2.0	1.6	11.5	1.6	17.5	18.9	25.6	34.9	23.5	1.1	2.5	4.5	1.2	10.7	17.6	0.9	3.5	0.9	6.9	1.6	9.7	6.0	1.3	3.6	3.8	19.8	1.0	1.0	1.4	1.7	6.2	18.6	8.9	2.5	1.5	0.0	1.3	0.0	1.8	1.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.1	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	26.9	0.0	0.1	0.2	0.1	0.1	0.0	1.2	0.0	36.8	0.6	0.0	0.0	0.0	1.5	0.0	1.0	1.3	9.5	0.0	0.3	1.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.9	7.9	0.0	0.0	0.1	0.0	0.0	1.0	8.9	1.1	32.9	0.3	0.0	0.1	0.0	1.7	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	22.7	7.0	44.8	34.9	23.5	10.7	17.6	9.7	1.5	6.0	2.6	0.0	1.5	0.3	7.5	26.6	66.2	34.8	10.3	0.0	7.9	0.2	0.0	3.8	0.3	0.5	0.0	0.0	0.2	0.1	0.4	8.4	0.0	0.8	0.0	12.7	17.9	0.0	0.3	0.4	4.9	0.2	0.0	0.0	0.9	0.8	4.7	0.2	15.2	0.4	3.1	0.0	1.0	0.2	0.4	0.5	0.1	0.0	0.0	0.6
VSTM4	"C10orf72, FLJ31737"	ENSG00000165633	"V-set and transmembrane domain containing 4"	Q8IW00	10	49014245-49115509	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 81.0;Late spermatids: 104.4;Sertoli cells: 58.2"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 22.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 6.9;RH-30: 8.0;SH-SY5Y: 6.8;U-138 MG: 9.1;U-2197: 20.4;U-87 MG: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017279	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Vesicles"		"HPA017279: AB_10959519"	"unprognostic (8.46e-2)"	"unprognostic (5.41e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.25e-4)"	13.0	31.6	7.2	3.4	6.7	0.4	10.5	3.3	7.1	18.2	6.2	9.3	3.1	2.0	13.2	5.9	6.1	6.5	11.7	10.3	7.2	4.4	9.3	3.0	8.9	7.0	8.9	5.4	27.2	1.3	22.8	4.6	7.7	10.1	11.2	4.4	15.1	2.8	9.2	3.8	4.2	4.1	12.5	7.9	2.8	5.4	7.8	6.0	2.9	20.8	6.9	3.4	9.4	8.6	1.8	0.9	2.7	0.9	1.7	0.7	0.2	0.0	0.1	2.7	0.1	1.1	0.6	0.1	2.1	3.5	0.8	0.2	0.1	0.1	0.1	0.1	5.0	2.9	0.1	0.1	0.0	0.4	2.6	1.2	0.1	0.0	0.1	0.1	0.1	0.0	4.1	0.0	3.6	0.0	0.0	0.0	0.7	6.9	0.1	0.6	0.1	0.0	0.1	0.5	0.0	0.0	0.0	8.0	4.1	0.0	0.1	0.1	6.8	0.1	0.1	0.0	0.3	0.1	0.2	0.0	9.1	1.1	20.4	0.1	0.0	5.5	0.0	10.0	0.1	0.1	1.9	0.9	0.4	0.6	0.3	0.5	0.8	0.4	0.3	0.2	1.8	0.7	0.6	2.7	1.7	0.5	0.9	0.3	0.2	7.2	6.7	3.3	7.1	7.2	4.4	8.9	5.4	10.1	6.0	3.0	17.4	0.0	1.7	5.8	5.0	12.1	0.0	6.7	17.0	0.0	2.0	0.4	1.7	0.1	81.0	6.4	0.0	0.0	0.0	0.3	22.4	0.7	11.6	3.2	0.5	4.8	0.0	3.7	1.9	104.4	8.9	4.0	6.8	1.0	0.0	10.9	0.2	0.0	13.8	6.1	2.7	58.2	30.0	1.4	3.4	3.8	0.3	1.3	0.0	0.6
VWA3A	"FLJ40941, FLJ46765"	ENSG00000175267	"Von Willebrand factor A domain containing 3A"	A6NCI4	16	22092538-22156966	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 26.8;fallopian tube: 27.0"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 101.7;Club cells: 27.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 1.5;U-266/70: 1.2;U-266/84: 2.5;WM-115: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041696, HPA042044"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA041696: AB_10964202, HPA042044: AB_10968997"	"unprognostic (2.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.75e-4)"	"prognostic favorable (8.15e-4)"	"unprognostic (2.70e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.79e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.06e-4)"	1.0	1.1	3.6	0.7	8.3	1.1	0.9	0.3	12.2	8.1	0.8	13.2	0.0	0.8	2.3	9.6	0.8	27.0	0.7	0.9	4.8	5.8	0.9	0.7	5.5	0.8	0.7	6.7	3.0	1.0	0.9	10.0	0.8	26.8	0.9	0.8	0.0	0.8	0.8	0.8	2.3	1.1	0.7	3.8	1.0	0.9	5.0	3.6	0.0	0.9	0.0	0.9	0.9	0.1	0.2	0.1	0.0	0.5	0.0	0.4	0.0	0.1	1.1	0.6	0.7	0.3	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.7	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.5	0.4	0.3	0.0	0.0	0.0	0.3	0.0	0.0	1.2	2.5	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	3.6	8.3	0.3	12.2	4.8	5.8	0.7	6.7	26.8	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	101.7	27.3	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777294	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.6;pituitary gland: 20.5"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Enterocytes: 1.8;Intestinal endocrine cells: 4.1;Paneth cells: 2.3;Proximal tubular cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.2;HeLa: 3.4;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.5"	"Group enriched"	"Detected in some"	5	"cerebellum: 7.8;pons and medulla: 4.1"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA			"Plasma membrane, Cytosol"		"HPA046954: AB_2679875, HPA054262: AB_2682430"	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	1.1	1.6	3.1	1.4	9.5	1.1	1.2	5.6	10.5	1.1	1.9	0.0	3.9	2.6	4.6	3.0	1.1	19.6	2.0	3.9	1.6	5.5	5.6	1.5	2.5	1.2	1.7	5.4	1.4	2.5	5.1	20.5	1.0	9.7	1.3	1.7	0.8	1.7	2.0	5.3	1.7	3.3	2.3	2.3	1.3	5.8	1.3	2.3	0.0	1.8	0.6	1.3	1.3	0.8	0.2	0.0	1.2	0.0	0.0	0.4	0.0	0.5	1.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.1	2.2	0.5	0.7	0.3	0.1	0.9	0.7	0.2	0.0	0.0	0.0	0.1	3.4	0.5	0.1	0.0	0.9	0.1	0.9	0.1	0.0	0.2	0.0	0.6	0.2	3.0	0.0	0.2	0.0	0.5	0.0	1.4	0.1	0.3	0.0	2.1	2.2	0.0	0.3	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.1	4.5	1.3	0.1	0.0	0.6	0.1	1.2	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	3.1	9.5	5.6	10.5	1.6	5.5	1.7	5.4	9.7	2.3	0.0	0.6	0.0	0.5	0.1	0.4	0.7	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.4	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.5
VWC2L		ENSG00000174453	"Von Willebrand factor C domain containing protein 2 like"	B2RUY7	2	214411065-214578959	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 8.9;pituitary gland: 2.3"	"Cell type enriched"	"Detected in single"	9	"Bipolar cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AF22: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044815, HPA059414"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA044815: AB_10962359, HPA059414: AB_2684007"	"unprognostic (8.77e-2)"				"unprognostic (2.83e-3)"			"unprognostic (2.05e-2)"		"unprognostic (8.49e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.36e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.05e-1)"		"unprognostic (3.89e-1)"		0.3	0.3	1.9	0.3	3.2	0.3	0.3	0.2	8.9	0.3	0.3	0.0	0.0	0.3	0.3	0.5	0.3	0.4	0.3	0.3	2.4	6.6	0.3	0.3	0.5	0.3	3.9	2.9	0.3	0.3	0.3	2.3	0.3	6.6	0.4	0.3	0.1	0.3	0.4	0.5	0.4	0.3	0.3	1.0	0.3	0.4	0.5	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.2	0.2	8.5	2.4	6.6	3.9	2.9	6.6	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VWCE	"FLJ32009, URG11, VWC1"	ENSG00000167992	"Von Willebrand factor C and EGF domains"	Q96DN2	11	61258286-61295424	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.8;ovary: 10.7"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 27.5;Hepatocytes: 14.0;Rod photoreceptor cells: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.7;Hep G2: 19.3;HSkMC: 11.4;REH: 10.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA040401, HPA043921"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		1300000	Nucleoplasm	"Vesicles, Cytosol"	"HPA040401: AB_2676963, HPA043921: AB_2678731"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-3)"	"unprognostic (9.27e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.58e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-1)"	2.9	1.1	0.9	0.6	1.3	2.3	3.1	0.7	1.3	2.8	1.0	1.4	3.4	0.5	1.4	2.9	1.5	5.7	1.4	1.0	1.3	1.2	0.6	19.8	0.8	0.3	0.4	1.1	10.7	0.1	0.5	0.5	9.1	0.3	1.8	0.6	1.3	1.7	1.0	1.9	0.9	1.1	1.2	0.2	0.9	0.3	1.8	0.5	6.5	0.8	1.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.2	1.1	0.4	0.2	1.8	0.0	0.3	5.7	0.0	0.3	0.0	0.4	0.1	0.0	2.0	0.0	0.1	0.4	0.0	0.5	0.0	19.3	1.1	0.0	0.1	11.4	0.5	0.5	0.0	0.1	1.8	2.6	0.2	0.3	0.3	0.1	4.2	0.0	1.6	0.0	0.0	10.9	0.1	0.0	0.1	0.1	0.4	0.9	0.0	0.1	0.6	2.0	0.7	0.0	0.5	0.2	0.3	0.5	0.1	0.2	0.4	0.9	0.8	0.2	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.7	1.3	1.3	1.2	0.4	1.1	0.3	0.5	3.0	1.7	0.0	1.5	1.5	3.2	0.7	0.0	5.3	2.3	0.0	27.5	0.9	0.0	0.1	0.4	2.2	0.0	0.0	0.4	2.2	1.4	0.4	3.5	14.0	1.1	0.0	1.7	3.1	4.0	0.0	6.4	2.2	1.7	1.8	0.0	3.2	0.0	0.0	1.8	0.3	17.1	0.0	0.5	0.9	3.0	1.9	3.7	0.5	0.1	0.7
VWDE	FLJ14712	ENSG00000146530	"Von Willebrand factor D and EGF domains"	Q8N2E2	7	12330885-12403941	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 29.5"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 1.7;Cardiomyocytes: 4.7;Ciliated cells: 1.4;Glandular cells: 2.2;Urothelial cells: 1.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 10.8;NTERA-2: 5.4;SCLC-21H: 8.7"					"Low region specificity"	"Detected in many"			"HPA026619, HPA036044"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Cytosol	Nucleoplasm	"HPA026619: AB_2671920, HPA036044: AB_2674916"	"unprognostic (6.39e-2)"	"unprognostic (1.65e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.78e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.73e-1)"	0.4	0.5	1.6	0.3	2.7	2.3	2.3	0.4	2.3	0.8	0.9	0.0	0.9	0.2	0.7	4.9	0.8	1.5	0.7	4.1	0.8	0.5	0.7	0.5	0.7	0.2	0.4	0.5	0.5	0.9	0.0	29.5	0.3	0.5	1.5	0.3	0.1	5.7	5.5	0.4	0.6	0.6	0.2	0.4	0.5	2.0	0.6	0.0	0.1	6.2	0.0	1.3	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	0.5	0.0	0.3	1.8	0.0	2.1	0.7	0.8	0.4	3.0	0.2	0.0	0.0	0.7	0.4	2.1	2.0	0.6	4.0	2.2	3.5	4.8	0.0	0.0	1.1	2.4	0.1	0.3	0.0	1.2	2.7	0.8	1.2	10.8	0.0	0.0	1.2	0.0	0.0	5.4	0.0	0.6	0.0	0.0	1.6	0.0	1.3	8.7	1.4	0.0	1.7	0.0	1.4	0.0	1.1	0.1	0.0	1.0	0.0	0.9	3.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.9	0.1	1.6	2.7	0.4	2.3	0.8	0.5	0.4	0.5	0.5	0.0	0.0	1.0	0.0	1.7	0.2	0.0	4.7	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.2	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.4	1.6
WFDC12	"C20orf122, dJ211D12.4, WAP2"	ENSG00000168703	"WAP four-disulfide core domain 12"	Q8WWY7	20	45123425-45124465	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 26.9;skin 1: 30.5"	"Cell type enhanced"	"Detected in some"	33	"Alveolar cells type 2: 1.6;Collecting duct cells: 5.2"	"Group enriched"	"Detected in many"	7	"head and neck cancer: 18.9;melanoma: 14.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"																"Secreted - unknown location"	NA	NA		20000					"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.18e-2)"		"unprognostic (5.42e-2)"		"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (8.70e-3)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (4.49e-2)"		"unprognostic (3.91e-1)"	"unprognostic (5.50e-3)"	0.1	0.0	0.1	0.1	0.1	0.5	1.9	0.1	0.1	1.5	0.1	0.1	26.9	0.2	0.1	1.2	6.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	3.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	1.3	0.0	0.1	1.8	4.1	0.2	30.5	0.1	0.1	0.1	0.1	0.0	1.0	0.1	2.2	0.1	6.4	0.9	0.1	10.0	0.8	0.3	0.9	0.4	0.0	1.1	0.0	0.9	0.6	0.3	0.6	3.5	0.4	1.3	0.3	1.8	0.2	1.6	0.6	0.4	0.9	0.3	0.4	0.7	0.6	0.3	0.9	2.3	1.5	0.0	0.0	1.1	1.3	1.4	0.0	1.3	0.0	0.3	1.4	0.9	1.5	1.1	0.6	0.9	1.2	1.1	0.4	0.4	1.3	1.7	1.5	0.4	0.3	2.0	0.4	2.1	0.6	0.0	0.2	0.0	1.0	0.0	1.0	0.6	2.6	0.0	0.2	0.4	1.2	1.2	1.4	1.3	1.3	0.9	3.2	0.6	0.1	0.4	0.9	0.1	0.4	1.1	0.3	0.1	0.2	0.1	0.8	0.4	0.3	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0